[ { "id": "source-00a6bd341ccbdbed2f4fc791", "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-15", "first_observed_at": "2026-10-12T19:24:10Z", "last_observed_at": "2026-10-12T19:24:10Z", "sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "format": "docx", "archive_key": "documents/b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752564703\"", "last_modified": "Tue, 15 Jul 2025 07:31:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3028, "changed_paragraphs": 99, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-013d20105a4b3b4c74c2d78b", "medicine_id": "EMEA/H/C/003981", "medicine_name": "Duloxetine Viatris (previously Duloxetine Mylan)", "medicine_slug": "duloxetine-viatris-previously-duloxetine-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/duloxetine-viatris-previously-duloxetine-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-15", "first_observed_at": "2026-10-12T19:05:27Z", "last_observed_at": "2026-10-12T19:05:27Z", "sha256": "367855ac0546054cc8272bc29520f2bf88d4319351112d47f14d7122f468db47", "format": "docx", "archive_key": "documents/367855ac0546054cc8272bc29520f2bf88d4319351112d47f14d7122f468db47.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760546267\"", "last_modified": "Wed, 15 Oct 2025 16:37:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2604, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-014fa68ffdad12cbe954d7a0", "medicine_id": "EMEA/H/C/002392", "medicine_name": "Eylea", "medicine_slug": "eylea", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eylea-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-04", "first_observed_at": "2026-10-12T13:53:34Z", "last_observed_at": "2026-10-12T13:53:34Z", "sha256": "03af134f054b3ca76ba18d4f6a4abf435a8c4a406ec9f00e730c3cd5cb244178", "format": "docx", "archive_key": "documents/03af134f054b3ca76ba18d4f6a4abf435a8c4a406ec9f00e730c3cd5cb244178.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772639094\"", "last_modified": "Wed, 04 Mar 2026 15:44:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7300, "changed_paragraphs": 356, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-01b7f43e80477af34b4fefc8", "medicine_id": "EMEA/H/C/005620", "medicine_name": "Mounjaro", "medicine_slug": "mounjaro", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/mounjaro-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-28", "first_observed_at": "2026-10-12T13:28:06Z", "last_observed_at": "2026-10-12T13:28:06Z", "sha256": "470db95d123b9f78106930042213a4fee5069aad9d085576ece30d2f5acffc35", "format": "docx", "archive_key": "documents/470db95d123b9f78106930042213a4fee5069aad9d085576ece30d2f5acffc35.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787922263\"", "last_modified": "Fri, 28 Aug 2026 13:04:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 10163, "changed_paragraphs": 83, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-021cd364629616c7e21a924d", "medicine_id": "EMEA/H/C/000717", "medicine_name": "Revlimid", "medicine_slug": "revlimid", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/revlimid-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:57Z", "last_observed_at": "2026-10-12T19:29:57Z", "sha256": "94529922a4f5049c4aa605847cb25208bea7e5a83a59f86fd84cc98c3c0e4e42", "format": "docx", "archive_key": "documents/94529922a4f5049c4aa605847cb25208bea7e5a83a59f86fd84cc98c3c0e4e42.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752155365\"", "last_modified": "Thu, 10 Jul 2025 13:49:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4744, "changed_paragraphs": 137, "unassigned_changed_paragraphs": 9 }, "pipeline_version": "2.0.0" }, { "id": "source-02db9a2d07edc83e7f89de6c", "medicine_id": "EMEA/H/C/005725", "medicine_name": "Vydura", "medicine_slug": "vydura", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vydura-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-26", "first_observed_at": "2026-10-12T19:01:02Z", "last_observed_at": "2026-10-12T19:01:02Z", "sha256": "25c3e80252b13576cb073c97a25c911b4ab42a67eff1b17d757fcc70261fcd73", "format": "docx", "archive_key": "documents/25c3e80252b13576cb073c97a25c911b4ab42a67eff1b17d757fcc70261fcd73.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772095515\"", "last_modified": "Thu, 26 Feb 2026 08:45:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1180, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-02fe3532c3f411ab8d701451", "medicine_id": "EMEA/H/C/000284", "medicine_name": "Lantus", "medicine_slug": "lantus", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lantus-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-05", "first_observed_at": "2026-10-12T13:53:15Z", "last_observed_at": "2026-10-12T13:53:15Z", "sha256": "195f6b1c1a12dbe37a56050c2db9cf95be56388a1aae81d0b8eab22469f06bef", "format": "docx", "archive_key": "documents/195f6b1c1a12dbe37a56050c2db9cf95be56388a1aae81d0b8eab22469f06bef.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772719645\"", "last_modified": "Thu, 05 Mar 2026 14:07:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2920, "changed_paragraphs": 43, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-031f90cd07def6d808f3a292", "medicine_id": "EMEA/H/C/005286", "medicine_name": "Alymsys", "medicine_slug": "alymsys", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/alymsys-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-06", "first_observed_at": "2026-10-12T19:02:07Z", "last_observed_at": "2026-10-12T19:02:07Z", "sha256": "8fef19b3e09caee6abcedaa762e16d4b3139843cc8ce41d68d572a4c2413df8b", "format": "docx", "archive_key": "documents/8fef19b3e09caee6abcedaa762e16d4b3139843cc8ce41d68d572a4c2413df8b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770388988\"", "last_modified": "Fri, 06 Feb 2026 14:43:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3290, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-0377a0f374da46618f13df9c", "medicine_id": "EMEA/H/C/002751", "medicine_name": "Anoro Ellipta (previously Anoro)", "medicine_slug": "anoro-ellipta-previously-anoro", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/anoro-ellipta-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-31", "first_observed_at": "2026-10-12T19:18:50Z", "last_observed_at": "2026-10-12T19:18:50Z", "sha256": "83b2fe4c87629e48ee1aefad7454d0f6f254155b73f5f2830247cafb022942ad", "format": "docx", "archive_key": "documents/83b2fe4c87629e48ee1aefad7454d0f6f254155b73f5f2830247cafb022942ad.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753947698\"", "last_modified": "Thu, 31 Jul 2025 07:41:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1759, "changed_paragraphs": 37, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-043b4003f4c66df240947f28", "medicine_id": "EMEA/H/C/000236", "medicine_name": "Ferriprox", "medicine_slug": "ferriprox", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ferriprox-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:47Z", "last_observed_at": "2026-10-12T19:16:47Z", "sha256": "cc461deb7027b3031d2b09d601fe7fec7c79c9f0f3a5864ba1024008d1a91dfa", "format": "docx", "archive_key": "documents/cc461deb7027b3031d2b09d601fe7fec7c79c9f0f3a5864ba1024008d1a91dfa.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755090915\"", "last_modified": "Wed, 13 Aug 2025 13:15:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2606, "changed_paragraphs": 27, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-04bdfb22903389cb41ef914f", "medicine_id": "EMEA/H/C/003780", "medicine_name": "Saxenda", "medicine_slug": "saxenda", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/saxenda-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-27", "first_observed_at": "2026-10-12T19:30:41Z", "last_observed_at": "2026-10-12T19:30:41Z", "sha256": "3485f18bbf0ff2c8137dff0986cf7f61fda9f7b2321dd94ed527f79a163851ba", "format": "docx", "archive_key": "documents/3485f18bbf0ff2c8137dff0986cf7f61fda9f7b2321dd94ed527f79a163851ba.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751021170\"", "last_modified": "Fri, 27 Jun 2025 10:46:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1933, "changed_paragraphs": 32, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-053e9c373eaa3cb19c69ceaf", "medicine_id": "EMEA/H/C/001085", "medicine_name": "Olanzapine Glenmark", "medicine_slug": "olanzapine-glenmark", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olanzapine-glenmark-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:36:54Z", "last_observed_at": "2026-10-12T13:36:54Z", "sha256": "9a695ea3d48dd66879d5bc3c8f9419c0dc3582cbb18dc0366c27c4e7545ae563", "format": "doc", "archive_key": "documents/9a695ea3d48dd66879d5bc3c8f9419c0dc3582cbb18dc0366c27c4e7545ae563.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778248298\"", "last_modified": "Fri, 08 May 2026 13:51:38 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-05a14676da56207ac5e3e5e1", "medicine_id": "EMEA/H/C/004649", "medicine_name": "Fulvestrant Mylan", "medicine_slug": "fulvestrant-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fulvestrant-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:56Z", "last_observed_at": "2026-10-12T13:35:56Z", "sha256": "81510bbbdea324cc17fdb220f717b73a1d45191982b977c410aad9cce989ec66", "format": "docx", "archive_key": "documents/81510bbbdea324cc17fdb220f717b73a1d45191982b977c410aad9cce989ec66.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781261588\"", "last_modified": "Fri, 12 Jun 2026 10:53:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2000, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-05d05546c3017ce91cc126a8", "medicine_id": "EMEA/H/C/000222", "medicine_name": "CoAprovel", "medicine_slug": "coaprovel", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/coaprovel-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:08:08Z", "last_observed_at": "2026-10-12T19:08:08Z", "sha256": "a4c555c549b0cdf54b197a1ab2674b057b1f9f473d42d0605c14fc00948213a5", "format": "docx", "archive_key": "documents/a4c555c549b0cdf54b197a1ab2674b057b1f9f473d42d0605c14fc00948213a5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758800484\"", "last_modified": "Thu, 25 Sep 2025 11:41:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5583, "changed_paragraphs": 88, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-07e7141487926f880234ff5b", "medicine_id": "EMEA/H/C/002681", "medicine_name": "Imatinib Accord", "medicine_slug": "imatinib-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imatinib-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:43:38Z", "last_observed_at": "2026-10-12T19:43:38Z", "sha256": "2c45f2819f1019e2397b4dea4a15a303e7c5736bfb44e2ba348659dd28102c68", "format": "docx", "archive_key": "documents/2c45f2819f1019e2397b4dea4a15a303e7c5736bfb44e2ba348659dd28102c68.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746514978\"", "last_modified": "Tue, 06 May 2025 07:02:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2240, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0820434a2b792587e7ccf425", "medicine_id": "EMEA/H/C/000943", "medicine_name": "Kuvan", "medicine_slug": "kuvan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kuvan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-10-07", "first_observed_at": "2026-10-12T13:27:29Z", "last_observed_at": "2026-10-12T13:27:29Z", "sha256": "1cc71b19252c7d6791acaf96008fec1ee7d69af4ae2fc57db8808fca0caf46b1", "format": "docx", "archive_key": "documents/1cc71b19252c7d6791acaf96008fec1ee7d69af4ae2fc57db8808fca0caf46b1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791382960\"", "last_modified": "Wed, 07 Oct 2026 14:22:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2652, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-08b4eba1f67d2654148f41c4", "medicine_id": "EMEA/H/C/000235", "medicine_name": "Arava", "medicine_slug": "arava", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/arava-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-09-07", "first_observed_at": "2026-10-12T13:27:58Z", "last_observed_at": "2026-10-12T13:27:58Z", "sha256": "2efff7967e2237bf8343431eef5e08b56c2441eb8a691a90c64b2635109fd697", "format": "docx", "archive_key": "documents/2efff7967e2237bf8343431eef5e08b56c2441eb8a691a90c64b2635109fd697.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789028990\"", "last_modified": "Thu, 10 Sep 2026 08:29:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3742, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0981388eec67052119e267e6", "medicine_id": "EMEA/H/C/000722", "medicine_name": "Januvia", "medicine_slug": "januvia", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/januvia-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-10-31", "first_observed_at": "2026-10-12T19:04:07Z", "last_observed_at": "2026-10-12T19:04:07Z", "sha256": "2093926d3da256eeb93bd0b006a5513804eefc58d9bbe876b64ac8896133197d", "format": "doc", "archive_key": "documents/2093926d3da256eeb93bd0b006a5513804eefc58d9bbe876b64ac8896133197d.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761905551\"", "last_modified": "Fri, 31 Oct 2025 10:12:31 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-09c35186fd73b77e66683634", "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:50Z", "last_observed_at": "2026-10-12T19:29:50Z", "sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "format": "docx", "archive_key": "documents/72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752152595\"", "last_modified": "Thu, 10 Jul 2025 13:03:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3296, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0a85e7e2df12437f113dc955", "medicine_id": "EMEA/H/C/002669", "medicine_name": "Voriconazole Accord", "medicine_slug": "voriconazole-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/voriconazole-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-28", "first_observed_at": "2026-10-12T19:20:16Z", "last_observed_at": "2026-10-12T19:20:16Z", "sha256": "49dafb606505f3f9666d1131438c774ecf3f87b1c8b6c82205458305587ec41f", "format": "docx", "archive_key": "documents/49dafb606505f3f9666d1131438c774ecf3f87b1c8b6c82205458305587ec41f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753701596\"", "last_modified": "Mon, 28 Jul 2025 11:19:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2334, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0a9efa4639b121b1b78dabf2", "medicine_id": "EMEA/H/C/004008", "medicine_name": "Aripiprazole Sandoz", "medicine_slug": "aripiprazole-sandoz", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aripiprazole-sandoz-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-13", "first_observed_at": "2026-10-12T13:40:26Z", "last_observed_at": "2026-10-12T13:40:26Z", "sha256": "e22ec2e1091ba644789161695b2abedce706b1188f584dcce10bbbc43adf986a", "format": "docx", "archive_key": "documents/e22ec2e1091ba644789161695b2abedce706b1188f584dcce10bbbc43adf986a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776077574\"", "last_modified": "Mon, 13 Apr 2026 10:52:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2599, "changed_paragraphs": 34, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0ad1d09bc3c4826a86e4a7c3", "medicine_id": "EMEA/H/C/005087", "medicine_name": "Livogiva", "medicine_slug": "livogiva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/livogiva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-10", "first_observed_at": "2026-10-12T17:28:25Z", "last_observed_at": "2026-10-12T17:28:25Z", "sha256": "4f239e765c1a69f35b92251309f6becdcfe1394489bfb3243cad1013ffc7e06f", "format": "docx", "archive_key": "documents/4f239e765c1a69f35b92251309f6becdcfe1394489bfb3243cad1013ffc7e06f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765376667\"", "last_modified": "Wed, 10 Dec 2025 14:24:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1273, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-0aeb883ec0ca39b6789156fb", "medicine_id": "EMEA/H/C/000863", "medicine_name": "Vimpat", "medicine_slug": "vimpat", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vimpat-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-08", "first_observed_at": "2026-10-12T19:42:47Z", "last_observed_at": "2026-10-12T19:42:47Z", "sha256": "4824c6fa62912332691a1239d813c095748ce02c69a1614f02df01d100751ec8", "format": "docx", "archive_key": "documents/4824c6fa62912332691a1239d813c095748ce02c69a1614f02df01d100751ec8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746697904\"", "last_modified": "Thu, 08 May 2025 09:51:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7420, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0b01b48cc469e4f820926f53", "medicine_id": "EMEA/H/C/005481", "medicine_name": "Opdualag", "medicine_slug": "opdualag", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/opdualag-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-24", "first_observed_at": "2026-10-12T19:23:04Z", "last_observed_at": "2026-10-12T19:23:04Z", "sha256": "888fee0d0b48f9ffe57f079b2e605bb527d4d801636da4f5389b810333991027", "format": "docx", "archive_key": "documents/888fee0d0b48f9ffe57f079b2e605bb527d4d801636da4f5389b810333991027.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753362658\"", "last_modified": "Thu, 24 Jul 2025 13:10:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1685, "changed_paragraphs": 44, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-0bb3b88cccd2a76cf24ecbb0", "medicine_id": "EMEA/H/C/000810", "medicine_name": "Olanzapine Teva", "medicine_slug": "olanzapine-teva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olanzapine-teva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:42:15Z", "last_observed_at": "2026-10-12T19:42:15Z", "sha256": "52bc54eaa2a85a1a3d0b428c38fa0c8648645ea67f95307a4293b5fffeb23f76", "format": "docx", "archive_key": "documents/52bc54eaa2a85a1a3d0b428c38fa0c8648645ea67f95307a4293b5fffeb23f76.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747053683\"", "last_modified": "Mon, 12 May 2025 12:41:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4435, "changed_paragraphs": 437, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0c0faddb540a1c60c41a2ccb", "medicine_id": "EMEA/H/C/004984", "medicine_name": "Azacitidine Mylan", "medicine_slug": "azacitidine-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/azacitidine-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:15Z", "last_observed_at": "2026-10-12T13:35:15Z", "sha256": "2dab763f1da8ff3942467e20de6d30b5746ef6030def3da15b9994facca1adaf", "format": "docx", "archive_key": "documents/2dab763f1da8ff3942467e20de6d30b5746ef6030def3da15b9994facca1adaf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781254593\"", "last_modified": "Fri, 12 Jun 2026 08:56:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1453, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0d17b5376a4f52d3b8e8b76f", "medicine_id": "EMEA/H/C/002198", "medicine_name": "Temozolomide Sun", "medicine_slug": "temozolomide-sun", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/temozolomide-sun-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:44Z", "last_observed_at": "2026-10-12T19:29:44Z", "sha256": "4cc634ca64ce202ca7e866bc922bf74257686ac0a57f272ffd129a31516fb277", "format": "doc", "archive_key": "documents/4cc634ca64ce202ca7e866bc922bf74257686ac0a57f272ffd129a31516fb277.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752143889\"", "last_modified": "Thu, 10 Jul 2025 10:38:09 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-0d1e23e42eadd2ff46017745", "medicine_id": "EMEA/H/C/004368", "medicine_name": "Movymia", "medicine_slug": "movymia", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/movymia-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-04-24", "first_observed_at": "2026-10-12T19:45:53Z", "last_observed_at": "2026-10-12T19:45:53Z", "sha256": "fabd50a63d9c3bd1f9754ac7a0d42b419e4dd5eb8acec84164af7dc3c193dd18", "format": "docx", "archive_key": "documents/fabd50a63d9c3bd1f9754ac7a0d42b419e4dd5eb8acec84164af7dc3c193dd18.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1745499267\"", "last_modified": "Thu, 24 Apr 2025 12:54:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1619, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0d296868a063a7fb7eaa3145", "medicine_id": "EMEA/H/C/003960", "medicine_name": "Cotellic", "medicine_slug": "cotellic", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cotellic-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-24", "first_observed_at": "2026-10-12T19:30:44Z", "last_observed_at": "2026-10-12T19:30:44Z", "sha256": "5b62f129f593b5079a0f5e9a47f83933bb019af62d7cc40ee07a9334d281bcf3", "format": "docx", "archive_key": "documents/5b62f129f593b5079a0f5e9a47f83933bb019af62d7cc40ee07a9334d281bcf3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750770591\"", "last_modified": "Tue, 24 Jun 2025 13:09:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1592, "changed_paragraphs": 90, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0d51acfc8eb11f61ad45d09c", "medicine_id": "EMEA/H/C/000778", "medicine_name": "Abraxane", "medicine_slug": "abraxane", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/abraxane-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-21", "first_observed_at": "2026-10-12T17:25:55Z", "last_observed_at": "2026-10-12T17:25:55Z", "sha256": "9a47cfa574514ea59e355a3299e25641bccda38dd04fb02f86cc0a028c7d336b", "format": "docx", "archive_key": "documents/9a47cfa574514ea59e355a3299e25641bccda38dd04fb02f86cc0a028c7d336b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768990882\"", "last_modified": "Wed, 21 Jan 2026 10:21:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2212, "changed_paragraphs": 106, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-0e32690d480d1ba79b9d2279", "medicine_id": "EMEA/H/C/005627", "medicine_name": "Lytgobi", "medicine_slug": "lytgobi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lytgobi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:17Z", "last_observed_at": "2026-10-12T19:04:17Z", "sha256": "922db976cab7c0a4fe7c96676f63aa415ee0fa8a7a0169080312e08fb90df35e", "format": "docx", "archive_key": "documents/922db976cab7c0a4fe7c96676f63aa415ee0fa8a7a0169080312e08fb90df35e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761739859\"", "last_modified": "Wed, 29 Oct 2025 12:10:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1055, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0ea0916f1ee4fe01ea3b5e96", "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-15", "first_observed_at": "2026-10-12T19:24:07Z", "last_observed_at": "2026-10-12T19:24:07Z", "sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "format": "docx", "archive_key": "documents/1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752564703\"", "last_modified": "Tue, 15 Jul 2025 07:31:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2932, "changed_paragraphs": 99, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0f53e750408c4d354e12a866", "medicine_id": "EMEA/H/C/004750", "medicine_name": "Zolgensma", "medicine_slug": "zolgensma", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zolgensma-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:18Z", "last_observed_at": "2026-10-12T13:28:18Z", "sha256": "1350583b1108de12c3ce4c20e0861790539ca7932561da1054d7c9e747778208", "format": "docx", "archive_key": "documents/1350583b1108de12c3ce4c20e0861790539ca7932561da1054d7c9e747778208.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787218693\"", "last_modified": "Thu, 20 Aug 2026 09:38:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1831, "changed_paragraphs": 15, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-0f57674cde87a4ecc5c19b52", "medicine_id": "EMEA/H/C/000209", "medicine_name": "Micardis", "medicine_slug": "micardis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/micardis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:20Z", "last_observed_at": "2026-10-12T13:39:20Z", "sha256": "cefad9d7ec5d6d66fe79529bd05be84d7c77e317562c1da24ab578d51b115291", "format": "docx", "archive_key": "documents/cefad9d7ec5d6d66fe79529bd05be84d7c77e317562c1da24ab578d51b115291.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777383724\"", "last_modified": "Tue, 28 Apr 2026 13:42:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2580, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-101e7d879bec1d833666fb58", "medicine_id": "EMEA/H/C/005391", "medicine_name": "Ogluo", "medicine_slug": "ogluo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ogluo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-16", "first_observed_at": "2026-10-12T19:38:53Z", "last_observed_at": "2026-10-12T19:38:53Z", "sha256": "949f1839a52e6ab95846cfefabd354fd6fff2971580eca6543d48f6625101843", "format": "docx", "archive_key": "documents/949f1839a52e6ab95846cfefabd354fd6fff2971580eca6543d48f6625101843.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747393868\"", "last_modified": "Fri, 16 May 2025 11:11:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2520, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1115e42c797b04c5bb58e8f0", "medicine_id": "EMEA/H/C/000284", "medicine_name": "Lantus", "medicine_slug": "lantus", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lantus-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-03-05", "first_observed_at": "2026-10-12T13:53:19Z", "last_observed_at": "2026-10-12T13:53:19Z", "sha256": "956f75ed65567f6cdc1064f0f9fd3aa120739bf3e3e5e9731791b01055fdab84", "format": "doc", "archive_key": "documents/956f75ed65567f6cdc1064f0f9fd3aa120739bf3e3e5e9731791b01055fdab84.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772719645\"", "last_modified": "Thu, 05 Mar 2026 14:07:25 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-112702cb422c8868fda09ffd", "medicine_id": "EMEA/H/C/004363", "medicine_name": "Trelegy Ellipta", "medicine_slug": "trelegy-ellipta", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trelegy-ellipta-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:38:40Z", "last_observed_at": "2026-10-12T13:38:40Z", "sha256": "0294b56482c18349cad8906f87bbe5fea1c07b54c1e62f4ee4615ab5c518b287", "format": "docx", "archive_key": "documents/0294b56482c18349cad8906f87bbe5fea1c07b54c1e62f4ee4615ab5c518b287.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778247700\"", "last_modified": "Fri, 08 May 2026 13:41:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1787, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-11b725ad337f36a7ee1e46c0", "medicine_id": "EMEA/H/C/006208", "medicine_name": "Apremilast Accord", "medicine_slug": "apremilast-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/apremilast-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:31Z", "last_observed_at": "2026-10-12T13:35:31Z", "sha256": "08c4d3196305b7b0fc9dde2eeb1d81d1bf001562592b1e281d192d8b8fd880b4", "format": "docx", "archive_key": "documents/08c4d3196305b7b0fc9dde2eeb1d81d1bf001562592b1e281d192d8b8fd880b4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781252446\"", "last_modified": "Fri, 12 Jun 2026 08:20:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2496, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-11d0beb027751f1d533d1385", "medicine_id": "EMEA/H/C/004037", "medicine_name": "Amlodipine / Valsartan Mylan", "medicine_slug": "amlodipine-valsartan-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/amlodipine-valsartan-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:38Z", "last_observed_at": "2026-10-12T13:35:38Z", "sha256": "dbb2d241391f1842fbe2af8d495fce7a68c0dd1274b21dbba2b09bd9bc167702", "format": "docx", "archive_key": "documents/dbb2d241391f1842fbe2af8d495fce7a68c0dd1274b21dbba2b09bd9bc167702.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781260486\"", "last_modified": "Fri, 12 Jun 2026 10:34:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2576, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-13055c4d0b296cdc13a6ec25", "medicine_id": "EMEA/H/C/004163", "medicine_name": "Cabometyx", "medicine_slug": "cabometyx", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cabometyx-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:46Z", "last_observed_at": "2026-10-12T19:00:46Z", "sha256": "e20617a9f2c17a1635475cbad30c6f5b591ea6084e6007d17fe2560a4fb05fce", "format": "docx", "archive_key": "documents/e20617a9f2c17a1635475cbad30c6f5b591ea6084e6007d17fe2560a4fb05fce.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772183837\"", "last_modified": "Fri, 27 Feb 2026 09:17:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2453, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 4 }, "pipeline_version": "2.0.0" }, { "id": "source-1382ac6707c86c7cfb6b2fa7", "medicine_id": "EMEA/H/C/004644", "medicine_name": "Prasugrel Viatris (previously Prasugrel Mylan)", "medicine_slug": "prasugrel-viatris-previously-prasugrel-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/prasugrel-viatris-previously-prasugrel-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-26", "first_observed_at": "2026-10-12T19:07:44Z", "last_observed_at": "2026-10-12T19:07:44Z", "sha256": "b02f083dcfc5765a244223ba93e0204544c573c5fca2445bd0c7843877e61264", "format": "docx", "archive_key": "documents/b02f083dcfc5765a244223ba93e0204544c573c5fca2445bd0c7843877e61264.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758895742\"", "last_modified": "Fri, 26 Sep 2025 14:09:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1789, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-13c1b90c4b6ee93c1fd78221", "medicine_id": "EMEA/H/C/002667", "medicine_name": "Zoledronic Acid Accord", "medicine_slug": "zoledronic-acid-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zoledronic-acid-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-24", "first_observed_at": "2026-10-12T19:01:12Z", "last_observed_at": "2026-10-12T19:01:12Z", "sha256": "35b9fc87c29f27c039b7a407461c229b6bbda49b839e33d797e66b6135d66d37", "format": "docx", "archive_key": "documents/35b9fc87c29f27c039b7a407461c229b6bbda49b839e33d797e66b6135d66d37.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771922834\"", "last_modified": "Tue, 24 Feb 2026 08:47:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1417, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-14af0afc8aafe97ec491dde2", "medicine_id": "EMEA/H/C/000306", "medicine_name": "Metalyse", "medicine_slug": "metalyse", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/metalyse-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-27", "first_observed_at": "2026-10-12T17:30:11Z", "last_observed_at": "2026-10-12T17:30:11Z", "sha256": "4460490d9e03b0eefa8f4ba217a5f17c9ea9d2e8df74a9d502b1098ff17e6408", "format": "docx", "archive_key": "documents/4460490d9e03b0eefa8f4ba217a5f17c9ea9d2e8df74a9d502b1098ff17e6408.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764244494\"", "last_modified": "Thu, 27 Nov 2025 11:54:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2658, "changed_paragraphs": 130, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-14ffea35b90ed19d08622ffd", "medicine_id": "EMEA/H/C/002751", "medicine_name": "Anoro Ellipta (previously Anoro)", "medicine_slug": "anoro-ellipta-previously-anoro", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/anoro-ellipta-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-31", "first_observed_at": "2026-10-12T19:17:37Z", "last_observed_at": "2026-10-12T19:17:37Z", "sha256": "7ebba8dd63bd37ec5d24ca7a9a63f2fcc64533b24cc9441412ad0beb523df07f", "format": "docx", "archive_key": "documents/7ebba8dd63bd37ec5d24ca7a9a63f2fcc64533b24cc9441412ad0beb523df07f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753947698\"", "last_modified": "Thu, 31 Jul 2025 07:41:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1739, "changed_paragraphs": 36, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-150d9eaa9739806e2cb84e1e", "medicine_id": "EMEA/H/C/000532", "medicine_name": "Kentera (previously Oxybutynin Nicobrand)", "medicine_slug": "kentera-previously-oxybutynin-nicobrand", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kentera-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-04-08", "first_observed_at": "2026-10-12T19:46:34Z", "last_observed_at": "2026-10-12T19:46:34Z", "sha256": "88edb51c682d53ba47bf039e4d9e9be74f57fd30eaffc5b58dec05e440cedfa1", "format": "docx", "archive_key": "documents/88edb51c682d53ba47bf039e4d9e9be74f57fd30eaffc5b58dec05e440cedfa1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1744112391\"", "last_modified": "Tue, 08 Apr 2025 11:39:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1356, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-152ac567a5f4fe2e6717ec74", "medicine_id": "EMEA/H/C/005984", "medicine_name": "Tocilizumab STADA (previously Tofidence)", "medicine_slug": "tocilizumab-stada-previously-tofidence", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tocilizumab-stada-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-20", "first_observed_at": "2026-10-12T17:26:01Z", "last_observed_at": "2026-10-12T17:26:01Z", "sha256": "166002fb92b5521ba07ad6fe610d3bee67062afbdf0f0b85b848043e72e44b61", "format": "docx", "archive_key": "documents/166002fb92b5521ba07ad6fe610d3bee67062afbdf0f0b85b848043e72e44b61.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768900643\"", "last_modified": "Tue, 20 Jan 2026 09:17:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2685, "changed_paragraphs": 91, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-15791f384b9e49792c9776dd", "medicine_id": "EMEA/H/C/002514", "medicine_name": "Aubagio", "medicine_slug": "aubagio", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aubagio-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-09", "first_observed_at": "2026-10-12T17:28:37Z", "last_observed_at": "2026-10-12T17:28:37Z", "sha256": "2583b2915ecedeb3bccc3ac6bea691e65d05f5e437bf8aa7970917b6fdeb700c", "format": "docx", "archive_key": "documents/2583b2915ecedeb3bccc3ac6bea691e65d05f5e437bf8aa7970917b6fdeb700c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765271903\"", "last_modified": "Tue, 09 Dec 2025 09:18:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2095, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-15b8b5681aba542ec1668c0b", "medicine_id": "EMEA/H/C/000980", "medicine_name": "Samsca", "medicine_slug": "samsca", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/samsca-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:23Z", "last_observed_at": "2026-10-12T13:28:23Z", "sha256": "b92d73a758b8976c4438a072d544f0d6c603112c90dfc9c084d362ce62419257", "format": "docx", "archive_key": "documents/b92d73a758b8976c4438a072d544f0d6c603112c90dfc9c084d362ce62419257.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787214364\"", "last_modified": "Thu, 20 Aug 2026 08:26:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1389, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1607aba3bbfc30952f3ddeca", "medicine_id": "EMEA/H/C/000089", "medicine_name": "Caelyx pegylated liposomal", "medicine_slug": "caelyx-pegylated-liposomal", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/caelyx-pegylated-liposomal-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-04-24", "first_observed_at": "2026-10-12T13:39:26Z", "last_observed_at": "2026-10-12T13:39:26Z", "sha256": "123453896ff68209a68f7b0565f1945886e81250e83ecd5b4cf1c17b8e245af1", "format": "doc", "archive_key": "documents/123453896ff68209a68f7b0565f1945886e81250e83ecd5b4cf1c17b8e245af1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777022203\"", "last_modified": "Fri, 24 Apr 2026 09:16:43 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-16253f9b4da5fbf06c04c7d0", "medicine_id": "EMEA/H/C/001046", "medicine_name": "Tepadina", "medicine_slug": "tepadina", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tepadina-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:03Z", "last_observed_at": "2026-10-12T19:06:03Z", "sha256": "4721504163a0ab5d0a4c8fb87f19b5756cc2e933f45bad0cd7861c410d97638c", "format": "docx", "archive_key": "documents/4721504163a0ab5d0a4c8fb87f19b5756cc2e933f45bad0cd7861c410d97638c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759826438\"", "last_modified": "Tue, 07 Oct 2025 08:40:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4877, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-162d8660e457429c79a228a3", "medicine_id": "EMEA/H/C/005391", "medicine_name": "Ogluo", "medicine_slug": "ogluo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ogluo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-16", "first_observed_at": "2026-10-12T19:38:43Z", "last_observed_at": "2026-10-12T19:38:43Z", "sha256": "e3198996c834019f9bd40b66034763b6bfa09c6ec3f91ea0b5095a8e7b76928f", "format": "docx", "archive_key": "documents/e3198996c834019f9bd40b66034763b6bfa09c6ec3f91ea0b5095a8e7b76928f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747393868\"", "last_modified": "Fri, 16 May 2025 11:11:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2585, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-16844de7fae5730522c6b454", "medicine_id": "EMEA/H/C/005898", "medicine_name": "Orserdu", "medicine_slug": "orserdu", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orserdu-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:41Z", "last_observed_at": "2026-10-12T13:46:41Z", "sha256": "0ba6ab59e906b970d09c856e23aa1a51c102a58fa8e1b1b1a21e7903b03fa5d0", "format": "docx", "archive_key": "documents/0ba6ab59e906b970d09c856e23aa1a51c102a58fa8e1b1b1a21e7903b03fa5d0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774450440\"", "last_modified": "Wed, 25 Mar 2026 14:54:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1188, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-168b6adf1ea9341ee37bf9e1", "medicine_id": "EMEA/H/C/004062", "medicine_name": "Entresto", "medicine_slug": "entresto", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/entresto-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-13", "first_observed_at": "2026-10-12T17:27:03Z", "last_observed_at": "2026-10-12T17:27:03Z", "sha256": "4bfd681659db0cf67d645318cb42517f4e2f4569cf33d9b01beb4ef5349e099b", "format": "docx", "archive_key": "documents/4bfd681659db0cf67d645318cb42517f4e2f4569cf33d9b01beb4ef5349e099b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768296035\"", "last_modified": "Tue, 13 Jan 2026 09:20:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3672, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-16926b79cbe5726d98017dda", "medicine_id": "EMEA/H/C/005005", "medicine_name": "Posaconazole Accord", "medicine_slug": "posaconazole-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/posaconazole-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:44:20Z", "last_observed_at": "2026-10-12T19:44:20Z", "sha256": "7460f306eac78327fd790283309041cbc0c325a23f123688fb6948c8015b6b82", "format": "docx", "archive_key": "documents/7460f306eac78327fd790283309041cbc0c325a23f123688fb6948c8015b6b82.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746515591\"", "last_modified": "Tue, 06 May 2025 07:13:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1606, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-16be7443e0003eb06e227549", "medicine_id": "EMEA/H/C/002695", "medicine_name": "Iclusig", "medicine_slug": "iclusig", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/iclusig-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-31", "first_observed_at": "2026-10-12T13:29:32Z", "last_observed_at": "2026-10-12T13:29:32Z", "sha256": "6ca9b28e67ca4d8dab03a0411596e2f49f7b58ac4c2849a51bc8ee47bf5fe155", "format": "docx", "archive_key": "documents/6ca9b28e67ca4d8dab03a0411596e2f49f7b58ac4c2849a51bc8ee47bf5fe155.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785510182\"", "last_modified": "Fri, 31 Jul 2026 15:03:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5364, "changed_paragraphs": 2536, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-17627897b0874bf1160c7372", "medicine_id": "EMEA/H/C/000112", "medicine_name": "Twinrix Adult", "medicine_slug": "twinrix-adult", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/twinrix-adult-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-04", "first_observed_at": "2026-10-12T13:29:23Z", "last_observed_at": "2026-10-12T13:29:23Z", "sha256": "cfad5fb0086c9b5d6a36b454f3f546373def1f56cded73e0652b498d02d68e41", "format": "docx", "archive_key": "documents/cfad5fb0086c9b5d6a36b454f3f546373def1f56cded73e0652b498d02d68e41.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785832884\"", "last_modified": "Tue, 04 Aug 2026 08:41:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1087, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-17f8e97750113c94636e8ed2", "medicine_id": "EMEA/H/C/001058", "medicine_name": "Zyllt", "medicine_slug": "zyllt", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zyllt-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:39:36Z", "last_observed_at": "2026-10-12T19:39:36Z", "sha256": "d0e99840b4fdfb561eb40b1399a565e5cda8adfcb19480f3dc25300bc0bc7d12", "format": "docx", "archive_key": "documents/d0e99840b4fdfb561eb40b1399a565e5cda8adfcb19480f3dc25300bc0bc7d12.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747206084\"", "last_modified": "Wed, 14 May 2025 07:01:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1298, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-18063ce7b055d9d4773a9421", "medicine_id": "EMEA/H/C/005067", "medicine_name": "Atectura Breezhaler", "medicine_slug": "atectura-breezhaler", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/atectura-breezhaler-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-20", "first_observed_at": "2026-10-12T17:31:04Z", "last_observed_at": "2026-10-12T17:31:04Z", "sha256": "4c80a98be9be1396fc5992c7f178fc47319e94953ae2dde37f50416b41668042", "format": "docx", "archive_key": "documents/4c80a98be9be1396fc5992c7f178fc47319e94953ae2dde37f50416b41668042.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763636991\"", "last_modified": "Thu, 20 Nov 2025 11:09:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2805, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-18665792536f9c0be526f0f6", "medicine_id": "EMEA/H/C/005312", "medicine_name": "Cegfila (previously Pegfilgrastim Mundipharma)", "medicine_slug": "cegfila-previously-pegfilgrastim-mundipharma", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cegfila-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:47:32Z", "last_observed_at": "2026-10-12T13:47:32Z", "sha256": "c817faef7d8a8650791b2eccc0afc9d687d22a4e3719cd73f9304a216d33baa6", "format": "docx", "archive_key": "documents/c817faef7d8a8650791b2eccc0afc9d687d22a4e3719cd73f9304a216d33baa6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773820583\"", "last_modified": "Wed, 18 Mar 2026 07:56:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1504, "changed_paragraphs": 126, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-195756913629ec5e8a28f5e1", "medicine_id": "EMEA/H/C/002649", "medicine_name": "Invokana", "medicine_slug": "invokana", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/invokana-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:27:36Z", "last_observed_at": "2026-10-12T17:27:36Z", "sha256": "5e753bb354983730f0789cadcbccb124df947f5b77daf5d446e1d52f45e8b1fe", "format": "docx", "archive_key": "documents/5e753bb354983730f0789cadcbccb124df947f5b77daf5d446e1d52f45e8b1fe.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766044981\"", "last_modified": "Thu, 18 Dec 2025 08:03:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2159, "changed_paragraphs": 89, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1b6beccd35df03f141828236", "medicine_id": "EMEA/H/C/004363", "medicine_name": "Trelegy Ellipta", "medicine_slug": "trelegy-ellipta", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/trelegy-ellipta-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:38:42Z", "last_observed_at": "2026-10-12T13:38:42Z", "sha256": "a9f1d1d6919f0a44d696093c8975d807ec0428c4fece680a70c4b87fc6c20c2e", "format": "docx", "archive_key": "documents/a9f1d1d6919f0a44d696093c8975d807ec0428c4fece680a70c4b87fc6c20c2e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778247701\"", "last_modified": "Fri, 08 May 2026 13:41:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1774, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1be3b6ad5f4c8e163318476e", "medicine_id": "EMEA/H/C/005476", "medicine_name": "Lyfnua", "medicine_slug": "lyfnua", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lyfnua-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-08", "first_observed_at": "2026-10-12T17:28:56Z", "last_observed_at": "2026-10-12T17:28:56Z", "sha256": "aedf5c688f9b78678eef422571efcc10d4051f096deb9ed7af738f549eec50db", "format": "docx", "archive_key": "documents/aedf5c688f9b78678eef422571efcc10d4051f096deb9ed7af738f549eec50db.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765183320\"", "last_modified": "Mon, 08 Dec 2025 08:42:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1271, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1c63d4f729cc3118fafd2887", "medicine_id": "EMEA/H/C/002409", "medicine_name": "Zelboraf", "medicine_slug": "zelboraf", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zelboraf-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-19", "first_observed_at": "2026-10-12T19:30:58Z", "last_observed_at": "2026-10-12T19:30:58Z", "sha256": "d2c1ed89892b30b6f19c5fc01ea5297bc80b99c29d18597350ba0b58af7a4868", "format": "docx", "archive_key": "documents/d2c1ed89892b30b6f19c5fc01ea5297bc80b99c29d18597350ba0b58af7a4868.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750334405\"", "last_modified": "Thu, 19 Jun 2025 12:00:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1635, "changed_paragraphs": 98, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1cc04a821f3df200ac0d4960", "medicine_id": "EMEA/H/C/000435", "medicine_name": "Zavesca", "medicine_slug": "zavesca", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zavesca-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-09", "first_observed_at": "2026-10-12T13:33:27Z", "last_observed_at": "2026-10-12T13:33:27Z", "sha256": "79981cf216cff03f1db847c7841373090598730eb504c6545b181f1a24577744", "format": "docx", "archive_key": "documents/79981cf216cff03f1db847c7841373090598730eb504c6545b181f1a24577744.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783603009\"", "last_modified": "Thu, 09 Jul 2026 13:16:49 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1031, "changed_paragraphs": 150, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1d08df56b69f3a568c16d538", "medicine_id": "EMEA/H/C/005454", "medicine_name": "Rybrevant", "medicine_slug": "rybrevant", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rybrevant-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:15Z", "last_observed_at": "2026-10-12T19:04:15Z", "sha256": "3ef9bd56fbe6c15ccababe40c1535aea96b8b8199d25d4af26558d1c455a58dd", "format": "docx", "archive_key": "documents/3ef9bd56fbe6c15ccababe40c1535aea96b8b8199d25d4af26558d1c455a58dd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761737119\"", "last_modified": "Wed, 29 Oct 2025 11:25:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3830, "changed_paragraphs": 22, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1d32e09ff639753d8484c2db", "medicine_id": "EMEA/H/C/005868", "medicine_name": "Vyloy", "medicine_slug": "vyloy", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyloy-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-01", "first_observed_at": "2026-10-12T19:17:07Z", "last_observed_at": "2026-10-12T19:17:07Z", "sha256": "030142b08cdcff67c9fd688c1defcba579b26d0648c5333886f20db276d1a867", "format": "docx", "archive_key": "documents/030142b08cdcff67c9fd688c1defcba579b26d0648c5333886f20db276d1a867.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754044774\"", "last_modified": "Fri, 01 Aug 2025 10:39:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1280, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1da886f479e0d9ae42b86f77", "medicine_id": "EMEA/H/C/000549", "medicine_name": "Pedea", "medicine_slug": "pedea", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pedea-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-25", "first_observed_at": "2026-10-12T17:30:15Z", "last_observed_at": "2026-10-12T17:30:15Z", "sha256": "1b0ae9decebab370100622495823d25b927417291dd97be35e9a7f3d03b76c5e", "format": "docx", "archive_key": "documents/1b0ae9decebab370100622495823d25b927417291dd97be35e9a7f3d03b76c5e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764061985\"", "last_modified": "Tue, 25 Nov 2025 09:13:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 925, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1e1e567efddae34509b5de34", "medicine_id": "EMEA/H/C/005352", "medicine_name": "Upstaza", "medicine_slug": "upstaza", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/upstaza-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-10", "first_observed_at": "2026-10-12T13:36:09Z", "last_observed_at": "2026-10-12T13:36:09Z", "sha256": "42d7861913c7c415a9acf1067eeb3f9f1287a4e4718affc1402af95754bd6fed", "format": "docx", "archive_key": "documents/42d7861913c7c415a9acf1067eeb3f9f1287a4e4718affc1402af95754bd6fed.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781076326\"", "last_modified": "Wed, 10 Jun 2026 07:25:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1101, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1eab2dd77b34f4c6fe6e82df", "medicine_id": "EMEA/H/C/000403", "medicine_name": "Arixtra", "medicine_slug": "arixtra", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/arixtra-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-07", "first_observed_at": "2026-10-12T13:38:45Z", "last_observed_at": "2026-10-12T13:38:45Z", "sha256": "d627c7ab3c0e2e04ec110e8a99901c16a8eb257c9c55138e1bd3875249a20bde", "format": "docx", "archive_key": "documents/d627c7ab3c0e2e04ec110e8a99901c16a8eb257c9c55138e1bd3875249a20bde.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778161333\"", "last_modified": "Thu, 07 May 2026 13:42:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4396, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-1eb1a3d7033ffda6f5770c03", "medicine_id": "EMEA/H/C/000727", "medicine_name": "Abseamed", "medicine_slug": "abseamed", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abseamed-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:28:15Z", "last_observed_at": "2026-10-12T19:28:15Z", "sha256": "7564a5273cfc8d20f902ad1df46070a33fa2e4aace544f81f02238b2e84b6dca", "format": "docx", "archive_key": "documents/7564a5273cfc8d20f902ad1df46070a33fa2e4aace544f81f02238b2e84b6dca.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752235164\"", "last_modified": "Fri, 11 Jul 2025 11:59:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3480, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1ef57638e1a307f1e5437651", "medicine_id": "EMEA/H/C/000619", "medicine_name": "Fosavance", "medicine_slug": "fosavance", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fosavance-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-12", "first_observed_at": "2026-10-12T19:01:49Z", "last_observed_at": "2026-10-12T19:01:49Z", "sha256": "97e93ccf75e837b32026ca36c34d5c78008211a75d5ef225c47e7b94a0027ab2", "format": "docx", "archive_key": "documents/97e93ccf75e837b32026ca36c34d5c78008211a75d5ef225c47e7b94a0027ab2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770891002\"", "last_modified": "Thu, 12 Feb 2026 10:10:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1339, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1f0c69f5bea684bae12db8c2", "medicine_id": "EMEA/H/C/005553", "medicine_name": "Aspaveli", "medicine_slug": "aspaveli", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aspaveli-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-10", "first_observed_at": "2026-10-12T19:03:46Z", "last_observed_at": "2026-10-12T19:03:46Z", "sha256": "86f4a87b61227842d3e9445141875f8d32664723dce946b7cdbb8f13dd93512e", "format": "docx", "archive_key": "documents/86f4a87b61227842d3e9445141875f8d32664723dce946b7cdbb8f13dd93512e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762774187\"", "last_modified": "Mon, 10 Nov 2025 11:29:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1789, "changed_paragraphs": 60, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-1fda25b331eb198b8b93feb3", "medicine_id": "EMEA/H/C/000554", "medicine_name": "Emselex", "medicine_slug": "emselex", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/emselex-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-15", "first_observed_at": "2026-10-12T19:12:04Z", "last_observed_at": "2026-10-12T19:12:04Z", "sha256": "4f2565612bc728ec67b7f9c0cd5799ef2c594911c76f323aef8bf6a85adde245", "format": "docx", "archive_key": "documents/4f2565612bc728ec67b7f9c0cd5799ef2c594911c76f323aef8bf6a85adde245.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757948480\"", "last_modified": "Mon, 15 Sep 2025 15:01:20 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2093, "changed_paragraphs": 47, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-20848bc694f80e54e12acbbe", "medicine_id": "EMEA/H/C/000943", "medicine_name": "Kuvan", "medicine_slug": "kuvan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kuvan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-10-07", "first_observed_at": "2026-10-12T13:27:30Z", "last_observed_at": "2026-10-12T13:27:30Z", "sha256": "cb49bf7246b5a91a36696e5747d9484abf0983e384c054ccf4a404dde191682f", "format": "docx", "archive_key": "documents/cb49bf7246b5a91a36696e5747d9484abf0983e384c054ccf4a404dde191682f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791382961\"", "last_modified": "Wed, 07 Oct 2026 14:22:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2628, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2125a3aad9630138398a9468", "medicine_id": "EMEA/H/C/000717", "medicine_name": "Revlimid", "medicine_slug": "revlimid", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/revlimid-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:54Z", "last_observed_at": "2026-10-12T19:29:54Z", "sha256": "276ea93100d5a4dfdad67b04cdb787ef956a8cf71e36b5e9df2e29166b273428", "format": "docx", "archive_key": "documents/276ea93100d5a4dfdad67b04cdb787ef956a8cf71e36b5e9df2e29166b273428.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752155365\"", "last_modified": "Thu, 10 Jul 2025 13:49:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4701, "changed_paragraphs": 127, "unassigned_changed_paragraphs": 9 }, "pipeline_version": "2.0.0" }, { "id": "source-215e5fbd703aae1bfb8b7f8b", "medicine_id": "EMEA/H/C/002154", "medicine_name": "Esbriet", "medicine_slug": "esbriet", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/esbriet-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-10", "first_observed_at": "2026-10-12T13:33:23Z", "last_observed_at": "2026-10-12T13:33:23Z", "sha256": "1c94f76794606f5da8bba59cce7aac025c02e0b7db8cbfb575d178ac07899bde", "format": "docx", "archive_key": "documents/1c94f76794606f5da8bba59cce7aac025c02e0b7db8cbfb575d178ac07899bde.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783689264\"", "last_modified": "Fri, 10 Jul 2026 13:14:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2678, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-21d50f23fabc205dafb30654", "medicine_id": "EMEA/H/C/006156", "medicine_name": "Stoboclo", "medicine_slug": "stoboclo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/stoboclo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:45Z", "last_observed_at": "2026-10-12T19:08:45Z", "sha256": "e0001db1d3c6b508fa269c3573cfe47a0de6261319a8651cee96a5472648b7f3", "format": "docx", "archive_key": "documents/e0001db1d3c6b508fa269c3573cfe47a0de6261319a8651cee96a5472648b7f3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758104458\"", "last_modified": "Wed, 17 Sep 2025 10:20:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1517, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2215bcdf70e2072721bcaa10", "medicine_id": "EMEA/H/C/000829", "medicine_name": "Pradaxa", "medicine_slug": "pradaxa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pradaxa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-24", "first_observed_at": "2026-10-12T17:30:32Z", "last_observed_at": "2026-10-12T17:30:32Z", "sha256": "e5400cd196ce3346b9decf1a229c89494bdc8a4df1bd6779af91c300e4dc3ea2", "format": "docx", "archive_key": "documents/e5400cd196ce3346b9decf1a229c89494bdc8a4df1bd6779af91c300e4dc3ea2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763975201\"", "last_modified": "Mon, 24 Nov 2025 09:06:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 11026, "changed_paragraphs": 15, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-22ca1025dfc29c23d7b323de", "medicine_id": "EMEA/H/C/002022", "medicine_name": "Xaluprine (previously Mercaptopurine Nova Laboratories)", "medicine_slug": "xaluprine-previously-mercaptopurine-nova-laboratories", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xaluprine-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:08:05Z", "last_observed_at": "2026-10-12T19:08:05Z", "sha256": "24d3b15ae521f391e697a4d72930da59f53e4eeefc26a100461fbfa83e960527", "format": "docx", "archive_key": "documents/24d3b15ae521f391e697a4d72930da59f53e4eeefc26a100461fbfa83e960527.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758811624\"", "last_modified": "Thu, 25 Sep 2025 14:47:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1466, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-22f145dc39e28cdd4f0b8742", "medicine_id": "EMEA/H/C/005304", "medicine_name": "Beyfortus", "medicine_slug": "beyfortus", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/beyfortus-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-17", "first_observed_at": "2026-10-12T19:33:09Z", "last_observed_at": "2026-10-12T19:33:09Z", "sha256": "ad65bed7ffacecae704f2e68da399968a96be891d092e2c4fc59253893384acc", "format": "docx", "archive_key": "documents/ad65bed7ffacecae704f2e68da399968a96be891d092e2c4fc59253893384acc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750171336\"", "last_modified": "Tue, 17 Jun 2025 14:42:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1312, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2305a67bd1e393ee340bb8e4", "medicine_id": "EMEA/H/C/001021", "medicine_name": "Adcirca (previously Tadalafil Lilly)", "medicine_slug": "adcirca-previously-tadalafil-lilly", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/adcirca-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:42Z", "last_observed_at": "2026-10-12T19:02:42Z", "sha256": "43438c8e53504a78747a8ff36049250fee294557f3a8b0e3acb80f71ad43ebc0", "format": "docx", "archive_key": "documents/43438c8e53504a78747a8ff36049250fee294557f3a8b0e3acb80f71ad43ebc0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769602270\"", "last_modified": "Wed, 28 Jan 2026 12:11:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2637, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-232735ecebf2ef9fd5dde897", "medicine_id": "EMEA/H/C/005793", "medicine_name": "Teriparatide Sun", "medicine_slug": "teriparatide-sun", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/teriparatide-sun-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-10", "first_observed_at": "2026-10-12T19:05:45Z", "last_observed_at": "2026-10-12T19:05:45Z", "sha256": "5313b2498f0c94c017ef88553e06a1b7ef2cad8ee469210d9e9a5e0dbdb6628e", "format": "docx", "archive_key": "documents/5313b2498f0c94c017ef88553e06a1b7ef2cad8ee469210d9e9a5e0dbdb6628e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760108961\"", "last_modified": "Fri, 10 Oct 2025 15:09:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1295, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2347d5a94b07194fbdc46b4e", "medicine_id": "EMEA/H/C/005793", "medicine_name": "Teriparatide Sun", "medicine_slug": "teriparatide-sun", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/teriparatide-sun-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-10", "first_observed_at": "2026-10-12T19:05:41Z", "last_observed_at": "2026-10-12T19:05:41Z", "sha256": "e990fae050964facd21ce7ae0109adc633aa02622a0c275b8a736f4a8c13cd01", "format": "docx", "archive_key": "documents/e990fae050964facd21ce7ae0109adc633aa02622a0c275b8a736f4a8c13cd01.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760108961\"", "last_modified": "Fri, 10 Oct 2025 15:09:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1270, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-23d152e59183817e7f7d5979", "medicine_id": "EMEA/H/C/005534", "medicine_name": "Vegzelma", "medicine_slug": "vegzelma", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vegzelma-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-10", "first_observed_at": "2026-10-12T19:12:32Z", "last_observed_at": "2026-10-12T19:12:32Z", "sha256": "3263e644bf0d92eb10294ce387b4b0e75a9c45a13c4a46d814f35977610f4485", "format": "docx", "archive_key": "documents/3263e644bf0d92eb10294ce387b4b0e75a9c45a13c4a46d814f35977610f4485.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757508399\"", "last_modified": "Wed, 10 Sep 2025 12:46:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3278, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-23dab68000941c5c02940193", "medicine_id": "EMEA/H/C/000240", "medicine_name": "Remicade", "medicine_slug": "remicade", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/remicade-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-15", "first_observed_at": "2026-10-12T17:28:19Z", "last_observed_at": "2026-10-12T17:28:19Z", "sha256": "002d6547678d895ae050dda28740f6838b3334c72b2afc437797389b1a8d75fd", "format": "docx", "archive_key": "documents/002d6547678d895ae050dda28740f6838b3334c72b2afc437797389b1a8d75fd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765799231\"", "last_modified": "Mon, 15 Dec 2025 11:47:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2418, "changed_paragraphs": 23, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-246d08888d5f52d006efa07f", "medicine_id": "EMEA/H/C/006469", "medicine_name": "Emtricitabine / Tenofovir alafenamide Viatris", "medicine_slug": "emtricitabine-tenofovir-alafenamide-viatris", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/emtricitabine-tenofovir-alafenamide-viatris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-16", "first_observed_at": "2026-10-12T13:40:14Z", "last_observed_at": "2026-10-12T13:40:14Z", "sha256": "247b89d7ca1efa91cffaeb0f00556dd381d81e804eb2f9c23631d01a49578ea7", "format": "docx", "archive_key": "documents/247b89d7ca1efa91cffaeb0f00556dd381d81e804eb2f9c23631d01a49578ea7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776339002\"", "last_modified": "Thu, 16 Apr 2026 11:30:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2282, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2489204fbae1153eae9875b4", "medicine_id": "EMEA/H/C/005678", "medicine_name": "Sitagliptin / Metformin hydrochloride Mylan", "medicine_slug": "sitagliptin-metformin-hydrochloride-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sitagliptin-metformin-hydrochloride-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-15", "first_observed_at": "2026-10-12T13:34:22Z", "last_observed_at": "2026-10-12T13:34:22Z", "sha256": "9738b169a338a5f07e9d380ee0f61a219838b8e98a6ea420224f9b8d4c15445b", "format": "docx", "archive_key": "documents/9738b169a338a5f07e9d380ee0f61a219838b8e98a6ea420224f9b8d4c15445b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781510292\"", "last_modified": "Mon, 15 Jun 2026 07:58:12 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2413, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-24f493984e89c6eaddb8121b", "medicine_id": "EMEA/H/C/005481", "medicine_name": "Opdualag", "medicine_slug": "opdualag", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/opdualag-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-24", "first_observed_at": "2026-10-12T19:23:01Z", "last_observed_at": "2026-10-12T19:23:01Z", "sha256": "4b2a29868ba38d3a92d75c1c163c32313e9f9cbde636039f4553e2ce3de0c8a9", "format": "docx", "archive_key": "documents/4b2a29868ba38d3a92d75c1c163c32313e9f9cbde636039f4553e2ce3de0c8a9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753362657\"", "last_modified": "Thu, 24 Jul 2025 13:10:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1686, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-25b874486f216b0dbd6ad5f0", "medicine_id": "EMEA/H/C/005824", "medicine_name": "Rystiggo", "medicine_slug": "rystiggo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rystiggo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:41:43Z", "last_observed_at": "2026-10-12T19:41:43Z", "sha256": "a1131c65aebcc24dc8660aa335b12baec0c48f66368a4b486014b57008077c81", "format": "docx", "archive_key": "documents/a1131c65aebcc24dc8660aa335b12baec0c48f66368a4b486014b57008077c81.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747047693\"", "last_modified": "Mon, 12 May 2025 11:01:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1971, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-25c65c76e3261d65c4dc2294", "medicine_id": "EMEA/H/C/004174", "medicine_name": "Ozempic", "medicine_slug": "ozempic", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ozempic-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-30", "first_observed_at": "2026-10-12T19:06:33Z", "last_observed_at": "2026-10-12T19:06:33Z", "sha256": "98ecee7b2491a67a0fff7a3d6876797d86fe5c76334c2444aa8b1b31c0198b96", "format": "docx", "archive_key": "documents/98ecee7b2491a67a0fff7a3d6876797d86fe5c76334c2444aa8b1b31c0198b96.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759231169\"", "last_modified": "Tue, 30 Sep 2025 11:19:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4367, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-26ece7d1cb806d3ad8238dc7", "medicine_id": "EMEA/H/C/004879", "medicine_name": "Amsparity", "medicine_slug": "amsparity", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/amsparity-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-05", "first_observed_at": "2026-10-12T19:15:08Z", "last_observed_at": "2026-10-12T19:15:08Z", "sha256": "ba2d2bebd7522cef09c6d189150f085d43e6510c2f227c0b5975c26e7bd9abd1", "format": "docx", "archive_key": "documents/ba2d2bebd7522cef09c6d189150f085d43e6510c2f227c0b5975c26e7bd9abd1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757079268\"", "last_modified": "Fri, 05 Sep 2025 13:34:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 10707, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-275a21c44e4c091ce5ff0c4d", "medicine_id": "EMEA/H/C/004143", "medicine_name": "Tecentriq", "medicine_slug": "tecentriq", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tecentriq-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:12Z", "last_observed_at": "2026-10-12T13:39:12Z", "sha256": "4d03af56762f7d9410ef220dd9b1e6fb4fdfebb4eb8cac9c908fa6281d5e2b5a", "format": "docx", "archive_key": "documents/4d03af56762f7d9410ef220dd9b1e6fb4fdfebb4eb8cac9c908fa6281d5e2b5a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777370386\"", "last_modified": "Tue, 28 Apr 2026 09:59:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6870, "changed_paragraphs": 43, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2791fc535da292a795b4176e", "medicine_id": "EMEA/H/C/000555", "medicine_name": "Orfadin", "medicine_slug": "orfadin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/orfadin-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-04", "first_observed_at": "2026-10-12T19:30:21Z", "last_observed_at": "2026-10-12T19:30:21Z", "sha256": "b7b9a2d5ecfeab85a4c9cb5e331a674393a38d8254108796684c5afed9c090b3", "format": "docx", "archive_key": "documents/b7b9a2d5ecfeab85a4c9cb5e331a674393a38d8254108796684c5afed9c090b3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751624758\"", "last_modified": "Fri, 04 Jul 2025 10:25:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1894, "changed_paragraphs": 64, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-27cd4c5d901ffff4936dfe84", "medicine_id": "EMEA/H/C/000555", "medicine_name": "Orfadin", "medicine_slug": "orfadin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orfadin-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-04", "first_observed_at": "2026-10-12T19:30:18Z", "last_observed_at": "2026-10-12T19:30:18Z", "sha256": "533dc10df9dc5e7196f7ae7905ac9713dfd2c7e1613a9dcca0737cd53105b807", "format": "docx", "archive_key": "documents/533dc10df9dc5e7196f7ae7905ac9713dfd2c7e1613a9dcca0737cd53105b807.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751624758\"", "last_modified": "Fri, 04 Jul 2025 10:25:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1916, "changed_paragraphs": 64, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-27e01c9d9f02ff9d6796fe48", "medicine_id": "EMEA/H/C/006188", "medicine_name": "Buprenorphine Neuraxpharm", "medicine_slug": "buprenorphine-neuraxpharm", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/buprenorphine-neuraxpharm-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-16", "first_observed_at": "2026-10-12T19:39:03Z", "last_observed_at": "2026-10-12T19:39:03Z", "sha256": "ba3471124a2eb32d4b294de55b522ed52fcd4916a236e260512b067d7985e7ae", "format": "docx", "archive_key": "documents/ba3471124a2eb32d4b294de55b522ed52fcd4916a236e260512b067d7985e7ae.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747395509\"", "last_modified": "Fri, 16 May 2025 11:38:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1416, "changed_paragraphs": 20, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-2839369d2097a7c3abfc6293", "medicine_id": "EMEA/H/C/000165", "medicine_name": "MabThera", "medicine_slug": "mabthera", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/mabthera-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:36Z", "last_observed_at": "2026-10-12T13:28:36Z", "sha256": "e4ba97f70d2d73d6fbeae4c4f1ad4d054a7841f0a2dc4dd921e8dc8ae2ca4dd6", "format": "docx", "archive_key": "documents/e4ba97f70d2d73d6fbeae4c4f1ad4d054a7841f0a2dc4dd921e8dc8ae2ca4dd6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787236174\"", "last_modified": "Thu, 20 Aug 2026 14:29:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6574, "changed_paragraphs": 335, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2864bce7b25be5450f0e0ac7", "medicine_id": "EMEA/H/C/000273", "medicine_name": "Rapamune", "medicine_slug": "rapamune", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rapamune-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-04", "first_observed_at": "2026-10-12T13:39:02Z", "last_observed_at": "2026-10-12T13:39:02Z", "sha256": "1bc6ada5e7d1ea7efaa7d7335dea3defceb38c76db5469ed0119010981160699", "format": "docx", "archive_key": "documents/1bc6ada5e7d1ea7efaa7d7335dea3defceb38c76db5469ed0119010981160699.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780566704\"", "last_modified": "Thu, 04 Jun 2026 09:51:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3065, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2896a486fd70393eb6e33055", "medicine_id": "EMEA/H/C/004049", "medicine_name": "Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan)", "medicine_slug": "tenofovir-disoproxil-viatris-previously-tenofovir-disoproxil-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tenofovir-disoproxil-viatris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-09", "first_observed_at": "2026-10-12T19:12:40Z", "last_observed_at": "2026-10-12T19:12:40Z", "sha256": "c68d80e66f1a35c9bca988c5ff1b63f4fe8e12ea3f11cf3b7be82e45484734e8", "format": "docx", "archive_key": "documents/c68d80e66f1a35c9bca988c5ff1b63f4fe8e12ea3f11cf3b7be82e45484734e8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757406013\"", "last_modified": "Tue, 09 Sep 2025 08:20:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3031, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-28a1371c0011b82ed12f2b58", "medicine_id": "EMEA/H/C/003960", "medicine_name": "Cotellic", "medicine_slug": "cotellic", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cotellic-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-24", "first_observed_at": "2026-10-12T19:30:48Z", "last_observed_at": "2026-10-12T19:30:48Z", "sha256": "66e7b1cf7c3ee91ab58bcb8c7e50be3a43143695117ecffd7f1b81c2539743c7", "format": "docx", "archive_key": "documents/66e7b1cf7c3ee91ab58bcb8c7e50be3a43143695117ecffd7f1b81c2539743c7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750770590\"", "last_modified": "Tue, 24 Jun 2025 13:09:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1541, "changed_paragraphs": 103, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-2924aac36bd07813fcc1891d", "medicine_id": "EMEA/H/C/001120", "medicine_name": "Prolia", "medicine_slug": "prolia", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/prolia-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-19", "first_observed_at": "2026-10-12T13:28:45Z", "last_observed_at": "2026-10-12T13:28:45Z", "sha256": "30e296cc06d303605f266e9544e10515b7e5c2063a0473f5aa3595a42d18a3e1", "format": "docx", "archive_key": "documents/30e296cc06d303605f266e9544e10515b7e5c2063a0473f5aa3595a42d18a3e1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787123425\"", "last_modified": "Wed, 19 Aug 2026 07:10:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1685, "changed_paragraphs": 19, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-295cdd4151b9b44b26c79f80", "medicine_id": "EMEA/H/C/001092", "medicine_name": "Urorec", "medicine_slug": "urorec", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-05-07", "first_observed_at": "2026-10-12T19:42:57Z", "last_observed_at": "2026-10-12T19:42:57Z", "sha256": "6e48f8a6549d0092f09984f312838dcbb5944a7d96148ca020fa6bf3a41a4afb", "format": "doc", "archive_key": "documents/6e48f8a6549d0092f09984f312838dcbb5944a7d96148ca020fa6bf3a41a4afb.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746603767\"", "last_modified": "Wed, 07 May 2025 07:42:47 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-29777a135f0d0c2293ada703", "medicine_id": "EMEA/H/C/000165", "medicine_name": "MabThera", "medicine_slug": "mabthera", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/mabthera-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:31Z", "last_observed_at": "2026-10-12T13:28:31Z", "sha256": "72ea6a5341800cc73f88cbf17dcc381ca03f76b815c0286b1db1afb4b472f9b8", "format": "docx", "archive_key": "documents/72ea6a5341800cc73f88cbf17dcc381ca03f76b815c0286b1db1afb4b472f9b8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787236174\"", "last_modified": "Thu, 20 Aug 2026 14:29:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6710, "changed_paragraphs": 331, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-298e615a279a7d362f4ef9c0", "medicine_id": "EMEA/H/C/002681", "medicine_name": "Imatinib Accord", "medicine_slug": "imatinib-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/imatinib-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:43:48Z", "last_observed_at": "2026-10-12T19:43:48Z", "sha256": "03c516c724532c139269c4e01ffceab51c701aa7bf039c40798036f538e280b9", "format": "docx", "archive_key": "documents/03c516c724532c139269c4e01ffceab51c701aa7bf039c40798036f538e280b9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746514978\"", "last_modified": "Tue, 06 May 2025 07:02:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2188, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2a1a686858d89a82b8a43cd8", "medicine_id": "EMEA/H/C/002790", "medicine_name": "Ongentys", "medicine_slug": "ongentys", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ongentys-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-05-07", "first_observed_at": "2026-10-12T19:43:27Z", "last_observed_at": "2026-10-12T19:43:27Z", "sha256": "7940e57f698499cf700c2ceb70705c2b84b659f6839357f30aaf07b1fcf46dd6", "format": "doc", "archive_key": "documents/7940e57f698499cf700c2ceb70705c2b84b659f6839357f30aaf07b1fcf46dd6.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746614017\"", "last_modified": "Wed, 07 May 2025 10:33:37 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-2a86ec15631906f9ad696319", "medicine_id": "EMEA/H/C/000860", "medicine_name": "Isentress", "medicine_slug": "isentress", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/isentress-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:40:17Z", "last_observed_at": "2026-10-12T19:40:17Z", "sha256": "a9b28f96997592d5d3bf0511219b8131c2418186f0122dff5e1ee14835c7a415", "format": "doc", "archive_key": "documents/a9b28f96997592d5d3bf0511219b8131c2418186f0122dff5e1ee14835c7a415.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747226309\"", "last_modified": "Wed, 14 May 2025 12:38:29 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-2aaca9a7408abe2ee0afc7b7", "medicine_id": "EMEA/H/C/002839", "medicine_name": "Odomzo", "medicine_slug": "odomzo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/odomzo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-17", "first_observed_at": "2026-10-12T19:03:11Z", "last_observed_at": "2026-10-12T19:03:11Z", "sha256": "396511e7c22813f4ab34424913a30b3a4eec94f2680319cf4d29c55f291edaf3", "format": "docx", "archive_key": "documents/396511e7c22813f4ab34424913a30b3a4eec94f2680319cf4d29c55f291edaf3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763390764\"", "last_modified": "Mon, 17 Nov 2025 14:46:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1478, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2b41da16a9267260a223cc8a", "medicine_id": "EMEA/H/C/005534", "medicine_name": "Vegzelma", "medicine_slug": "vegzelma", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vegzelma-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-10", "first_observed_at": "2026-10-12T19:12:36Z", "last_observed_at": "2026-10-12T19:12:36Z", "sha256": "657ea7cb41d06551abbba0545389a9c22545a84f272643eb8f1e2cecd0c28dfa", "format": "docx", "archive_key": "documents/657ea7cb41d06551abbba0545389a9c22545a84f272643eb8f1e2cecd0c28dfa.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757508399\"", "last_modified": "Wed, 10 Sep 2025 12:46:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3337, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2b83429986b00509e2e9753d", "medicine_id": "EMEA/H/C/000089", "medicine_name": "Caelyx pegylated liposomal", "medicine_slug": "caelyx-pegylated-liposomal", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/caelyx-pegylated-liposomal-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-24", "first_observed_at": "2026-10-12T13:39:24Z", "last_observed_at": "2026-10-12T13:39:24Z", "sha256": "105b7194075dd91dfa9b4c53ccb8c5cafcef1398ea9d8e22cee320f1905e9896", "format": "docx", "archive_key": "documents/105b7194075dd91dfa9b4c53ccb8c5cafcef1398ea9d8e22cee320f1905e9896.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777022203\"", "last_modified": "Fri, 24 Apr 2026 09:16:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1854, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 4 }, "pipeline_version": "2.0.0" }, { "id": "source-2beb188d8043a16cadc6b063", "medicine_id": "EMEA/H/C/000274", "medicine_name": "Orgalutran", "medicine_slug": "orgalutran", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orgalutran-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:27:40Z", "last_observed_at": "2026-10-12T17:27:40Z", "sha256": "2e00854f8a03d7707fd57dca828a1e8b789a09a67e92a431058bce5c8e120916", "format": "docx", "archive_key": "documents/2e00854f8a03d7707fd57dca828a1e8b789a09a67e92a431058bce5c8e120916.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766057444\"", "last_modified": "Thu, 18 Dec 2025 11:30:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 936, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2c39c998fdaf05159687c016", "medicine_id": "EMEA/H/C/004325", "medicine_name": "Nyxoid", "medicine_slug": "nyxoid", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nyxoid-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-12", "first_observed_at": "2026-10-12T19:36:33Z", "last_observed_at": "2026-10-12T19:36:33Z", "sha256": "21d66bf1e9a74479f577de09da3cf8517d65c1ce1b1d8bbdfe4bc38f79410def", "format": "docx", "archive_key": "documents/21d66bf1e9a74479f577de09da3cf8517d65c1ce1b1d8bbdfe4bc38f79410def.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749722704\"", "last_modified": "Thu, 12 Jun 2025 10:05:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1096, "changed_paragraphs": 27, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2c73733a62841847142b69c1", "medicine_id": "EMEA/H/C/004076", "medicine_name": "Bortezomib Sun", "medicine_slug": "bortezomib-sun", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/bortezomib-sun-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-10-14", "first_observed_at": "2026-10-12T19:05:34Z", "last_observed_at": "2026-10-12T19:05:34Z", "sha256": "0fea779df7ccbb56f8df404151dba76af078d2484c7b7c7f8f028c2b09decfa6", "format": "doc", "archive_key": "documents/0fea779df7ccbb56f8df404151dba76af078d2484c7b7c7f8f028c2b09decfa6.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760455056\"", "last_modified": "Tue, 14 Oct 2025 15:17:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-2d15c8bbc1703da693775086", "medicine_id": "EMEA/H/C/006196", "medicine_name": "Avtozma", "medicine_slug": "avtozma", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/avtozma-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-24", "first_observed_at": "2026-10-12T19:08:25Z", "last_observed_at": "2026-10-12T19:08:25Z", "sha256": "af06c9bc155d0395dcc161183896ab3d1d2fb2ff66f287d3d066f9db43216f8c", "format": "docx", "archive_key": "documents/af06c9bc155d0395dcc161183896ab3d1d2fb2ff66f287d3d066f9db43216f8c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758704879\"", "last_modified": "Wed, 24 Sep 2025 09:07:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7514, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-2d34a37c349a23ae85f81df9", "medicine_id": "EMEA/H/C/004443", "medicine_name": "Lacosamide Accord", "medicine_slug": "lacosamide-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lacosamide-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-28", "first_observed_at": "2026-10-12T19:37:29Z", "last_observed_at": "2026-10-12T19:37:29Z", "sha256": "cd3a95dc2f796cdb53458047b58cf6dec86ec7f028409ac05a0a03ff71e51db0", "format": "docx", "archive_key": "documents/cd3a95dc2f796cdb53458047b58cf6dec86ec7f028409ac05a0a03ff71e51db0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1748442944\"", "last_modified": "Wed, 28 May 2025 14:35:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4954, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2eb0efd9d974536e9c3b569d", "medicine_id": "EMEA/H/C/004237", "medicine_name": "Xerava", "medicine_slug": "xerava", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xerava-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-06", "first_observed_at": "2026-10-12T19:02:10Z", "last_observed_at": "2026-10-12T19:02:10Z", "sha256": "0ac70f189ae2575038e6766d6395f7552305d851d6cbb5e8983710eb00af91cb", "format": "docx", "archive_key": "documents/0ac70f189ae2575038e6766d6395f7552305d851d6cbb5e8983710eb00af91cb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770366673\"", "last_modified": "Fri, 06 Feb 2026 08:31:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2781, "changed_paragraphs": 296, "unassigned_changed_paragraphs": 51 }, "pipeline_version": "2.0.0" }, { "id": "source-2f83d7242e53112054613097", "medicine_id": "EMEA/H/C/000807", "medicine_name": "Eucreas", "medicine_slug": "eucreas", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eucreas-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-08", "first_observed_at": "2026-10-12T17:28:45Z", "last_observed_at": "2026-10-12T17:28:45Z", "sha256": "479b29fe6a72424faf87a59437db3aac067504aed76852267f19a06af04d9455", "format": "docx", "archive_key": "documents/479b29fe6a72424faf87a59437db3aac067504aed76852267f19a06af04d9455.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764940569\"", "last_modified": "Fri, 05 Dec 2025 13:16:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1846, "changed_paragraphs": 39, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-2f9ae65220663d4e0dbb5c63", "medicine_id": "EMEA/H/C/003791", "medicine_name": "Imbruvica", "medicine_slug": "imbruvica", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/imbruvica-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-27", "first_observed_at": "2026-10-12T19:04:40Z", "last_observed_at": "2026-10-12T19:04:40Z", "sha256": "4b0b32ce32024a965e4ce48fb2cbdea69dafe9803472bdd5e64e2c6b939c8445", "format": "docx", "archive_key": "documents/4b0b32ce32024a965e4ce48fb2cbdea69dafe9803472bdd5e64e2c6b939c8445.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761565941\"", "last_modified": "Mon, 27 Oct 2025 11:52:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6673, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-312c11aae5d59cae975290d1", "medicine_id": "EMEA/H/C/001120", "medicine_name": "Prolia", "medicine_slug": "prolia", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/prolia-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-19", "first_observed_at": "2026-10-12T13:28:42Z", "last_observed_at": "2026-10-12T13:28:42Z", "sha256": "5984d05d5bd9987a8e6f5cf86ff2e5032af0bc8bf5fe7a137a9f36a8466c5b97", "format": "docx", "archive_key": "documents/5984d05d5bd9987a8e6f5cf86ff2e5032af0bc8bf5fe7a137a9f36a8466c5b97.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787123427\"", "last_modified": "Wed, 19 Aug 2026 07:10:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1688, "changed_paragraphs": 19, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-318d0e8c03f9a757c46aa69b", "medicine_id": "EMEA/H/C/002783", "medicine_name": "Levetiracetam Hospira", "medicine_slug": "levetiracetam-hospira", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/levetiracetam-hospira-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:10:18Z", "last_observed_at": "2026-10-12T19:10:18Z", "sha256": "cc525bb8083ac09a4a74aed67dab1077814902d1742398508e9ffee347cb280c", "format": "docx", "archive_key": "documents/cc525bb8083ac09a4a74aed67dab1077814902d1742398508e9ffee347cb280c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758097154\"", "last_modified": "Wed, 17 Sep 2025 08:19:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1576, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-31cbab584b8de5d9ea90bad0", "medicine_id": "EMEA/H/C/004541", "medicine_name": "LysaKare", "medicine_slug": "lysakare", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lysakare-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-07", "first_observed_at": "2026-10-12T19:16:50Z", "last_observed_at": "2026-10-12T19:16:50Z", "sha256": "31d018e941307e8e89efe8e0a8ee0cd83cbd42e01fb134fdb9937a1a9ed74d42", "format": "docx", "archive_key": "documents/31d018e941307e8e89efe8e0a8ee0cd83cbd42e01fb134fdb9937a1a9ed74d42.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754575047\"", "last_modified": "Thu, 07 Aug 2025 13:57:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 970, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-323177f5016285ca7db08865", "medicine_id": "EMEA/H/C/000885", "medicine_name": "Bridion", "medicine_slug": "bridion", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/bridion-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-11-06", "first_observed_at": "2026-10-12T19:04:02Z", "last_observed_at": "2026-10-12T19:04:02Z", "sha256": "51b947ba62089fdc26209dfff68078bf2d88641896affe22045f1edfc320a1e8", "format": "doc", "archive_key": "documents/51b947ba62089fdc26209dfff68078bf2d88641896affe22045f1edfc320a1e8.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762443761\"", "last_modified": "Thu, 06 Nov 2025 15:42:41 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-324751bde2e11edc76c2dbfe", "medicine_id": "EMEA/H/C/002066", "medicine_name": "Ikervis", "medicine_slug": "ikervis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ikervis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-23", "first_observed_at": "2026-10-12T13:34:16Z", "last_observed_at": "2026-10-12T13:34:16Z", "sha256": "ab05f9fab48768c68482390488c5b90c577e852974d4448da6ea8fe5a4eda856", "format": "docx", "archive_key": "documents/ab05f9fab48768c68482390488c5b90c577e852974d4448da6ea8fe5a4eda856.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782212951\"", "last_modified": "Tue, 23 Jun 2026 11:09:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1876, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-331c917f03e289e05c6dd9af", "medicine_id": "EMEA/H/C/002639", "medicine_name": "Xtandi", "medicine_slug": "xtandi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xtandi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-29", "first_observed_at": "2026-10-12T13:30:37Z", "last_observed_at": "2026-10-12T13:30:37Z", "sha256": "5ab28fb569f2fd21a2331b810ec038440ac438d84a6b8a346e430d7979fee559", "format": "docx", "archive_key": "documents/5ab28fb569f2fd21a2331b810ec038440ac438d84a6b8a346e430d7979fee559.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785331043\"", "last_modified": "Wed, 29 Jul 2026 13:17:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2573, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3391e5c4d8af438fa2e3720e", "medicine_id": "EMEA/H/C/004050", "medicine_name": "Emtricitabine/Tenofovir disoproxil Mylan", "medicine_slug": "emtricitabine-tenofovir-disoproxil-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/emtricitabine-tenofovir-disoproxil-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:51Z", "last_observed_at": "2026-10-12T13:35:51Z", "sha256": "7a5a04d549250cb67ad770d743021a0458cbd7895ad18a20df3607fc5facb642", "format": "docx", "archive_key": "documents/7a5a04d549250cb67ad770d743021a0458cbd7895ad18a20df3607fc5facb642.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781271564\"", "last_modified": "Fri, 12 Jun 2026 13:39:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2661, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-340a83fc9d44bbc138a92bb2", "medicine_id": "EMEA/H/C/005964", "medicine_name": "Jubbonti", "medicine_slug": "jubbonti", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/jubbonti-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-19", "first_observed_at": "2026-10-12T19:08:27Z", "last_observed_at": "2026-10-12T19:08:27Z", "sha256": "c8be583e8c4bc4f050847900363e5111e9dde378657ef91ec2c8445d34a6fb78", "format": "docx", "archive_key": "documents/c8be583e8c4bc4f050847900363e5111e9dde378657ef91ec2c8445d34a6fb78.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758292475\"", "last_modified": "Fri, 19 Sep 2025 14:34:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1459, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3456bb4aee43034a7e5c7a84", "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-27", "first_observed_at": "2026-10-12T13:28:10Z", "last_observed_at": "2026-10-12T13:28:10Z", "sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "format": "docx", "archive_key": "documents/49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787837496\"", "last_modified": "Thu, 27 Aug 2026 13:31:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3360, "changed_paragraphs": 122, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-34689da4d07d48b1dbd0d784", "medicine_id": "EMEA/H/C/002345", "medicine_name": "Revestive", "medicine_slug": "revestive", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/revestive-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-23", "first_observed_at": "2026-10-12T19:38:11Z", "last_observed_at": "2026-10-12T19:38:11Z", "sha256": "a977434b47f1efb8356de57d0e4e212d0d42a4215af7d29769e6a19a6e5b7354", "format": "docx", "archive_key": "documents/a977434b47f1efb8356de57d0e4e212d0d42a4215af7d29769e6a19a6e5b7354.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747983692\"", "last_modified": "Fri, 23 May 2025 07:01:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2970, "changed_paragraphs": 93, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-348add8773f66361b32876e2", "medicine_id": "EMEA/H/C/003780", "medicine_name": "Saxenda", "medicine_slug": "saxenda", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/saxenda-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-27", "first_observed_at": "2026-10-12T19:30:36Z", "last_observed_at": "2026-10-12T19:30:36Z", "sha256": "f7663b8bb3cd8c78a9ef0b3fd433a7e69cf639a97d93c8493ac51c4fc9e41ca0", "format": "docx", "archive_key": "documents/f7663b8bb3cd8c78a9ef0b3fd433a7e69cf639a97d93c8493ac51c4fc9e41ca0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751021170\"", "last_modified": "Fri, 27 Jun 2025 10:46:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1946, "changed_paragraphs": 40, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-35cc27f70d724d28bd19021a", "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:40:55Z", "last_observed_at": "2026-10-12T13:40:55Z", "sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "format": "docx", "archive_key": "documents/0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775036893\"", "last_modified": "Wed, 01 Apr 2026 09:48:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1696, "changed_paragraphs": 54, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3739a5682b5bef388497ee9d", "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:17Z", "last_observed_at": "2026-10-12T17:29:17Z", "sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "format": "docx", "archive_key": "documents/88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764765556\"", "last_modified": "Wed, 03 Dec 2025 12:39:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2169, "changed_paragraphs": 36, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-37e2b4861582c1ae3d52e277", "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-07-13", "first_observed_at": "2026-10-12T13:31:39Z", "last_observed_at": "2026-10-12T13:31:39Z", "sha256": "9970b3fcc2011698f60b6a41aa81a5eb31fb1ceb503ca60b7707e8f2ca5a03a8", "format": "doc", "archive_key": "documents/9970b3fcc2011698f60b6a41aa81a5eb31fb1ceb503ca60b7707e8f2ca5a03a8.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783950548\"", "last_modified": "Mon, 13 Jul 2026 13:49:08 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-388b2751fe1c91dafb54f515", "medicine_id": "EMEA/H/C/002018", "medicine_name": "Jevtana", "medicine_slug": "jevtana", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/jevtana-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-30", "first_observed_at": "2026-10-12T19:06:25Z", "last_observed_at": "2026-10-12T19:06:25Z", "sha256": "ecf065146b4b6b287568bb6d34740462cfc44772d77a68eaa16279ae7b0c29b3", "format": "docx", "archive_key": "documents/ecf065146b4b6b287568bb6d34740462cfc44772d77a68eaa16279ae7b0c29b3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759233749\"", "last_modified": "Tue, 30 Sep 2025 12:02:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2242, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3928189033effb8c51e260d8", "medicine_id": "EMEA/H/C/005083", "medicine_name": "Icatibant Accord", "medicine_slug": "icatibant-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/icatibant-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-27", "first_observed_at": "2026-10-12T19:15:36Z", "last_observed_at": "2026-10-12T19:15:36Z", "sha256": "e4637cbeed8a956ecec8a1d24e94e8dde692b1ee7a85e801838f6b55b52fe17f", "format": "docx", "archive_key": "documents/e4637cbeed8a956ecec8a1d24e94e8dde692b1ee7a85e801838f6b55b52fe17f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756310331\"", "last_modified": "Wed, 27 Aug 2025 15:58:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1476, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3937665bf9f071368c5a0e7b", "medicine_id": "EMEA/H/C/000175", "medicine_name": "Iscover", "medicine_slug": "iscover", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/iscover-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-26", "first_observed_at": "2026-10-12T19:15:45Z", "last_observed_at": "2026-10-12T19:15:45Z", "sha256": "bf539ffd7457c879f499923049f1226023248a963ca7816a448220a649e84e9d", "format": "docx", "archive_key": "documents/bf539ffd7457c879f499923049f1226023248a963ca7816a448220a649e84e9d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756217147\"", "last_modified": "Tue, 26 Aug 2025 14:05:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1883, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-39699294478247b4be23fa61", "medicine_id": "EMEA/H/C/001059", "medicine_name": "Grepid", "medicine_slug": "grepid", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-06-23", "first_observed_at": "2026-10-12T19:30:54Z", "last_observed_at": "2026-10-12T19:30:54Z", "sha256": "116538870e12e19e97b7b67ef14a9ecdd94044023f47a6e107e27177490b138f", "format": "doc", "archive_key": "documents/116538870e12e19e97b7b67ef14a9ecdd94044023f47a6e107e27177490b138f.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750678335\"", "last_modified": "Mon, 23 Jun 2025 11:32:15 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-3988578a040d2ac57b455d32", "medicine_id": "EMEA/H/C/002482", "medicine_name": "Zoledronic acid Mylan", "medicine_slug": "zoledronic-acid-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zoledronic-acid-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-31", "first_observed_at": "2026-10-12T13:45:25Z", "last_observed_at": "2026-10-12T13:45:25Z", "sha256": "1519080a3e41eb7a26bcc2b3c059ccd9d9e6212d1a71a6a8c3802ec4f202a610", "format": "docx", "archive_key": "documents/1519080a3e41eb7a26bcc2b3c059ccd9d9e6212d1a71a6a8c3802ec4f202a610.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774956326\"", "last_modified": "Tue, 31 Mar 2026 11:25:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1671, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-39d14defaaa30dc741c01dfc", "medicine_id": "EMEA/H/C/000406", "medicine_name": "Glivec", "medicine_slug": "glivec", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/glivec-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-12", "first_observed_at": "2026-10-12T19:03:38Z", "last_observed_at": "2026-10-12T19:03:38Z", "sha256": "95c79dedfc53e396fad5a311bbe8a6df4004476bbd633a148be93f027da818fe", "format": "docx", "archive_key": "documents/95c79dedfc53e396fad5a311bbe8a6df4004476bbd633a148be93f027da818fe.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762955680\"", "last_modified": "Wed, 12 Nov 2025 13:54:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2409, "changed_paragraphs": 68, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-39ee8bf457d439dc02096a2b", "medicine_id": "EMEA/H/C/002409", "medicine_name": "Zelboraf", "medicine_slug": "zelboraf", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zelboraf-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-19", "first_observed_at": "2026-10-12T19:31:02Z", "last_observed_at": "2026-10-12T19:31:02Z", "sha256": "8a568de35f474060aade2baa4979d413864e5051a9a473f5aead5174400e6da4", "format": "docx", "archive_key": "documents/8a568de35f474060aade2baa4979d413864e5051a9a473f5aead5174400e6da4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750334404\"", "last_modified": "Thu, 19 Jun 2025 12:00:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1692, "changed_paragraphs": 156, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3a401c2438b40107ebf125c4", "medicine_id": "EMEA/H/C/000413", "medicine_name": "MicardisPlus", "medicine_slug": "micardisplus", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/micardisplus-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:05Z", "last_observed_at": "2026-10-12T13:39:05Z", "sha256": "8de186dd0d2fb9c4921b68913138baceee817390775dc4cea5a7ff8c7a4be224", "format": "docx", "archive_key": "documents/8de186dd0d2fb9c4921b68913138baceee817390775dc4cea5a7ff8c7a4be224.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777378431\"", "last_modified": "Tue, 28 Apr 2026 12:13:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3995, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3a7a8db98719dd67a2a12fab", "medicine_id": "EMEA/H/C/000992", "medicine_name": "Simponi", "medicine_slug": "simponi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/simponi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:32Z", "last_observed_at": "2026-10-12T19:02:32Z", "sha256": "1a1239651c23a86bc841f47c86336103ad978e9ff64d9205b83e310c257e18bc", "format": "docx", "archive_key": "documents/1a1239651c23a86bc841f47c86336103ad978e9ff64d9205b83e310c257e18bc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769788168\"", "last_modified": "Fri, 30 Jan 2026 15:49:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 11380, "changed_paragraphs": 864, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-3aac7bf42b99529f25ac013b", "medicine_id": "EMEA/H/C/000554", "medicine_name": "Emselex", "medicine_slug": "emselex", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/emselex-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-15", "first_observed_at": "2026-10-12T19:12:07Z", "last_observed_at": "2026-10-12T19:12:07Z", "sha256": "9a4f1d7e260c7b80eaf397503623b63302e5945b579e9612177835e07c4ab888", "format": "docx", "archive_key": "documents/9a4f1d7e260c7b80eaf397503623b63302e5945b579e9612177835e07c4ab888.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757948480\"", "last_modified": "Mon, 15 Sep 2025 15:01:20 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2080, "changed_paragraphs": 46, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3ab1af890e3622bfbf594b39", "medicine_id": "EMEA/H/C/004728", "medicine_name": "Mvasi", "medicine_slug": "mvasi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/mvasi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-16", "first_observed_at": "2026-10-12T19:05:22Z", "last_observed_at": "2026-10-12T19:05:22Z", "sha256": "a37a7026b3fe5f943bf2dfae1da40e8922cb9100634f93bc6a182245d68b91bd", "format": "docx", "archive_key": "documents/a37a7026b3fe5f943bf2dfae1da40e8922cb9100634f93bc6a182245d68b91bd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760598994\"", "last_modified": "Thu, 16 Oct 2025 07:16:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3476, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3b8f8e4357eb2da16aa8b50f", "medicine_id": "EMEA/H/C/000236", "medicine_name": "Ferriprox", "medicine_slug": "ferriprox", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ferriprox-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:46Z", "last_observed_at": "2026-10-12T19:16:46Z", "sha256": "47f97c701962e81f7f15f37dc4a75d8ea756178013085f22dba6f616a512622c", "format": "docx", "archive_key": "documents/47f97c701962e81f7f15f37dc4a75d8ea756178013085f22dba6f616a512622c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755090914\"", "last_modified": "Wed, 13 Aug 2025 13:15:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2623, "changed_paragraphs": 36, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3b91c610b5b7416e45a9b971", "medicine_id": "EMEA/H/C/000150", "medicine_name": "Quadramet", "medicine_slug": "quadramet", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/quadramet-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-06", "first_observed_at": "2026-10-12T19:04:00Z", "last_observed_at": "2026-10-12T19:04:00Z", "sha256": "53f2282b249f5da30536442c82198053756a89b160cdc9b367e3cad45d4ba94f", "format": "docx", "archive_key": "documents/53f2282b249f5da30536442c82198053756a89b160cdc9b367e3cad45d4ba94f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762436139\"", "last_modified": "Thu, 06 Nov 2025 13:35:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1089, "changed_paragraphs": 302, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-3bbc808200dfa0c170049382", "medicine_id": "EMEA/H/C/004771", "medicine_name": "Imfinzi", "medicine_slug": "imfinzi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imfinzi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:26Z", "last_observed_at": "2026-10-12T19:01:26Z", "sha256": "26e535b30fe62ec927a143041c95687e8b49c6faacdbee3a17683bd7302a5834", "format": "docx", "archive_key": "documents/26e535b30fe62ec927a143041c95687e8b49c6faacdbee3a17683bd7302a5834.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771513877\"", "last_modified": "Thu, 19 Feb 2026 15:11:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4727, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-3bd1523a1889a3e131d42db6", "medicine_id": "EMEA/H/C/000461", "medicine_name": "Carbaglu", "medicine_slug": "carbaglu", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/carbaglu-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-09", "first_observed_at": "2026-10-12T17:28:33Z", "last_observed_at": "2026-10-12T17:28:33Z", "sha256": "aa9661ca3f9b552f45bacfdb4824be5bf399f9d95a1940ec175ce2f05566bcf4", "format": "docx", "archive_key": "documents/aa9661ca3f9b552f45bacfdb4824be5bf399f9d95a1940ec175ce2f05566bcf4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765293426\"", "last_modified": "Tue, 09 Dec 2025 15:17:06 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1058, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3be20854841dd8e6b1c05116", "medicine_id": "EMEA/H/C/000481", "medicine_name": "Humira", "medicine_slug": "humira", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/humira-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-08", "first_observed_at": "2026-10-12T19:05:58Z", "last_observed_at": "2026-10-12T19:05:58Z", "sha256": "838fa74d683105747766f79fbda32abdc6ca30a43c391bf9460c7303fb89a72d", "format": "docx", "archive_key": "documents/838fa74d683105747766f79fbda32abdc6ca30a43c391bf9460c7303fb89a72d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759932961\"", "last_modified": "Wed, 08 Oct 2025 14:16:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 19807, "changed_paragraphs": 5028, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3c12bd36dfef7de0e37e7662", "medicine_id": "EMEA/H/C/002638", "medicine_name": "Ibandronic acid Accord", "medicine_slug": "ibandronic-acid-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ibandronic-acid-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-26", "first_observed_at": "2026-10-12T19:07:09Z", "last_observed_at": "2026-10-12T19:07:09Z", "sha256": "a8c43956184f7a8def57deecc599037a3680760be80f7412e6fb694c49b8dd7c", "format": "docx", "archive_key": "documents/a8c43956184f7a8def57deecc599037a3680760be80f7412e6fb694c49b8dd7c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758898738\"", "last_modified": "Fri, 26 Sep 2025 14:58:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2385, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3c85146f21d9567602052934", "medicine_id": "EMEA/H/C/006046", "medicine_name": "Sugammadex Adroiq", "medicine_slug": "sugammadex-adroiq", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-adroiq-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:07:53Z", "last_observed_at": "2026-10-12T19:07:53Z", "sha256": "0a13dc6281fd01787849893dda4d2eac6ed2655c364a8d8bb784fc13398a51ee", "format": "docx", "archive_key": "documents/0a13dc6281fd01787849893dda4d2eac6ed2655c364a8d8bb784fc13398a51ee.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758789876\"", "last_modified": "Thu, 25 Sep 2025 08:44:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1533, "changed_paragraphs": 78, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3ebcec333efac741d891b84d", "medicine_id": "EMEA/H/C/005145", "medicine_name": "Evrysdi", "medicine_slug": "evrysdi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/evrysdi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:47Z", "last_observed_at": "2026-10-12T13:46:47Z", "sha256": "f5094517a5d78789213b60c9fa0442deb139e705572fe895a60294e9fb4cf77d", "format": "docx", "archive_key": "documents/f5094517a5d78789213b60c9fa0442deb139e705572fe895a60294e9fb4cf77d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774426234\"", "last_modified": "Wed, 25 Mar 2026 08:10:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3053, "changed_paragraphs": 83, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3efca388cb26b8b5cc1ea4a0", "medicine_id": "EMEA/H/C/003916", "medicine_name": "Terrosa", "medicine_slug": "terrosa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/terrosa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:28Z", "last_observed_at": "2026-10-12T13:39:28Z", "sha256": "124ca3471ef7192c011d303ca5375c8fbd010a74ab7a9d5500fd62987b007d1a", "format": "docx", "archive_key": "documents/124ca3471ef7192c011d303ca5375c8fbd010a74ab7a9d5500fd62987b007d1a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776947355\"", "last_modified": "Thu, 23 Apr 2026 12:29:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2544, "changed_paragraphs": 66, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3f3f2dd58e108cf4e372d1e8", "medicine_id": "EMEA/H/C/001137", "medicine_name": "Clopidogrel Krka d.d. (previously Zopya)", "medicine_slug": "clopidogrel-krka-d-d-previously-zopya", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/clopidogrel-krka-dd-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:41:21Z", "last_observed_at": "2026-10-12T19:41:21Z", "sha256": "ef03db89f0f2d0710fbaa9e476ced4cb729a0d60fa5d2d25f47a1c09eec3a167", "format": "docx", "archive_key": "documents/ef03db89f0f2d0710fbaa9e476ced4cb729a0d60fa5d2d25f47a1c09eec3a167.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747148280\"", "last_modified": "Tue, 13 May 2025 14:58:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1269, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3f5e3d8a9ef30a41ad45c883", "medicine_id": "EMEA/H/C/004984", "medicine_name": "Azacitidine Mylan", "medicine_slug": "azacitidine-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/azacitidine-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:18Z", "last_observed_at": "2026-10-12T13:35:18Z", "sha256": "8a23b15a1ee68b06c39713bce2cbde058eec479426bfc524dfa8d65f8d0f9265", "format": "docx", "archive_key": "documents/8a23b15a1ee68b06c39713bce2cbde058eec479426bfc524dfa8d65f8d0f9265.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781254599\"", "last_modified": "Fri, 12 Jun 2026 08:56:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1511, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-3fbe27b834c623f80c780864", "medicine_id": "EMEA/H/C/006294", "medicine_name": "Pomalidomide Zentiva", "medicine_slug": "pomalidomide-zentiva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pomalidomide-zentiva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:42:05Z", "last_observed_at": "2026-10-12T19:42:05Z", "sha256": "c33554a2b25ca1e8ebce51033bbfa38ac74c9a137d8b5cf59cdc73dc0d939a2e", "format": "docx", "archive_key": "documents/c33554a2b25ca1e8ebce51033bbfa38ac74c9a137d8b5cf59cdc73dc0d939a2e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747052750\"", "last_modified": "Mon, 12 May 2025 12:25:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3411, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-40ba3b78323d87e8cc2d7c26", "medicine_id": "EMEA/H/C/005751", "medicine_name": "Columvi", "medicine_slug": "columvi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/columvi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-24", "first_observed_at": "2026-10-12T19:04:49Z", "last_observed_at": "2026-10-12T19:04:49Z", "sha256": "3c2b225fc049aa95a2237c8f3ac5fc9d393befb22a88686f0ffed5b634143e1a", "format": "docx", "archive_key": "documents/3c2b225fc049aa95a2237c8f3ac5fc9d393befb22a88686f0ffed5b634143e1a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761306678\"", "last_modified": "Fri, 24 Oct 2025 11:51:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2433, "changed_paragraphs": 53, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-40e74f515485caa7c4d1ba67", "medicine_id": "EMEA/H/C/002682", "medicine_name": "Imnovid (previously Pomalidomide Celgene)", "medicine_slug": "imnovid-previously-pomalidomide-celgene", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imnovid-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-05", "first_observed_at": "2026-10-12T17:28:59Z", "last_observed_at": "2026-10-12T17:28:59Z", "sha256": "607e8fddd38094b14a62f9be64938dd5f0e4ef9caf485ccdac6000eebeff213c", "format": "docx", "archive_key": "documents/607e8fddd38094b14a62f9be64938dd5f0e4ef9caf485ccdac6000eebeff213c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764932082\"", "last_modified": "Fri, 05 Dec 2025 10:54:42 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3507, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 11 }, "pipeline_version": "2.0.0" }, { "id": "source-4122d076f3d584debf3d4b8e", "medicine_id": "EMEA/H/C/000577", "medicine_name": "Zonegran", "medicine_slug": "zonegran", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zonegran-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-22", "first_observed_at": "2026-10-12T13:31:06Z", "last_observed_at": "2026-10-12T13:31:06Z", "sha256": "57108f41ae344baabe7018ad5cb20d2a878850f19890f2b53ea0165f129d848b", "format": "docx", "archive_key": "documents/57108f41ae344baabe7018ad5cb20d2a878850f19890f2b53ea0165f129d848b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784705946\"", "last_modified": "Wed, 22 Jul 2026 07:39:06 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3735, "changed_paragraphs": 21, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-41379e2d4c112af97cc010cf", "medicine_id": "EMEA/H/C/002465", "medicine_name": "Procysbi", "medicine_slug": "procysbi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/procysbi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-08", "first_observed_at": "2026-10-12T19:15:02Z", "last_observed_at": "2026-10-12T19:15:02Z", "sha256": "f6fd3f4b47755da276819e7b68cea28867153d64bca404c398c92e250fc8fa41", "format": "docx", "archive_key": "documents/f6fd3f4b47755da276819e7b68cea28867153d64bca404c398c92e250fc8fa41.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757338502\"", "last_modified": "Mon, 08 Sep 2025 13:35:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2410, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-41ed33b21bebdd39a8d62a0f", "medicine_id": "EMEA/H/C/006152", "medicine_name": "Izamby", "medicine_slug": "izamby", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/izamby-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-02", "first_observed_at": "2026-10-12T17:29:33Z", "last_observed_at": "2026-10-12T17:29:33Z", "sha256": "22055d02cbf4b21687ba5e305913144a4ca76d57480c343be76e6cef1d394299", "format": "docx", "archive_key": "documents/22055d02cbf4b21687ba5e305913144a4ca76d57480c343be76e6cef1d394299.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764672248\"", "last_modified": "Tue, 02 Dec 2025 10:44:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1475, "changed_paragraphs": 23, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-42052ac1932265c3bcc066cc", "medicine_id": "EMEA/H/C/005787", "medicine_name": "Livtencity", "medicine_slug": "livtencity", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/livtencity-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-05", "first_observed_at": "2026-10-12T19:17:04Z", "last_observed_at": "2026-10-12T19:17:04Z", "sha256": "4282129896a44defd584d25a898b6cd62ffa2724793db408cbee38952713e544", "format": "docx", "archive_key": "documents/4282129896a44defd584d25a898b6cd62ffa2724793db408cbee38952713e544.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754397057\"", "last_modified": "Tue, 05 Aug 2025 12:30:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1534, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4222dc61a5c401d9ea981d06", "medicine_id": "EMEA/H/C/004361", "medicine_name": "Kanjinti", "medicine_slug": "kanjinti", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kanjinti-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:40:28Z", "last_observed_at": "2026-10-12T19:40:28Z", "sha256": "9f4119e69f965285688c3402ad669f6dc3298fbbaf20f5909a83d03f0f927312", "format": "docx", "archive_key": "documents/9f4119e69f965285688c3402ad669f6dc3298fbbaf20f5909a83d03f0f927312.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747146648\"", "last_modified": "Tue, 13 May 2025 14:30:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2868, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-426f55e57819909673823c48", "medicine_id": "EMEA/H/C/000863", "medicine_name": "Vimpat", "medicine_slug": "vimpat", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vimpat-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-08", "first_observed_at": "2026-10-12T19:42:36Z", "last_observed_at": "2026-10-12T19:42:36Z", "sha256": "926a201f932daf5840a282f502c0cdb1f5992b45ec82b0716483956d69050335", "format": "docx", "archive_key": "documents/926a201f932daf5840a282f502c0cdb1f5992b45ec82b0716483956d69050335.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746697904\"", "last_modified": "Thu, 08 May 2025 09:51:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7521, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4456be6b996cfeb28427785f", "medicine_id": "EMEA/H/C/005935", "medicine_name": "Sugammadex Amomed", "medicine_slug": "sugammadex-amomed", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-amomed-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-04", "first_observed_at": "2026-10-12T19:02:23Z", "last_observed_at": "2026-10-12T19:02:23Z", "sha256": "943c70dddd097ee185a75ee1a225ccc92223423f733612478da8f4be33f3295a", "format": "docx", "archive_key": "documents/943c70dddd097ee185a75ee1a225ccc92223423f733612478da8f4be33f3295a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770220483\"", "last_modified": "Wed, 04 Feb 2026 15:54:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1675, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-447fe2ad388d474a60047676", "medicine_id": "EMEA/H/C/000610", "medicine_name": "Noxafil", "medicine_slug": "noxafil", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/noxafil-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-07-01", "first_observed_at": "2026-10-12T13:33:56Z", "last_observed_at": "2026-10-12T13:33:56Z", "sha256": "9692c812e27b1c7e9445f31032a4a37a3febbc6c6df10fc1ab103ac9d09137df", "format": "doc", "archive_key": "documents/9692c812e27b1c7e9445f31032a4a37a3febbc6c6df10fc1ab103ac9d09137df.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782891438\"", "last_modified": "Wed, 01 Jul 2026 07:37:18 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-44df4a8e5513d920d46cd291", "medicine_id": "EMEA/H/C/005896", "medicine_name": "Hyftor", "medicine_slug": "hyftor", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/hyftor-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-04", "first_observed_at": "2026-10-12T19:30:24Z", "last_observed_at": "2026-10-12T19:30:24Z", "sha256": "20b87f11031a18aee940ad1e4d2b615fe687dbead6d8f219db8e214b814f1acc", "format": "docx", "archive_key": "documents/20b87f11031a18aee940ad1e4d2b615fe687dbead6d8f219db8e214b814f1acc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751647072\"", "last_modified": "Fri, 04 Jul 2025 16:37:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 953, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-45cae85347843df2c648779e", "medicine_id": "EMEA/H/C/002604", "medicine_name": "Tafinlar", "medicine_slug": "tafinlar", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tafinlar-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-23", "first_observed_at": "2026-10-12T19:23:10Z", "last_observed_at": "2026-10-12T19:23:10Z", "sha256": "14e54eb77a1474c24df458ab64b865f37c096a7f85e671fb7a319692eaeaf949", "format": "docx", "archive_key": "documents/14e54eb77a1474c24df458ab64b865f37c096a7f85e671fb7a319692eaeaf949.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753284917\"", "last_modified": "Wed, 23 Jul 2025 15:35:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3622, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-469265d9b6d6251540ddde37", "medicine_id": "EMEA/H/C/000309", "medicine_name": "Toujeo (previously Optisulin)", "medicine_slug": "toujeo-previously-optisulin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/toujeo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-09", "first_observed_at": "2026-10-12T19:30:06Z", "last_observed_at": "2026-10-12T19:30:06Z", "sha256": "958e68d317ead1784b761df53174f59803bbabb77bcf31c3603b908121943aff", "format": "docx", "archive_key": "documents/958e68d317ead1784b761df53174f59803bbabb77bcf31c3603b908121943aff.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752069443\"", "last_modified": "Wed, 09 Jul 2025 13:57:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3227, "changed_paragraphs": 605, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-469ae8461ccf580305326e88", "medicine_id": "EMEA/H/C/002268", "medicine_name": "Dexdor", "medicine_slug": "dexdor", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/dexdor-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:49Z", "last_observed_at": "2026-10-12T19:02:49Z", "sha256": "a82ddaada6d27c41ab60f7da03372fe7dfb8c77739c4ee77bcc78a2214c2531c", "format": "docx", "archive_key": "documents/a82ddaada6d27c41ab60f7da03372fe7dfb8c77739c4ee77bcc78a2214c2531c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769600848\"", "last_modified": "Wed, 28 Jan 2026 11:47:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1241, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-470cd3081161c442709128ab", "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-18", "first_observed_at": "2026-10-12T19:31:08Z", "last_observed_at": "2026-10-12T19:31:08Z", "sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "format": "docx", "archive_key": "documents/416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750238581\"", "last_modified": "Wed, 18 Jun 2025 09:23:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1035, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4745d2a445d8a94c2efecc1a", "medicine_id": "EMEA/H/C/001192", "medicine_name": "Topotecan Hospira", "medicine_slug": "topotecan-hospira", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/topotecan-hospira-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-31", "first_observed_at": "2026-10-12T13:46:32Z", "last_observed_at": "2026-10-12T13:46:32Z", "sha256": "49c16d73fc91846bd835c61d4db91ea575df62b4532a85c559834f2d327359e2", "format": "docx", "archive_key": "documents/49c16d73fc91846bd835c61d4db91ea575df62b4532a85c559834f2d327359e2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774959141\"", "last_modified": "Tue, 31 Mar 2026 12:12:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1219, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-47a3bd7fbf930750d7ef7891", "medicine_id": "EMEA/H/C/000141", "medicine_name": "Aprovel", "medicine_slug": "aprovel", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aprovel-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:17Z", "last_observed_at": "2026-10-12T17:26:17Z", "sha256": "8bb8b2b3057f8f9a8fac8321a222a7c020fa068739f1494a85cf638bf4f41b88", "format": "docx", "archive_key": "documents/8bb8b2b3057f8f9a8fac8321a222a7c020fa068739f1494a85cf638bf4f41b88.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768814466\"", "last_modified": "Mon, 19 Jan 2026 09:21:06 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5299, "changed_paragraphs": 54, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4810c76f34b1a2c27935d391", "medicine_id": "EMEA/H/C/004368", "medicine_name": "Movymia", "medicine_slug": "movymia", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/movymia-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-04-24", "first_observed_at": "2026-10-12T19:45:42Z", "last_observed_at": "2026-10-12T19:45:42Z", "sha256": "5df92e3c75f752276d02985a9cd081bb25026c4c2ad26ef33050e64797bb4187", "format": "docx", "archive_key": "documents/5df92e3c75f752276d02985a9cd081bb25026c4c2ad26ef33050e64797bb4187.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1745499267\"", "last_modified": "Thu, 24 Apr 2025 12:54:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1614, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-485fcd5d784f5f7083eefc05", "medicine_id": "EMEA/H/C/004061", "medicine_name": "Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau)", "medicine_slug": "chenodeoxycholic-acid-leadiant-previously-chenodeoxycholic-acid-sigma-tau", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/chenodeoxycholic-acid-leadiant-epar-product-information_fr.doc", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:30Z", "last_observed_at": "2026-10-12T19:16:30Z", "sha256": "3bd2bba540bec088ca38d75a9173da5e98b98565ca5211757c916479d457173e", "format": "doc", "archive_key": "documents/3bd2bba540bec088ca38d75a9173da5e98b98565ca5211757c916479d457173e.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755075015\"", "last_modified": "Wed, 13 Aug 2025 08:50:15 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-488cc476f581f7601b0f7879", "medicine_id": "EMEA/H/C/000695", "medicine_name": "Circadin", "medicine_slug": "circadin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/circadin-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-07", "first_observed_at": "2026-10-12T19:30:15Z", "last_observed_at": "2026-10-12T19:30:15Z", "sha256": "4ab777b767183ae5b19a056580dc77385a2608dea782bb5c982b76e169c52c1a", "format": "docx", "archive_key": "documents/4ab777b767183ae5b19a056580dc77385a2608dea782bb5c982b76e169c52c1a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751897654\"", "last_modified": "Mon, 07 Jul 2025 14:14:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1107, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-48ac7786f0746a4c47d98836", "medicine_id": "EMEA/H/C/005183", "medicine_name": "Klisyri", "medicine_slug": "klisyri", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/klisyri-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:34Z", "last_observed_at": "2026-10-12T19:01:34Z", "sha256": "13dcdaafcd3943fe2d3adaac9749ec6fad7dffb436d23b572718983cd5e6cdb7", "format": "docx", "archive_key": "documents/13dcdaafcd3943fe2d3adaac9749ec6fad7dffb436d23b572718983cd5e6cdb7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771512875\"", "last_modified": "Thu, 19 Feb 2026 14:54:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 936, "changed_paragraphs": 21, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-48f6182a78cf7770947302ab", "medicine_id": "EMEA/H/C/004037", "medicine_name": "Amlodipine / Valsartan Mylan", "medicine_slug": "amlodipine-valsartan-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/amlodipine-valsartan-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:39Z", "last_observed_at": "2026-10-12T13:35:39Z", "sha256": "fef655284bc3e833ca7b4a2070cc1afbef5e73f7f31bf45aa3565d9df88381f0", "format": "docx", "archive_key": "documents/fef655284bc3e833ca7b4a2070cc1afbef5e73f7f31bf45aa3565d9df88381f0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781260513\"", "last_modified": "Fri, 12 Jun 2026 10:35:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2514, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4901cc83e55cf0c00b3f089f", "medicine_id": "EMEA/H/C/006490", "medicine_name": "Kefdensis", "medicine_slug": "kefdensis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kefdensis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-17", "first_observed_at": "2026-10-12T13:31:27Z", "last_observed_at": "2026-10-12T13:31:27Z", "sha256": "56de1aac811bfd6a1ef24a2aed086465bff2825f743cce84e72d5ca39a56f0b2", "format": "docx", "archive_key": "documents/56de1aac811bfd6a1ef24a2aed086465bff2825f743cce84e72d5ca39a56f0b2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784284852\"", "last_modified": "Fri, 17 Jul 2026 10:40:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1411, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-49ac79fb98e8a5f00535ae35", "medicine_id": "EMEA/H/C/004212", "medicine_name": "Amgevita", "medicine_slug": "amgevita", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/amgevita-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:47Z", "last_observed_at": "2026-10-12T13:39:47Z", "sha256": "495de747483c4d23bf886e5c2174a036eaa23b3ee105284779c8eca84fa7417d", "format": "docx", "archive_key": "documents/495de747483c4d23bf886e5c2174a036eaa23b3ee105284779c8eca84fa7417d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776937457\"", "last_modified": "Thu, 23 Apr 2026 09:44:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 11907, "changed_paragraphs": 142, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-49baac54d1d69a53e6772b38", "medicine_id": "EMEA/H/C/005306", "medicine_name": "Lenalidomide Mylan", "medicine_slug": "lenalidomide-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lenalidomide-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:59Z", "last_observed_at": "2026-10-12T13:35:59Z", "sha256": "ad837a050ae2ebb1149b23c68fd1449d2d3c647a705074e93bcbb79a0787fecc", "format": "docx", "archive_key": "documents/ad837a050ae2ebb1149b23c68fd1449d2d3c647a705074e93bcbb79a0787fecc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781263646\"", "last_modified": "Fri, 12 Jun 2026 11:27:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4754, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-4a801f62cfb41d9c873d7b83", "medicine_id": "EMEA/H/C/003791", "medicine_name": "Imbruvica", "medicine_slug": "imbruvica", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imbruvica-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-27", "first_observed_at": "2026-10-12T19:04:37Z", "last_observed_at": "2026-10-12T19:04:37Z", "sha256": "21bfa7a97b1dbb4cfcbb1d14bfa960d84c5eee81bfc4425b19e34ad257c6619b", "format": "docx", "archive_key": "documents/21bfa7a97b1dbb4cfcbb1d14bfa960d84c5eee81bfc4425b19e34ad257c6619b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761565941\"", "last_modified": "Mon, 27 Oct 2025 11:52:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6613, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4aafd85c426f76bea2198b7c", "medicine_id": "EMEA/H/C/004954", "medicine_name": "Ultomiris", "medicine_slug": "ultomiris", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ultomiris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-22", "first_observed_at": "2026-10-12T19:05:14Z", "last_observed_at": "2026-10-12T19:05:14Z", "sha256": "06b18172f8a9b4ca76447486f4af6242f0d49615d063dd6270c5d6a6d4ba1d96", "format": "docx", "archive_key": "documents/06b18172f8a9b4ca76447486f4af6242f0d49615d063dd6270c5d6a6d4ba1d96.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761120163\"", "last_modified": "Wed, 22 Oct 2025 08:02:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3622, "changed_paragraphs": 124, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4ad843ef8e3dd9f86ed13b08", "medicine_id": "EMEA/H/C/004237", "medicine_name": "Xerava", "medicine_slug": "xerava", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xerava-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-06", "first_observed_at": "2026-10-12T19:02:12Z", "last_observed_at": "2026-10-12T19:02:12Z", "sha256": "263d3ee147b0360b9af7a2f8482dad0491caf07a9cbd85e97930e37ff272c34a", "format": "docx", "archive_key": "documents/263d3ee147b0360b9af7a2f8482dad0491caf07a9cbd85e97930e37ff272c34a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770366674\"", "last_modified": "Fri, 06 Feb 2026 08:31:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2813, "changed_paragraphs": 296, "unassigned_changed_paragraphs": 52 }, "pipeline_version": "2.0.0" }, { "id": "source-4aff1b64c7cf58337d33ecfa", "medicine_id": "EMEA/H/C/000174", "medicine_name": "Plavix", "medicine_slug": "plavix", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/plavix-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-14", "first_observed_at": "2026-10-12T19:27:50Z", "last_observed_at": "2026-10-12T19:27:50Z", "sha256": "3818c2e3c9979bf5f8be3f164dfce187fccfccf62bbd1e3227c64ca7c00ad02f", "format": "docx", "archive_key": "documents/3818c2e3c9979bf5f8be3f164dfce187fccfccf62bbd1e3227c64ca7c00ad02f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752505557\"", "last_modified": "Mon, 14 Jul 2025 15:05:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1913, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4b3a83613c1e7f4ba485af87", "medicine_id": "EMEA/H/C/004646", "medicine_name": "Lorviqua", "medicine_slug": "lorviqua", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lorviqua-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-15", "first_observed_at": "2026-10-12T13:40:19Z", "last_observed_at": "2026-10-12T13:40:19Z", "sha256": "c1acad257653d9c3f32e8fa4b9483faa716876ef1368cf5d5cfe1c51bf6cd06f", "format": "docx", "archive_key": "documents/c1acad257653d9c3f32e8fa4b9483faa716876ef1368cf5d5cfe1c51bf6cd06f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776248508\"", "last_modified": "Wed, 15 Apr 2026 10:21:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1774, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4b712d5f9e4e2e8cd620aa93", "medicine_id": "EMEA/H/C/005352", "medicine_name": "Upstaza", "medicine_slug": "upstaza", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/upstaza-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-10", "first_observed_at": "2026-10-12T13:36:07Z", "last_observed_at": "2026-10-12T13:36:07Z", "sha256": "8561a0c5aed752dd415d30acef76bf620ad205d702080a0bca765e086873fe20", "format": "docx", "archive_key": "documents/8561a0c5aed752dd415d30acef76bf620ad205d702080a0bca765e086873fe20.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781076326\"", "last_modified": "Wed, 10 Jun 2026 07:25:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1086, "changed_paragraphs": 15, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4b7ea3b78addea82376b3432", "medicine_id": "EMEA/H/C/000235", "medicine_name": "Arava", "medicine_slug": "arava", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/arava-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-09-07", "first_observed_at": "2026-10-12T13:28:00Z", "last_observed_at": "2026-10-12T13:28:00Z", "sha256": "98b73c5c6b1e5009c9d048f8f11257f3a8407759fd25a4c8d5ef5c611519e916", "format": "docx", "archive_key": "documents/98b73c5c6b1e5009c9d048f8f11257f3a8407759fd25a4c8d5ef5c611519e916.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789028990\"", "last_modified": "Thu, 10 Sep 2026 08:29:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3789, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-4b9528e2c46a08a33304e20c", "medicine_id": "EMEA/H/C/000839", "medicine_name": "Volibris", "medicine_slug": "volibris", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/volibris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-22", "first_observed_at": "2026-10-12T13:40:11Z", "last_observed_at": "2026-10-12T13:40:11Z", "sha256": "5770c82d9b364a43432b3e3eae3867596d43761f9b107d92fd6d5245cc8956b2", "format": "docx", "archive_key": "documents/5770c82d9b364a43432b3e3eae3867596d43761f9b107d92fd6d5245cc8956b2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776864817\"", "last_modified": "Wed, 22 Apr 2026 13:33:37 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1847, "changed_paragraphs": 36, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4c8d17fb79a74816821e816e", "medicine_id": "EMEA/H/C/000606", "medicine_name": "Xolair", "medicine_slug": "xolair", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xolair-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-28", "first_observed_at": "2026-10-12T19:37:39Z", "last_observed_at": "2026-10-12T19:37:39Z", "sha256": "bf3628eaab0eb0c7c232c7bcfee7453350e1572a5b69bac92d44d7179b37484d", "format": "docx", "archive_key": "documents/bf3628eaab0eb0c7c232c7bcfee7453350e1572a5b69bac92d44d7179b37484d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1748445425\"", "last_modified": "Wed, 28 May 2025 15:17:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12453, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4e152dde578b80a63ee2fcd5", "medicine_id": "EMEA/H/C/002682", "medicine_name": "Imnovid (previously Pomalidomide Celgene)", "medicine_slug": "imnovid-previously-pomalidomide-celgene", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/imnovid-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-05", "first_observed_at": "2026-10-12T17:29:04Z", "last_observed_at": "2026-10-12T17:29:04Z", "sha256": "5583cc334bc038ccc5a55a97f36d59c566b5938a3732fd08845b50e84358a414", "format": "docx", "archive_key": "documents/5583cc334bc038ccc5a55a97f36d59c566b5938a3732fd08845b50e84358a414.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764932082\"", "last_modified": "Fri, 05 Dec 2025 10:54:42 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3516, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 11 }, "pipeline_version": "2.0.0" }, { "id": "source-4e319ccd719735dc0a35b6f8", "medicine_id": "EMEA/H/C/000309", "medicine_name": "Toujeo (previously Optisulin)", "medicine_slug": "toujeo-previously-optisulin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/toujeo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-09", "first_observed_at": "2026-10-12T19:30:09Z", "last_observed_at": "2026-10-12T19:30:09Z", "sha256": "002ed116c467ebd888c93443a95c452e0346312b86945e11ab401f6442cf8402", "format": "docx", "archive_key": "documents/002ed116c467ebd888c93443a95c452e0346312b86945e11ab401f6442cf8402.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752069443\"", "last_modified": "Wed, 09 Jul 2025 13:57:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3566, "changed_paragraphs": 730, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4e7682c382d4a48311174234", "medicine_id": "EMEA/H/C/000262", "medicine_name": "Enbrel", "medicine_slug": "enbrel", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/enbrel-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:34Z", "last_observed_at": "2026-10-12T19:16:34Z", "sha256": "878ae96bd12ba62b45d781081f86186d8ffd76bcb5ca365a21fb706a93d76b91", "format": "docx", "archive_key": "documents/878ae96bd12ba62b45d781081f86186d8ffd76bcb5ca365a21fb706a93d76b91.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755069484\"", "last_modified": "Wed, 13 Aug 2025 07:18:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12331, "changed_paragraphs": 86, "unassigned_changed_paragraphs": 15 }, "pipeline_version": "2.0.0" }, { "id": "source-4efe4ecf3ebf08d338a763a5", "medicine_id": "EMEA/H/C/002500", "medicine_name": "Pheburane", "medicine_slug": "pheburane", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pheburane-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-17", "first_observed_at": "2026-10-12T13:29:14Z", "last_observed_at": "2026-10-12T13:29:14Z", "sha256": "8b8c4cc8e6f1a21fedee4bf0743c9c03e454b50f5eaba0e3760416d7fe0a74ec", "format": "docx", "archive_key": "documents/8b8c4cc8e6f1a21fedee4bf0743c9c03e454b50f5eaba0e3760416d7fe0a74ec.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1786955526\"", "last_modified": "Mon, 17 Aug 2026 08:32:06 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2100, "changed_paragraphs": 227, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-4f49b1cf43a8981c0338aaa6", "medicine_id": "EMEA/H/C/002465", "medicine_name": "Procysbi", "medicine_slug": "procysbi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/procysbi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-08", "first_observed_at": "2026-10-12T19:15:05Z", "last_observed_at": "2026-10-12T19:15:05Z", "sha256": "11896dd32e97f8b07701d49b529e91d1cef03f7dcf473e4d4ed050f83643f081", "format": "docx", "archive_key": "documents/11896dd32e97f8b07701d49b529e91d1cef03f7dcf473e4d4ed050f83643f081.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757338503\"", "last_modified": "Mon, 08 Sep 2025 13:35:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2410, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4f5f231043a10fa86fe7c54e", "medicine_id": "EMEA/H/C/005178", "medicine_name": "Cabazitaxel Accord", "medicine_slug": "cabazitaxel-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cabazitaxel-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-07", "first_observed_at": "2026-10-12T17:27:14Z", "last_observed_at": "2026-10-12T17:27:14Z", "sha256": "bc0ce1d6b53254c9a2b024b8f7663d5e4643110206fd9f658a365f6b1417f4b2", "format": "docx", "archive_key": "documents/bc0ce1d6b53254c9a2b024b8f7663d5e4643110206fd9f658a365f6b1417f4b2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1767801682\"", "last_modified": "Wed, 07 Jan 2026 16:01:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2158, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-4fbb041e667be41fe956bf6f", "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:59Z", "last_observed_at": "2026-10-12T19:02:59Z", "sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "format": "docx", "archive_key": "documents/77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769602107\"", "last_modified": "Wed, 28 Jan 2026 12:08:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3507, "changed_paragraphs": 53, "unassigned_changed_paragraphs": 33 }, "pipeline_version": "2.0.0" }, { "id": "source-53499b0dc424d91754b53435", "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-05", "first_observed_at": "2026-10-12T19:02:21Z", "last_observed_at": "2026-10-12T19:02:21Z", "sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "format": "docx", "archive_key": "documents/2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770301859\"", "last_modified": "Thu, 05 Feb 2026 14:30:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3979, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-54738d28f531abce15846adb", "medicine_id": "EMEA/H/C/004214", "medicine_name": "Xeljanz", "medicine_slug": "xeljanz", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xeljanz-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-09-10", "first_observed_at": "2026-10-12T13:27:53Z", "last_observed_at": "2026-10-12T13:27:53Z", "sha256": "ddfa8542274e838123aee9b82862e18ca48041f1eabbe271f6d4fa70a7783239", "format": "docx", "archive_key": "documents/ddfa8542274e838123aee9b82862e18ca48041f1eabbe271f6d4fa70a7783239.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789044791\"", "last_modified": "Thu, 10 Sep 2026 12:53:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9158, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-54c95de30aab8f0bb3f740d8", "medicine_id": "EMEA/H/C/002387", "medicine_name": "Zyclara", "medicine_slug": "zyclara", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zyclara-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-07-22", "first_observed_at": "2026-10-12T19:23:16Z", "last_observed_at": "2026-10-12T19:23:16Z", "sha256": "313ab64b7297df015b2aeddbdc74fe51ebd6c0dff9e01232039a32cd044f01ec", "format": "doc", "archive_key": "documents/313ab64b7297df015b2aeddbdc74fe51ebd6c0dff9e01232039a32cd044f01ec.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753194111\"", "last_modified": "Tue, 22 Jul 2025 14:21:51 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-550626ef9c9548aff9c455d0", "medicine_id": "EMEA/H/C/005627", "medicine_name": "Lytgobi", "medicine_slug": "lytgobi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lytgobi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:19Z", "last_observed_at": "2026-10-12T19:04:19Z", "sha256": "d1821569c9b8f228d546b6d85f2a57ad454770c232dbbd342520455e40c7c6fe", "format": "docx", "archive_key": "documents/d1821569c9b8f228d546b6d85f2a57ad454770c232dbbd342520455e40c7c6fe.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761739859\"", "last_modified": "Wed, 29 Oct 2025 12:10:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1053, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-55765f484af9c246c4e50218", "medicine_id": "EMEA/H/C/002392", "medicine_name": "Eylea", "medicine_slug": "eylea", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eylea-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-04", "first_observed_at": "2026-10-12T13:53:22Z", "last_observed_at": "2026-10-12T13:53:22Z", "sha256": "8ec9f7841188f4e35251feb5051d47572abbe281531b8bdaeb3e1668a767b648", "format": "docx", "archive_key": "documents/8ec9f7841188f4e35251feb5051d47572abbe281531b8bdaeb3e1668a767b648.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772639094\"", "last_modified": "Wed, 04 Mar 2026 15:44:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7006, "changed_paragraphs": 373, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-55cabb812710a2b82a37ee04", "medicine_id": "EMEA/H/C/004117", "medicine_name": "Ivabradine Zentiva", "medicine_slug": "ivabradine-zentiva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ivabradine-zentiva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:55Z", "last_observed_at": "2026-10-12T19:23:55Z", "sha256": "7ab46b256f31a8b3b58d00df06d32cce784304e6aa4bb189b835150dce5e92ab", "format": "docx", "archive_key": "documents/7ab46b256f31a8b3b58d00df06d32cce784304e6aa4bb189b835150dce5e92ab.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752756116\"", "last_modified": "Thu, 17 Jul 2025 12:41:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1414, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-56214aa6c9af3c351802e5fe", "medicine_id": "EMEA/H/C/004750", "medicine_name": "Zolgensma", "medicine_slug": "zolgensma", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zolgensma-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:20Z", "last_observed_at": "2026-10-12T13:28:20Z", "sha256": "82d7c1f28aaaad8c410377e276c234e68e83efb2290f018e6853968961cb3ea0", "format": "docx", "archive_key": "documents/82d7c1f28aaaad8c410377e276c234e68e83efb2290f018e6853968961cb3ea0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787218694\"", "last_modified": "Thu, 20 Aug 2026 09:38:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1850, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-574b1317595f81e7b0f3c26e", "medicine_id": "EMEA/H/C/000574", "medicine_name": "Azilect", "medicine_slug": "azilect", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/azilect-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-04-08", "first_observed_at": "2026-10-12T19:46:13Z", "last_observed_at": "2026-10-12T19:46:13Z", "sha256": "4a9f0ad98fe4fb3dd9a2d3dd9df8389953bc2d36a1f2f3066a9d6b9c294ac3db", "format": "docx", "archive_key": "documents/4a9f0ad98fe4fb3dd9a2d3dd9df8389953bc2d36a1f2f3066a9d6b9c294ac3db.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1744111707\"", "last_modified": "Tue, 08 Apr 2025 11:28:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1343, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-57cacf862ad96a9ba0dce8b8", "medicine_id": "EMEA/H/C/000546", "medicine_name": "Lyrica", "medicine_slug": "lyrica", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lyrica-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:34Z", "last_observed_at": "2026-10-12T13:46:34Z", "sha256": "1f825ba38c0278f8bb8e237079cc83c46207316efb95fe578b3b2754bc6f4626", "format": "docx", "archive_key": "documents/1f825ba38c0278f8bb8e237079cc83c46207316efb95fe578b3b2754bc6f4626.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774450118\"", "last_modified": "Wed, 25 Mar 2026 14:48:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5900, "changed_paragraphs": 174, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-57cbab9f72138f946cfe70c9", "medicine_id": "EMEA/H/C/001046", "medicine_name": "Tepadina", "medicine_slug": "tepadina", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tepadina-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:06Z", "last_observed_at": "2026-10-12T19:06:06Z", "sha256": "a0386906fe33bf507676b22117ba60616a4b3d371ffce4282ae1cb4ffaaa9e06", "format": "doc", "archive_key": "documents/a0386906fe33bf507676b22117ba60616a4b3d371ffce4282ae1cb4ffaaa9e06.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759826436\"", "last_modified": "Tue, 07 Oct 2025 08:40:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-58693c6b0ca29b120728eb71", "medicine_id": "EMEA/H/C/004163", "medicine_name": "Cabometyx", "medicine_slug": "cabometyx", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cabometyx-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:43Z", "last_observed_at": "2026-10-12T19:00:43Z", "sha256": "cf423ddfceb40266985f904586e5f8b6b0a3b9d310d777ef0d857743c37def88", "format": "docx", "archive_key": "documents/cf423ddfceb40266985f904586e5f8b6b0a3b9d310d777ef0d857743c37def88.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772183836\"", "last_modified": "Fri, 27 Feb 2026 09:17:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2595, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-58a9ecf053a0ab93bbcc0173", "medicine_id": "EMEA/H/C/004697", "medicine_name": "Zirabev", "medicine_slug": "zirabev", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zirabev-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:42Z", "last_observed_at": "2026-10-12T19:08:42Z", "sha256": "845774ee3d135dcbab2d035e014eb75d076ae724c8a5ea323882196493b05d44", "format": "docx", "archive_key": "documents/845774ee3d135dcbab2d035e014eb75d076ae724c8a5ea323882196493b05d44.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758101028\"", "last_modified": "Wed, 17 Sep 2025 09:23:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3442, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5a56c1fa913d12547d692303", "medicine_id": "EMEA/H/C/000306", "medicine_name": "Metalyse", "medicine_slug": "metalyse", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/metalyse-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-27", "first_observed_at": "2026-10-12T17:29:58Z", "last_observed_at": "2026-10-12T17:29:58Z", "sha256": "716dd0729579449b3c51df41345fcb51a5631c70c92aaa8a20694176bc4e9179", "format": "docx", "archive_key": "documents/716dd0729579449b3c51df41345fcb51a5631c70c92aaa8a20694176bc4e9179.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764244494\"", "last_modified": "Thu, 27 Nov 2025 11:54:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2651, "changed_paragraphs": 110, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5a963b257532afbfd4ca477b", "medicine_id": "EMEA/H/C/000992", "medicine_name": "Simponi", "medicine_slug": "simponi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/simponi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:36Z", "last_observed_at": "2026-10-12T19:02:36Z", "sha256": "359338f13851566c1b5a50785093846e9e52980167d40c4e41d57c7d5eda0080", "format": "docx", "archive_key": "documents/359338f13851566c1b5a50785093846e9e52980167d40c4e41d57c7d5eda0080.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769788169\"", "last_modified": "Fri, 30 Jan 2026 15:49:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 11494, "changed_paragraphs": 856, "unassigned_changed_paragraphs": 8 }, "pipeline_version": "2.0.0" }, { "id": "source-5ac218cfbc8d31c772d067b2", "medicine_id": "EMEA/H/C/005764", "medicine_name": "Fabhalta", "medicine_slug": "fabhalta", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fabhalta-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:24Z", "last_observed_at": "2026-10-12T19:04:24Z", "sha256": "bbcf62a1345cbaee4b864a73ed22d43792599eac8376d9eb6138126af1060dff", "format": "docx", "archive_key": "documents/bbcf62a1345cbaee4b864a73ed22d43792599eac8376d9eb6138126af1060dff.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761751352\"", "last_modified": "Wed, 29 Oct 2025 15:22:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1889, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5b4dfd7af827d6f9e5f17380", "medicine_id": "EMEA/H/C/000727", "medicine_name": "Abseamed", "medicine_slug": "abseamed", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/abseamed-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:28:18Z", "last_observed_at": "2026-10-12T19:28:18Z", "sha256": "b3d63dadfa6fdf4652fae3986e79b54bacaf944ebd0e37554dc28913c8c2a8c8", "format": "docx", "archive_key": "documents/b3d63dadfa6fdf4652fae3986e79b54bacaf944ebd0e37554dc28913c8c2a8c8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752235164\"", "last_modified": "Fri, 11 Jul 2025 11:59:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3420, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5bdbc4d577efdd7a9686cef8", "medicine_id": "EMEA/H/C/000141", "medicine_name": "Aprovel", "medicine_slug": "aprovel", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aprovel-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:13Z", "last_observed_at": "2026-10-12T17:26:13Z", "sha256": "3383665e6161202d11d8bb1a5a78a3be101fa9b6720ab511c7aff1deade77098", "format": "doc", "archive_key": "documents/3383665e6161202d11d8bb1a5a78a3be101fa9b6720ab511c7aff1deade77098.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768814466\"", "last_modified": "Mon, 19 Jan 2026 09:21:06 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-5c4b1563074cf370abd731d2", "medicine_id": "EMEA/H/C/006444", "medicine_name": "Yesintek", "medicine_slug": "yesintek", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/yesintek-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-16", "first_observed_at": "2026-10-12T19:01:42Z", "last_observed_at": "2026-10-12T19:01:42Z", "sha256": "af36675dabb26aa82f859ba13511b99517d8c35dfac15efb09c7f3fce4e70335", "format": "docx", "archive_key": "documents/af36675dabb26aa82f859ba13511b99517d8c35dfac15efb09c7f3fce4e70335.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771234000\"", "last_modified": "Mon, 16 Feb 2026 09:26:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7206, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5c630f886d2b1aea20d16c93", "medicine_id": "EMEA/H/C/001086", "medicine_name": "Olanzapine Glenmark Europe", "medicine_slug": "olanzapine-glenmark-europe", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olanzapine-glenmark-europe-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:36:55Z", "last_observed_at": "2026-10-12T13:36:55Z", "sha256": "141987f974c998a73803826b4c27040609d9b4d25fa70192250fe63168540714", "format": "doc", "archive_key": "documents/141987f974c998a73803826b4c27040609d9b4d25fa70192250fe63168540714.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778248875\"", "last_modified": "Fri, 08 May 2026 14:01:15 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-5cc7e60b7ce7491db0871744", "medicine_id": "EMEA/H/C/000277", "medicine_name": "Keppra", "medicine_slug": "keppra", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/keppra-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:40:48Z", "last_observed_at": "2026-10-12T13:40:48Z", "sha256": "74ef623005d36ee5c55466c546571211e70d55ed0682dc86570d24204be5a004", "format": "docx", "archive_key": "documents/74ef623005d36ee5c55466c546571211e70d55ed0682dc86570d24204be5a004.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775058839\"", "last_modified": "Wed, 01 Apr 2026 15:53:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6984, "changed_paragraphs": 28, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5d0ddbcbf15bf2217dcd7d29", "medicine_id": "EMEA/H/C/003904", "medicine_name": "Evotaz", "medicine_slug": "evotaz", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/evotaz-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:30:00Z", "last_observed_at": "2026-10-12T19:30:00Z", "sha256": "c1c81e29fc6ac333270e0137ac89849b3158977371d246308818d2cb0b12eaa5", "format": "docx", "archive_key": "documents/c1c81e29fc6ac333270e0137ac89849b3158977371d246308818d2cb0b12eaa5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752140308\"", "last_modified": "Thu, 10 Jul 2025 09:38:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1989, "changed_paragraphs": 493, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-5d4fd550118c7ba4b101e6f4", "medicine_id": "EMEA/H/C/006206", "medicine_name": "Axitinib Accord", "medicine_slug": "axitinib-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/axitinib-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-22", "first_observed_at": "2026-10-12T19:23:19Z", "last_observed_at": "2026-10-12T19:23:19Z", "sha256": "2e3bab208b94c70a8b5e22660fce0da159bbeca269390fcabc1d97dbcbffa2bf", "format": "docx", "archive_key": "documents/2e3bab208b94c70a8b5e22660fce0da159bbeca269390fcabc1d97dbcbffa2bf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753198740\"", "last_modified": "Tue, 22 Jul 2025 15:39:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2254, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5e60d5ca382f2c8103a43a9f", "medicine_id": "EMEA/H/C/000638", "medicine_name": "Revatio", "medicine_slug": "revatio", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/revatio-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:54Z", "last_observed_at": "2026-10-12T19:08:54Z", "sha256": "6c76ebca3d160f6e6247735b08832aff244f11590a807346afa8ca96b68b6f4c", "format": "docx", "archive_key": "documents/6c76ebca3d160f6e6247735b08832aff244f11590a807346afa8ca96b68b6f4c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758110665\"", "last_modified": "Wed, 17 Sep 2025 12:04:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3704, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-5ec469b534c264beb55c4562", "medicine_id": "EMEA/H/C/004700", "medicine_name": "Pelmeg", "medicine_slug": "pelmeg", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pelmeg-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:47:34Z", "last_observed_at": "2026-10-12T13:47:34Z", "sha256": "c3c48c436d46e094564a4264abeb3b64ba46030a34ff73cf712ceab8909a640e", "format": "docx", "archive_key": "documents/c3c48c436d46e094564a4264abeb3b64ba46030a34ff73cf712ceab8909a640e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773819967\"", "last_modified": "Wed, 18 Mar 2026 07:46:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1512, "changed_paragraphs": 123, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5f59e83e3e217d7dc0e9cce4", "medicine_id": "EMEA/H/C/006132", "medicine_name": "Wezenla", "medicine_slug": "wezenla", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/wezenla-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-01", "first_observed_at": "2026-10-12T13:33:41Z", "last_observed_at": "2026-10-12T13:33:41Z", "sha256": "d63fed33f96ccb747354bdd140e7ab8ff082b8871d5bc4a447e3b85b09c23b43", "format": "docx", "archive_key": "documents/d63fed33f96ccb747354bdd140e7ab8ff082b8871d5bc4a447e3b85b09c23b43.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782891101\"", "last_modified": "Wed, 01 Jul 2026 07:31:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6471, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-5fd40ff094c59a3730a0fa6c", "medicine_id": "EMEA/H/C/000610", "medicine_name": "Noxafil", "medicine_slug": "noxafil", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/noxafil-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-01", "first_observed_at": "2026-10-12T13:33:54Z", "last_observed_at": "2026-10-12T13:33:54Z", "sha256": "c04e50f3a55f2c8b60cd02dee87c8124ac98e6498185faaa13f3afcb3a098ecf", "format": "docx", "archive_key": "documents/c04e50f3a55f2c8b60cd02dee87c8124ac98e6498185faaa13f3afcb3a098ecf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776854779\"", "last_modified": "Wed, 22 Apr 2026 10:46:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7173, "changed_paragraphs": 1202, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-5ff0e792002ee89d9eb06e5d", "medicine_id": "EMEA/H/C/002066", "medicine_name": "Ikervis", "medicine_slug": "ikervis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ikervis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-23", "first_observed_at": "2026-10-12T13:34:10Z", "last_observed_at": "2026-10-12T13:34:10Z", "sha256": "7995ffe3d4b9c2e870327b45fae2f1d35ae1ab0e1e9e22b434fd9805b58a174e", "format": "docx", "archive_key": "documents/7995ffe3d4b9c2e870327b45fae2f1d35ae1ab0e1e9e22b434fd9805b58a174e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782212950\"", "last_modified": "Tue, 23 Jun 2026 11:09:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1870, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6018e28234a9d5c37071870c", "medicine_id": "EMEA/H/C/000637", "medicine_name": "Cubicin", "medicine_slug": "cubicin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cubicin-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-11-07", "first_observed_at": "2026-10-12T19:03:54Z", "last_observed_at": "2026-10-12T19:03:54Z", "sha256": "c1f08405bd58da9f437064c7822962f69565fa907534773d30cfc4bda11dd2cc", "format": "doc", "archive_key": "documents/c1f08405bd58da9f437064c7822962f69565fa907534773d30cfc4bda11dd2cc.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762508902\"", "last_modified": "Fri, 07 Nov 2025 09:48:22 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-6048aed0c6a5fd892436dd1f", "medicine_id": "EMEA/H/C/004837", "medicine_name": "Xromi", "medicine_slug": "xromi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xromi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-17", "first_observed_at": "2026-10-12T19:32:45Z", "last_observed_at": "2026-10-12T19:32:45Z", "sha256": "09fc95ca63cda4685a64f9a6f2786bf839a7e56efe05863cd60781314e5f87b5", "format": "docx", "archive_key": "documents/09fc95ca63cda4685a64f9a6f2786bf839a7e56efe05863cd60781314e5f87b5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750152672\"", "last_modified": "Tue, 17 Jun 2025 09:31:12 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1288, "changed_paragraphs": 42, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-612ea509efcaa0d2b9737d51", "medicine_id": "EMEA/H/C/004062", "medicine_name": "Entresto", "medicine_slug": "entresto", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/entresto-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-13", "first_observed_at": "2026-10-12T17:27:07Z", "last_observed_at": "2026-10-12T17:27:07Z", "sha256": "78649f2acc3217865ac07597094479c983d20c4268f66cb083c7979394ff345a", "format": "docx", "archive_key": "documents/78649f2acc3217865ac07597094479c983d20c4268f66cb083c7979394ff345a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768296036\"", "last_modified": "Tue, 13 Jan 2026 09:20:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3674, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-614e91f5970645497b96d67b", "medicine_id": "EMEA/H/C/002618", "medicine_name": "Nexium Control", "medicine_slug": "nexium-control", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nexium-control-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-03", "first_observed_at": "2026-10-12T13:36:18Z", "last_observed_at": "2026-10-12T13:36:18Z", "sha256": "dd192e79554a2cf904e3b717c765e723c89937d2250f85a0df30f9a56f6cb2e1", "format": "docx", "archive_key": "documents/dd192e79554a2cf904e3b717c765e723c89937d2250f85a0df30f9a56f6cb2e1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780482097\"", "last_modified": "Wed, 03 Jun 2026 10:21:37 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2116, "changed_paragraphs": 34, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-626a660cdaede0f74d56eeb0", "medicine_id": "EMEA/H/C/004214", "medicine_name": "Xeljanz", "medicine_slug": "xeljanz", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xeljanz-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-09-10", "first_observed_at": "2026-10-12T13:27:48Z", "last_observed_at": "2026-10-12T13:27:48Z", "sha256": "567c1f4ea6a73867a27dace3f5e27b47b4f7b4bee40b23992e05d06a0f5c870b", "format": "docx", "archive_key": "documents/567c1f4ea6a73867a27dace3f5e27b47b4f7b4bee40b23992e05d06a0f5c870b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789377549\"", "last_modified": "Mon, 14 Sep 2026 09:19:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9242, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-62a7db72503613e8f533a8c9", "medicine_id": "EMEA/H/C/005787", "medicine_name": "Livtencity", "medicine_slug": "livtencity", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/livtencity-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-05", "first_observed_at": "2026-10-12T19:16:56Z", "last_observed_at": "2026-10-12T19:16:56Z", "sha256": "1993086d076f16aae0606ac6e1de144dba82adf266f3979aec36b5596b057c3a", "format": "docx", "archive_key": "documents/1993086d076f16aae0606ac6e1de144dba82adf266f3979aec36b5596b057c3a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754397057\"", "last_modified": "Tue, 05 Aug 2025 12:30:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1543, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-63094e0e363a8df4cf45d497", "medicine_id": "EMEA/H/C/002697", "medicine_name": "Opsumit", "medicine_slug": "opsumit", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/opsumit-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:35Z", "last_observed_at": "2026-10-12T13:39:35Z", "sha256": "a47909a0ba6b5a7b0d2d0272b3ede6d466c755d471494f8b7fbb1b07b4cf2e6f", "format": "docx", "archive_key": "documents/a47909a0ba6b5a7b0d2d0272b3ede6d466c755d471494f8b7fbb1b07b4cf2e6f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776940923\"", "last_modified": "Thu, 23 Apr 2026 10:42:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2566, "changed_paragraphs": 33, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-633d511d05f1fff2eb0de73a", "medicine_id": "EMEA/H/C/000107", "medicine_name": "Epivir", "medicine_slug": "epivir", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/epivir-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:26Z", "last_observed_at": "2026-10-12T13:28:26Z", "sha256": "0719999535f36d1593098041092a62a85b74621a9bc5998fad6b31917f9b03b2", "format": "docx", "archive_key": "documents/0719999535f36d1593098041092a62a85b74621a9bc5998fad6b31917f9b03b2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787233239\"", "last_modified": "Thu, 20 Aug 2026 13:40:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3350, "changed_paragraphs": 347, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-63ba5976f2b2d4350a9afd16", "medicine_id": "EMEA/H/C/000725", "medicine_name": "Binocrit", "medicine_slug": "binocrit", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/binocrit-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:29:33Z", "last_observed_at": "2026-10-12T19:29:33Z", "sha256": "2110517cc45ca102ca5957f2578ba74090631cf709d5be3e5f6e34712f237bdb", "format": "docx", "archive_key": "documents/2110517cc45ca102ca5957f2578ba74090631cf709d5be3e5f6e34712f237bdb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752235789\"", "last_modified": "Fri, 11 Jul 2025 12:09:49 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3525, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-63c315f99ed4b0a7abc474b7", "medicine_id": "EMEA/H/C/003983", "medicine_name": "Nordimet", "medicine_slug": "nordimet", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nordimet-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:42Z", "last_observed_at": "2026-10-12T19:23:42Z", "sha256": "e7f04a283520007c0c784b04639c89eb37457990c57bdf9680c88f34ad56058f", "format": "docx", "archive_key": "documents/e7f04a283520007c0c784b04639c89eb37457990c57bdf9680c88f34ad56058f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752771204\"", "last_modified": "Thu, 17 Jul 2025 16:53:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6676, "changed_paragraphs": 78, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-64831dec5ebf55535e19d91b", "medicine_id": "EMEA/H/C/006047", "medicine_name": "Lacosamide Adroiq", "medicine_slug": "lacosamide-adroiq", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lacosamide-adroiq-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:07:56Z", "last_observed_at": "2026-10-12T19:07:56Z", "sha256": "0578c53a5e1c785c4d9d4dc0dabae49dbfa89e237aa571556bee548c3f9cf4d5", "format": "docx", "archive_key": "documents/0578c53a5e1c785c4d9d4dc0dabae49dbfa89e237aa571556bee548c3f9cf4d5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758792881\"", "last_modified": "Thu, 25 Sep 2025 09:34:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2058, "changed_paragraphs": 69, "unassigned_changed_paragraphs": 63 }, "pipeline_version": "2.0.0" }, { "id": "source-654079757d4a529e6fb6e369", "medicine_id": "EMEA/H/C/004954", "medicine_name": "Ultomiris", "medicine_slug": "ultomiris", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ultomiris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-22", "first_observed_at": "2026-10-12T19:05:12Z", "last_observed_at": "2026-10-12T19:05:12Z", "sha256": "30a8e705970ae61f24dba14e17b51655434cb3e6766c5050356d6bc9283b20d6", "format": "docx", "archive_key": "documents/30a8e705970ae61f24dba14e17b51655434cb3e6766c5050356d6bc9283b20d6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761120162\"", "last_modified": "Wed, 22 Oct 2025 08:02:42 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3511, "changed_paragraphs": 67, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-655cd60c5475e58b35c5a1c3", "medicine_id": "EMEA/H/C/001029", "medicine_name": "Nimvastid", "medicine_slug": "nimvastid", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nimvastid-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:24:04Z", "last_observed_at": "2026-10-12T19:24:04Z", "sha256": "8e6eaa143ff5f69cfa4caba1806dbd754ee713f2f64ce6a1b369433c9e511b46", "format": "docx", "archive_key": "documents/8e6eaa143ff5f69cfa4caba1806dbd754ee713f2f64ce6a1b369433c9e511b46.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752759917\"", "last_modified": "Thu, 17 Jul 2025 13:45:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3712, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-66a9b311e221786e939d11cd", "medicine_id": "EMEA/H/C/002036", "medicine_name": "Rivastigmine Actavis", "medicine_slug": "rivastigmine-actavis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rivastigmine-actavis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-13", "first_observed_at": "2026-10-12T19:36:31Z", "last_observed_at": "2026-10-12T19:36:31Z", "sha256": "2dc5a31daa72546008bd6fc537e9d469bc1b67d5ac3c177552df4e8957e42f91", "format": "docx", "archive_key": "documents/2dc5a31daa72546008bd6fc537e9d469bc1b67d5ac3c177552df4e8957e42f91.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749820241\"", "last_modified": "Fri, 13 Jun 2025 13:10:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2664, "changed_paragraphs": 64, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-66eff26170aa99059b087fe9", "medicine_id": "EMEA/H/C/000209", "medicine_name": "Micardis", "medicine_slug": "micardis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/micardis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:22Z", "last_observed_at": "2026-10-12T13:39:22Z", "sha256": "d102545ad80ecfee02702302c6f96b7445d571e24b76ee9c2b7cfbe2ddb00d0a", "format": "docx", "archive_key": "documents/d102545ad80ecfee02702302c6f96b7445d571e24b76ee9c2b7cfbe2ddb00d0a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777383724\"", "last_modified": "Tue, 28 Apr 2026 13:42:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2630, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6734c149d0cfab550c98319c", "medicine_id": "EMEA/H/C/005600", "medicine_name": "Rivaroxaban Viatris (previously Rivaroxaban Mylan)", "medicine_slug": "rivaroxaban-viatris-previously-rivaroxaban-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rivaroxaban-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-04", "first_observed_at": "2026-10-12T19:37:08Z", "last_observed_at": "2026-10-12T19:37:08Z", "sha256": "0a259647b297ee400ee98db938921b80900e015ef366694c6fbdf31e9b54f8bf", "format": "docx", "archive_key": "documents/0a259647b297ee400ee98db938921b80900e015ef366694c6fbdf31e9b54f8bf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749040054\"", "last_modified": "Wed, 04 Jun 2025 12:27:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8970, "changed_paragraphs": 43, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-67361df9477a2fb44b856987", "medicine_id": "EMEA/H/C/000387", "medicine_name": "Vfend", "medicine_slug": "vfend", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vfend-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-21", "first_observed_at": "2026-10-12T13:31:18Z", "last_observed_at": "2026-10-12T13:31:18Z", "sha256": "94cc6991b0ebb3cbab9fd3f1ff74793cc695a1e7382f1bae64ead346aee4f172", "format": "docx", "archive_key": "documents/94cc6991b0ebb3cbab9fd3f1ff74793cc695a1e7382f1bae64ead346aee4f172.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784618681\"", "last_modified": "Tue, 21 Jul 2026 07:24:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6725, "changed_paragraphs": 30, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-67edb5bf4917c536eec03461", "medicine_id": "EMEA/H/C/005155", "medicine_name": "Qdenga", "medicine_slug": "qdenga", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/qdenga-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:39Z", "last_observed_at": "2026-10-12T19:02:39Z", "sha256": "b728ede91da43e090207b0b91b65c1338bc82e0b4d99aee56d00eac27d113dbf", "format": "docx", "archive_key": "documents/b728ede91da43e090207b0b91b65c1338bc82e0b4d99aee56d00eac27d113dbf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769758320\"", "last_modified": "Fri, 30 Jan 2026 07:32:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2393, "changed_paragraphs": 50, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-688b729dcd27e19812bc7629", "medicine_id": "EMEA/H/C/005124", "medicine_name": "Enhertu", "medicine_slug": "enhertu", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/enhertu-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:30Z", "last_observed_at": "2026-10-12T17:29:30Z", "sha256": "2c1186179585b093922581e31e2dd472b88990f61f7c579f915e4cba3e2e16d0", "format": "docx", "archive_key": "documents/2c1186179585b093922581e31e2dd472b88990f61f7c579f915e4cba3e2e16d0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764772410\"", "last_modified": "Wed, 03 Dec 2025 14:33:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1905, "changed_paragraphs": 136, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-6897a05da7751ed6781e8850", "medicine_id": "EMEA/H/C/005286", "medicine_name": "Alymsys", "medicine_slug": "alymsys", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/alymsys-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-06", "first_observed_at": "2026-10-12T19:02:06Z", "last_observed_at": "2026-10-12T19:02:06Z", "sha256": "5bb6b472d886d4b44238eb3be4943592bb93672ef59e2424935ca8190fe65c5d", "format": "docx", "archive_key": "documents/5bb6b472d886d4b44238eb3be4943592bb93672ef59e2424935ca8190fe65c5d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770388988\"", "last_modified": "Fri, 06 Feb 2026 14:43:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3260, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-68b1486782aa24b2e1780d1a", "medicine_id": "EMEA/H/C/004691", "medicine_name": "Bylvay", "medicine_slug": "bylvay", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/bylvay-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:37:55Z", "last_observed_at": "2026-10-12T13:37:55Z", "sha256": "74cbff6904a88609bf126a1a5d75dd0095dbed08e2ba44afa7255f17700a8f26", "format": "docx", "archive_key": "documents/74cbff6904a88609bf126a1a5d75dd0095dbed08e2ba44afa7255f17700a8f26.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778243234\"", "last_modified": "Fri, 08 May 2026 12:27:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2154, "changed_paragraphs": 20, "unassigned_changed_paragraphs": 14 }, "pipeline_version": "2.0.0" }, { "id": "source-692f9c0ab54a6784e718a1c8", "medicine_id": "EMEA/H/C/006490", "medicine_name": "Kefdensis", "medicine_slug": "kefdensis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kefdensis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-17", "first_observed_at": "2026-10-12T13:31:24Z", "last_observed_at": "2026-10-12T13:31:24Z", "sha256": "68d5d0fdfc844ed21d50d246145dc128ededd715098f96cc7f0e7056dceadce6", "format": "docx", "archive_key": "documents/68d5d0fdfc844ed21d50d246145dc128ededd715098f96cc7f0e7056dceadce6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784284851\"", "last_modified": "Fri, 17 Jul 2026 10:40:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1415, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-69612ad0a7130272ef80a0bb", "medicine_id": "EMEA/H/C/002576", "medicine_name": "Remsima", "medicine_slug": "remsima", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/remsima-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:38:34Z", "last_observed_at": "2026-10-12T13:38:34Z", "sha256": "81284f9e87a57aa2b4bb159ee98e1cea5423cbaa00905564e50cc56c9e14fc81", "format": "docx", "archive_key": "documents/81284f9e87a57aa2b4bb159ee98e1cea5423cbaa00905564e50cc56c9e14fc81.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778245890\"", "last_modified": "Fri, 08 May 2026 13:11:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9415, "changed_paragraphs": 669, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6a3bc96c2a8d4e6a76f1de5f", "medicine_id": "EMEA/H/C/002322", "medicine_name": "Forxiga", "medicine_slug": "forxiga", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/forxiga-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-04-22", "first_observed_at": "2026-10-12T13:40:02Z", "last_observed_at": "2026-10-12T13:40:02Z", "sha256": "b7e9b6dc05aafa4e10a95d5d36359a9aee59f9b218244a211e92c2a95bb43d2f", "format": "doc", "archive_key": "documents/b7e9b6dc05aafa4e10a95d5d36359a9aee59f9b218244a211e92c2a95bb43d2f.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776862175\"", "last_modified": "Wed, 22 Apr 2026 12:49:35 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-6aea7cb32cb6b9ca9d172ab7", "medicine_id": "EMEA/H/C/000716", "medicine_name": "Exforge", "medicine_slug": "exforge", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exforge-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-19", "first_observed_at": "2026-10-12T17:31:07Z", "last_observed_at": "2026-10-12T17:31:07Z", "sha256": "02886f7b4db731b0682f3397373713ebc82b68e4dc0ce3736a528742d6852570", "format": "docx", "archive_key": "documents/02886f7b4db731b0682f3397373713ebc82b68e4dc0ce3736a528742d6852570.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763549620\"", "last_modified": "Wed, 19 Nov 2025 10:53:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2771, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6b2f9808dc7b5721775c9280", "medicine_id": "EMEA/H/C/006156", "medicine_name": "Stoboclo", "medicine_slug": "stoboclo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/stoboclo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:48Z", "last_observed_at": "2026-10-12T19:08:48Z", "sha256": "333f6c97855028e7dd6c52dd3e41e946d4c139c14aa4b6bab97c81affa0ae504", "format": "docx", "archive_key": "documents/333f6c97855028e7dd6c52dd3e41e946d4c139c14aa4b6bab97c81affa0ae504.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758104458\"", "last_modified": "Wed, 17 Sep 2025 10:20:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1544, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6c0a174e3252eed6113ab112", "medicine_id": "EMEA/H/C/006331", "medicine_name": "Sephience", "medicine_slug": "sephience", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sephience-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-22", "first_observed_at": "2026-10-12T13:36:33Z", "last_observed_at": "2026-10-12T13:36:33Z", "sha256": "3bd9c395fd1963d3c1be5f873f8c45eddfe7431c217731b39f007f524e65db6c", "format": "docx", "archive_key": "documents/3bd9c395fd1963d3c1be5f873f8c45eddfe7431c217731b39f007f524e65db6c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1779443740\"", "last_modified": "Fri, 22 May 2026 09:55:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1860, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6c6fdb137b5a91b3c0bdfa39", "medicine_id": "EMEA/H/C/006157", "medicine_name": "Osenvelt", "medicine_slug": "osenvelt", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/osenvelt-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:18Z", "last_observed_at": "2026-10-12T13:47:18Z", "sha256": "e74ea24fb9dba91ab1b6ba63cf2fbbf8cc5d2abd0a787ab2373576bcaa232ea2", "format": "docx", "archive_key": "documents/e74ea24fb9dba91ab1b6ba63cf2fbbf8cc5d2abd0a787ab2373576bcaa232ea2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773932556\"", "last_modified": "Thu, 19 Mar 2026 15:02:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1424, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6c9cd3ce9d08acf18f2e6071", "medicine_id": "EMEA/H/C/000861", "medicine_name": "Janumet", "medicine_slug": "janumet", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/janumet-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-11-13", "first_observed_at": "2026-10-12T19:03:15Z", "last_observed_at": "2026-10-12T19:03:15Z", "sha256": "734fad417d8520960826143e4c4668ab0093297743f90472db7326382f07b45a", "format": "doc", "archive_key": "documents/734fad417d8520960826143e4c4668ab0093297743f90472db7326382f07b45a.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763021856\"", "last_modified": "Thu, 13 Nov 2025 08:17:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-6d8e9743211a1bd771234a79", "medicine_id": "EMEA/H/C/000314", "medicine_name": "Neoclarityn", "medicine_slug": "neoclarityn", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/neoclarityn-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:27Z", "last_observed_at": "2026-10-12T13:47:27Z", "sha256": "95c77b8bb79a4be584e66485b8cba7ae8d117f73ed71304c72deeb2fdaf1bdd6", "format": "docx", "archive_key": "documents/95c77b8bb79a4be584e66485b8cba7ae8d117f73ed71304c72deeb2fdaf1bdd6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773917134\"", "last_modified": "Thu, 19 Mar 2026 10:45:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1872, "changed_paragraphs": 38, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6dd42b0061d687f44f1d489c", "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:47Z", "last_observed_at": "2026-10-12T19:29:47Z", "sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "format": "docx", "archive_key": "documents/e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752152595\"", "last_modified": "Thu, 10 Jul 2025 13:03:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3239, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6de14ff57b8ce7397893a636", "medicine_id": "EMEA/H/C/000955", "medicine_name": "RoActemra", "medicine_slug": "roactemra", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/roactemra-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:42:39Z", "last_observed_at": "2026-10-12T13:42:39Z", "sha256": "72afdc53bbcc6479ec5acd0b7d60ba3c37dbb0d17876de3458e30d98dddaf154", "format": "docx", "archive_key": "documents/72afdc53bbcc6479ec5acd0b7d60ba3c37dbb0d17876de3458e30d98dddaf154.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775037439\"", "last_modified": "Wed, 01 Apr 2026 09:57:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7436, "changed_paragraphs": 1272, "unassigned_changed_paragraphs": 28 }, "pipeline_version": "2.0.0" }, { "id": "source-6e674964b906c6da271ee30d", "medicine_id": "EMEA/H/C/005851", "medicine_name": "Veoza", "medicine_slug": "veoza", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/veoza-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:47:39Z", "last_observed_at": "2026-10-12T13:47:39Z", "sha256": "ae983856456c6ca826f3a4d7354722e8db2b236d98401bd2e35fb238e1654275", "format": "docx", "archive_key": "documents/ae983856456c6ca826f3a4d7354722e8db2b236d98401bd2e35fb238e1654275.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773827829\"", "last_modified": "Wed, 18 Mar 2026 09:57:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 944, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6f1687522fd00b52ee83fd24", "medicine_id": "EMEA/H/C/000577", "medicine_name": "Zonegran", "medicine_slug": "zonegran", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zonegran-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-07-22", "first_observed_at": "2026-10-12T13:30:59Z", "last_observed_at": "2026-10-12T13:30:59Z", "sha256": "5aa491413e553c60bcbdad36daa2369392795b6687646891a699875a905289a9", "format": "doc", "archive_key": "documents/5aa491413e553c60bcbdad36daa2369392795b6687646891a699875a905289a9.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784705945\"", "last_modified": "Wed, 22 Jul 2026 07:39:05 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-6f41957f3e226ba3c2017b1b", "medicine_id": "EMEA/H/C/004541", "medicine_name": "LysaKare", "medicine_slug": "lysakare", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lysakare-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-07", "first_observed_at": "2026-10-12T19:16:53Z", "last_observed_at": "2026-10-12T19:16:53Z", "sha256": "91a7871b49f26c01712cd132cbf3718ec6edc38d6ba5f57c3c725b7d88d6c682", "format": "docx", "archive_key": "documents/91a7871b49f26c01712cd132cbf3718ec6edc38d6ba5f57c3c725b7d88d6c682.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754575046\"", "last_modified": "Thu, 07 Aug 2025 13:57:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 967, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-6fe04bbf4adebecc8fc5931f", "medicine_id": "EMEA/H/C/000123", "medicine_name": "Hycamtin", "medicine_slug": "hycamtin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/hycamtin-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-20", "first_observed_at": "2026-10-12T17:26:10Z", "last_observed_at": "2026-10-12T17:26:10Z", "sha256": "5c152141b53e2793fa084f4367d516f378805cad1930405e70758c7fdb02fb17", "format": "docx", "archive_key": "documents/5c152141b53e2793fa084f4367d516f378805cad1930405e70758c7fdb02fb17.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768913183\"", "last_modified": "Tue, 20 Jan 2026 12:46:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2624, "changed_paragraphs": 153, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-70a38464ff06de59375a15c3", "medicine_id": "EMEA/H/C/005106", "medicine_name": "Aybintio", "medicine_slug": "aybintio", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aybintio-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-09-11", "first_observed_at": "2026-10-12T13:27:44Z", "last_observed_at": "2026-10-12T13:27:44Z", "sha256": "4a45f4a7b4e7df4dbc475a3f92ce3f16543120b39806a2fc6e5399c3925ecba4", "format": "docx", "archive_key": "documents/4a45f4a7b4e7df4dbc475a3f92ce3f16543120b39806a2fc6e5399c3925ecba4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789137855\"", "last_modified": "Fri, 11 Sep 2026 14:44:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3435, "changed_paragraphs": 149, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-722a64f3e6551937da0b93d9", "medicine_id": "EMEA/H/C/000582", "medicine_name": "Avastin", "medicine_slug": "avastin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/avastin-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-19", "first_observed_at": "2026-10-12T17:27:21Z", "last_observed_at": "2026-10-12T17:27:21Z", "sha256": "8ef22a54b74bb234ed68489d904e9509f2ab58faeab1688109ec72b9aa5a8ea1", "format": "docx", "archive_key": "documents/8ef22a54b74bb234ed68489d904e9509f2ab58faeab1688109ec72b9aa5a8ea1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766158920\"", "last_modified": "Fri, 19 Dec 2025 15:42:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3412, "changed_paragraphs": 98, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-724f8adea0b2dac54fbd6668", "medicine_id": "EMEA/H/C/000637", "medicine_name": "Cubicin", "medicine_slug": "cubicin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cubicin-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-11-07", "first_observed_at": "2026-10-12T19:03:55Z", "last_observed_at": "2026-10-12T19:03:55Z", "sha256": "61ca40bfea03b296126cc264518849502215ebf70d7826a7f30425d21ecfb016", "format": "doc", "archive_key": "documents/61ca40bfea03b296126cc264518849502215ebf70d7826a7f30425d21ecfb016.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762508902\"", "last_modified": "Fri, 07 Nov 2025 09:48:22 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-736087fcf75075c699ca6d07", "medicine_id": "EMEA/H/C/003825", "medicine_name": "Kovaltry", "medicine_slug": "kovaltry", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kovaltry-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:21Z", "last_observed_at": "2026-10-12T19:16:21Z", "sha256": "37f8207bea98621f0b4c381f86336ad33efe5afbb6a749e3883f215b8b5e1252", "format": "docx", "archive_key": "documents/37f8207bea98621f0b4c381f86336ad33efe5afbb6a749e3883f215b8b5e1252.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755092403\"", "last_modified": "Wed, 13 Aug 2025 13:40:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3051, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-73865bb2a5ff8c08db12d0a5", "medicine_id": "EMEA/H/C/002148", "medicine_name": "Eliquis", "medicine_slug": "eliquis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eliquis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-10", "first_observed_at": "2026-10-12T13:40:34Z", "last_observed_at": "2026-10-12T13:40:34Z", "sha256": "c54abbd2894fde8e42e5403d9db3de0fa7604eb7fed075a561968d212abc50e2", "format": "docx", "archive_key": "documents/c54abbd2894fde8e42e5403d9db3de0fa7604eb7fed075a561968d212abc50e2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775807731\"", "last_modified": "Fri, 10 Apr 2026 07:55:31 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8238, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-741a303e650c879c64a10299", "medicine_id": "EMEA/H/C/000726", "medicine_name": "Epoetin Alfa Hexal", "medicine_slug": "epoetin-alfa-hexal", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/epoetin-alfa-hexal-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:29:34Z", "last_observed_at": "2026-10-12T19:29:34Z", "sha256": "6b302cb4a449e96d46ae569112fc8fd34af0c680a2e54ae4dff49413090ca3ba", "format": "docx", "archive_key": "documents/6b302cb4a449e96d46ae569112fc8fd34af0c680a2e54ae4dff49413090ca3ba.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752236350\"", "last_modified": "Fri, 11 Jul 2025 12:19:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3592, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-74a972f326a56852636a8d73", "medicine_id": "EMEA/H/C/003899", "medicine_name": "Aripiprazole Zentiva", "medicine_slug": "aripiprazole-zentiva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aripiprazole-zentiva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:46Z", "last_observed_at": "2026-10-12T19:23:46Z", "sha256": "d6a2f089f9ac163473ce85080c2dd3cb30d0da573ba0f2a94a071bbf520e39e1", "format": "docx", "archive_key": "documents/d6a2f089f9ac163473ce85080c2dd3cb30d0da573ba0f2a94a071bbf520e39e1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752755294\"", "last_modified": "Thu, 17 Jul 2025 12:28:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1867, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-74cb508bb20024b25ca75f56", "medicine_id": "EMEA/H/C/000770", "medicine_name": "Avamys", "medicine_slug": "avamys", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avamys-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-27", "first_observed_at": "2026-10-12T19:30:29Z", "last_observed_at": "2026-10-12T19:30:29Z", "sha256": "30f949bc5059758fc7a5c6971f20b61b1a1216476650dc650963a3ac481e29e3", "format": "docx", "archive_key": "documents/30f949bc5059758fc7a5c6971f20b61b1a1216476650dc650963a3ac481e29e3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751030345\"", "last_modified": "Fri, 27 Jun 2025 13:19:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1134, "changed_paragraphs": 46, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-74d99b58ea458b890be55112", "medicine_id": "EMEA/H/C/000861", "medicine_name": "Janumet", "medicine_slug": "janumet", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/janumet-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-11-13", "first_observed_at": "2026-10-12T19:03:38Z", "last_observed_at": "2026-10-12T19:03:38Z", "sha256": "ae6c5cfea7ba34d5704aa4426572f04481cbab2df2cd86b3b4b463396b2c90dd", "format": "doc", "archive_key": "documents/ae6c5cfea7ba34d5704aa4426572f04481cbab2df2cd86b3b4b463396b2c90dd.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763021856\"", "last_modified": "Thu, 13 Nov 2025 08:17:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-7508e7201bb8a43bd9b91ec2", "medicine_id": "EMEA/H/C/005188", "medicine_name": "Yuflyma", "medicine_slug": "yuflyma", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/yuflyma-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-29", "first_observed_at": "2026-10-12T19:06:55Z", "last_observed_at": "2026-10-12T19:06:55Z", "sha256": "73adf93ea478d4bf38fe3cf8a5c23bbe19099e6d7de821eefcfbee37943efcc0", "format": "docx", "archive_key": "documents/73adf93ea478d4bf38fe3cf8a5c23bbe19099e6d7de821eefcfbee37943efcc0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759132228\"", "last_modified": "Mon, 29 Sep 2025 07:50:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12281, "changed_paragraphs": 81, "unassigned_changed_paragraphs": 68 }, "pipeline_version": "2.0.0" }, { "id": "source-750c7d46a048359f1c3ff91d", "medicine_id": "EMEA/H/C/000229", "medicine_name": "Temodal", "medicine_slug": "temodal", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/temodal-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:29:11Z", "last_observed_at": "2026-10-12T13:29:11Z", "sha256": "062fdc919f262fcf3dde48b64a3c02fa7d96cec91d202dce934382469ed96477", "format": "doc", "archive_key": "documents/062fdc919f262fcf3dde48b64a3c02fa7d96cec91d202dce934382469ed96477.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787043683\"", "last_modified": "Tue, 18 Aug 2026 09:01:23 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-753ed8ea69e2a319805bb49a", "medicine_id": "EMEA/H/C/000709", "medicine_name": "Sprycel", "medicine_slug": "sprycel", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sprycel-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-10-02", "first_observed_at": "2026-10-12T13:27:38Z", "last_observed_at": "2026-10-12T13:27:38Z", "sha256": "f19afb6c99c9f6c4da575a1ec1ad2116d41e1ee33bed1a9a3406fd820f8970ff", "format": "docx", "archive_key": "documents/f19afb6c99c9f6c4da575a1ec1ad2116d41e1ee33bed1a9a3406fd820f8970ff.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1790943274\"", "last_modified": "Fri, 02 Oct 2026 12:14:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5670, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-7564891c75c2f1a5d64da8ed", "medicine_id": "EMEA/H/C/005408", "medicine_name": "Abiraterone Accord", "medicine_slug": "abiraterone-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abiraterone-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:43:59Z", "last_observed_at": "2026-10-12T19:43:59Z", "sha256": "fa312c7bfb93879e66d97718ee1587e6a15c0d2d0a7f105c38f56500753d2c82", "format": "docx", "archive_key": "documents/fa312c7bfb93879e66d97718ee1587e6a15c0d2d0a7f105c38f56500753d2c82.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746513758\"", "last_modified": "Tue, 06 May 2025 06:42:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2450, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7580660f482eb37f545c6326", "medicine_id": "EMEA/H/C/002268", "medicine_name": "Dexdor", "medicine_slug": "dexdor", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/dexdor-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:47Z", "last_observed_at": "2026-10-12T19:02:47Z", "sha256": "593ac7853608bf9ee93a86c1e2055297f16055936e33894b23fded909b70adcd", "format": "docx", "archive_key": "documents/593ac7853608bf9ee93a86c1e2055297f16055936e33894b23fded909b70adcd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769600848\"", "last_modified": "Wed, 28 Jan 2026 11:47:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1194, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-769b51656353ff61c92cebe7", "medicine_id": "EMEA/H/C/002667", "medicine_name": "Zoledronic Acid Accord", "medicine_slug": "zoledronic-acid-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zoledronic-acid-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-24", "first_observed_at": "2026-10-12T19:01:19Z", "last_observed_at": "2026-10-12T19:01:19Z", "sha256": "a5fcf681ea64231b44df43b25723edbb5baa2913dbb68b77a75d6d29c4327818", "format": "docx", "archive_key": "documents/a5fcf681ea64231b44df43b25723edbb5baa2913dbb68b77a75d6d29c4327818.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771922835\"", "last_modified": "Tue, 24 Feb 2026 08:47:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1443, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-775bf49790604674d3549dac", "medicine_id": "EMEA/H/C/001029", "medicine_name": "Nimvastid", "medicine_slug": "nimvastid", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nimvastid-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:24:00Z", "last_observed_at": "2026-10-12T19:24:00Z", "sha256": "fa4c6e344db60bf4064eb3cc2d76d72c0fc858894147724d88ab2d66b9f9a0dc", "format": "docx", "archive_key": "documents/fa4c6e344db60bf4064eb3cc2d76d72c0fc858894147724d88ab2d66b9f9a0dc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752759917\"", "last_modified": "Thu, 17 Jul 2025 13:45:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3788, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-77d6cc5bd19bd71f20e22a8e", "medicine_id": "EMEA/H/C/000174", "medicine_name": "Plavix", "medicine_slug": "plavix", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/plavix-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-14", "first_observed_at": "2026-10-12T19:26:25Z", "last_observed_at": "2026-10-12T19:26:25Z", "sha256": "8d1630f20e7a86728cac32eaccf248b0a0e88d4d9a2a9cfa6e6429b883e20247", "format": "docx", "archive_key": "documents/8d1630f20e7a86728cac32eaccf248b0a0e88d4d9a2a9cfa6e6429b883e20247.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752505558\"", "last_modified": "Mon, 14 Jul 2025 15:05:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1944, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-78446c8b8a3f407daebb9a37", "medicine_id": "EMEA/H/C/000179", "medicine_name": "Aldara", "medicine_slug": "aldara", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aldara-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-07-18", "first_observed_at": "2026-10-12T19:23:32Z", "last_observed_at": "2026-10-12T19:23:32Z", "sha256": "6266980ef33b131c7e82a36c62cf97793a9ac0514aa40f006dfbbdc3c0639fab", "format": "doc", "archive_key": "documents/6266980ef33b131c7e82a36c62cf97793a9ac0514aa40f006dfbbdc3c0639fab.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752844835\"", "last_modified": "Fri, 18 Jul 2025 13:20:35 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-791eb96e62fdebcce4c81ec4", "medicine_id": "EMEA/H/C/002547", "medicine_name": "Perjeta", "medicine_slug": "perjeta", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/perjeta-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:17Z", "last_observed_at": "2026-10-12T13:39:17Z", "sha256": "dfc85998efa134fbc08630f7e0f1d1183bd4fb18ec62a15b680bda3fd94b49bd", "format": "docx", "archive_key": "documents/dfc85998efa134fbc08630f7e0f1d1183bd4fb18ec62a15b680bda3fd94b49bd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777364388\"", "last_modified": "Tue, 28 Apr 2026 08:19:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1817, "changed_paragraphs": 70, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-7977bdc4691529bbe235aace", "medicine_id": "EMEA/H/C/001137", "medicine_name": "Clopidogrel Krka d.d. (previously Zopya)", "medicine_slug": "clopidogrel-krka-d-d-previously-zopya", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/clopidogrel-krka-dd-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:41:11Z", "last_observed_at": "2026-10-12T19:41:11Z", "sha256": "c0f3df56eb219312644909037f2a5c0fdd2f3250f4ca506cff139bc603a20e30", "format": "docx", "archive_key": "documents/c0f3df56eb219312644909037f2a5c0fdd2f3250f4ca506cff139bc603a20e30.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747148280\"", "last_modified": "Tue, 13 May 2025 14:58:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1277, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-79bede7a4a9cd1c040f622e0", "medicine_id": "EMEA/H/C/000403", "medicine_name": "Arixtra", "medicine_slug": "arixtra", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/arixtra-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-07", "first_observed_at": "2026-10-12T13:38:50Z", "last_observed_at": "2026-10-12T13:38:50Z", "sha256": "123deb3dbdc841a7adc2b8046138993b8a6a1c228bde13a95278b14d17c5cefd", "format": "docx", "archive_key": "documents/123deb3dbdc841a7adc2b8046138993b8a6a1c228bde13a95278b14d17c5cefd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778161333\"", "last_modified": "Thu, 07 May 2026 13:42:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4405, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-79c735b5dcac04ba6a20c112", "medicine_id": "EMEA/H/C/000123", "medicine_name": "Hycamtin", "medicine_slug": "hycamtin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/hycamtin-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-20", "first_observed_at": "2026-10-12T17:26:11Z", "last_observed_at": "2026-10-12T17:26:11Z", "sha256": "cc740ce34adc3137bbf79ea76fa7ba5cd9093619d96b5fb84f05b9163c07a229", "format": "docx", "archive_key": "documents/cc740ce34adc3137bbf79ea76fa7ba5cd9093619d96b5fb84f05b9163c07a229.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768913183\"", "last_modified": "Tue, 20 Jan 2026 12:46:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2631, "changed_paragraphs": 152, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7af7b31f2ef15dac3ee8669d", "medicine_id": "EMEA/H/C/000461", "medicine_name": "Carbaglu", "medicine_slug": "carbaglu", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/carbaglu-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-12-09", "first_observed_at": "2026-10-12T17:28:30Z", "last_observed_at": "2026-10-12T17:28:30Z", "sha256": "045a4f1a74b185cb1d60fa5a9d54875e361c89d919994ec557dcbf36a77e8e9d", "format": "doc", "archive_key": "documents/045a4f1a74b185cb1d60fa5a9d54875e361c89d919994ec557dcbf36a77e8e9d.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765293426\"", "last_modified": "Tue, 09 Dec 2025 15:17:06 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-7b72b6a5a1bcef463d8d4c09", "medicine_id": "EMEA/H/C/005649", "medicine_name": "Abiraterone Krka", "medicine_slug": "abiraterone-krka", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abiraterone-krka-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-16", "first_observed_at": "2026-10-12T17:26:54Z", "last_observed_at": "2026-10-12T17:26:54Z", "sha256": "e9ad57d1bf9a116fcc1e3ff7e3fde52af4007952137d8e27755f50a8c750fe1c", "format": "docx", "archive_key": "documents/e9ad57d1bf9a116fcc1e3ff7e3fde52af4007952137d8e27755f50a8c750fe1c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768569797\"", "last_modified": "Fri, 16 Jan 2026 13:23:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1343, "changed_paragraphs": 19, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7bf05856cb694d311b006534", "medicine_id": "EMEA/H/C/005083", "medicine_name": "Icatibant Accord", "medicine_slug": "icatibant-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/icatibant-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-27", "first_observed_at": "2026-10-12T19:15:33Z", "last_observed_at": "2026-10-12T19:15:33Z", "sha256": "470b6da012e1dd5d6e009003da916284a54c66dab3888e4b288da25a866c1a23", "format": "docx", "archive_key": "documents/470b6da012e1dd5d6e009003da916284a54c66dab3888e4b288da25a866c1a23.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756310331\"", "last_modified": "Wed, 27 Aug 2025 15:58:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1449, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-7c08662da3f3659ef8e2a64b", "medicine_id": "EMEA/H/C/001092", "medicine_name": "Urorec", "medicine_slug": "urorec", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-05-07", "first_observed_at": "2026-10-12T19:43:07Z", "last_observed_at": "2026-10-12T19:43:07Z", "sha256": "bdf68a3c68a2441792b51ec68d227b0ca2545b9d14730d3e621a911f04ece799", "format": "doc", "archive_key": "documents/bdf68a3c68a2441792b51ec68d227b0ca2545b9d14730d3e621a911f04ece799.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746603767\"", "last_modified": "Wed, 07 May 2025 07:42:47 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-7ce336750684e46ba3e4e54c", "medicine_id": "EMEA/H/C/004697", "medicine_name": "Zirabev", "medicine_slug": "zirabev", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zirabev-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:39Z", "last_observed_at": "2026-10-12T19:08:39Z", "sha256": "ef33f1350f1fcae139a251926014b13e3e973646fc918d603307fbce8dac4777", "format": "docx", "archive_key": "documents/ef33f1350f1fcae139a251926014b13e3e973646fc918d603307fbce8dac4777.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758101028\"", "last_modified": "Wed, 17 Sep 2025 09:23:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3437, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7d0e02438c6e7c5e837951cb", "medicine_id": "EMEA/H/C/006315", "medicine_name": "Nilotinib Accord", "medicine_slug": "nilotinib-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nilotinib-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-27", "first_observed_at": "2026-10-12T19:15:30Z", "last_observed_at": "2026-10-12T19:15:30Z", "sha256": "29f7f7fa138127cade700306bb16ae046efeac84454af171222cf609232d28ad", "format": "docx", "archive_key": "documents/29f7f7fa138127cade700306bb16ae046efeac84454af171222cf609232d28ad.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756309981\"", "last_modified": "Wed, 27 Aug 2025 15:53:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3671, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7d6ee877ee45091e559446f5", "medicine_id": "EMEA/H/C/004978", "medicine_name": "Brukinsa", "medicine_slug": "brukinsa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/brukinsa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-10-07", "first_observed_at": "2026-10-12T13:27:26Z", "last_observed_at": "2026-10-12T13:27:26Z", "sha256": "efec7bab67f8714aa0fdd45569bd6351972f18b19a073cffc0c53d347ad4ce72", "format": "docx", "archive_key": "documents/efec7bab67f8714aa0fdd45569bd6351972f18b19a073cffc0c53d347ad4ce72.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791375386\"", "last_modified": "Wed, 07 Oct 2026 12:16:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3766, "changed_paragraphs": 23, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7d90e140ea04fe82f7b1c281", "medicine_id": "EMEA/H/C/005964", "medicine_name": "Jubbonti", "medicine_slug": "jubbonti", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/jubbonti-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-19", "first_observed_at": "2026-10-12T19:08:30Z", "last_observed_at": "2026-10-12T19:08:30Z", "sha256": "df6b97acc2d782b761f939572b7292740dd9eb14cd692875fb83dea28bac754d", "format": "docx", "archive_key": "documents/df6b97acc2d782b761f939572b7292740dd9eb14cd692875fb83dea28bac754d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758292475\"", "last_modified": "Fri, 19 Sep 2025 14:34:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1441, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7e84dc3bae05202871efa7ac", "medicine_id": "EMEA/H/C/004117", "medicine_name": "Ivabradine Zentiva", "medicine_slug": "ivabradine-zentiva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ivabradine-zentiva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:57Z", "last_observed_at": "2026-10-12T19:23:57Z", "sha256": "c131ef3ede875f5cd9e2fa5e172723e1559e5bce9457ffb41810bafda52c9d35", "format": "docx", "archive_key": "documents/c131ef3ede875f5cd9e2fa5e172723e1559e5bce9457ffb41810bafda52c9d35.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752756116\"", "last_modified": "Thu, 17 Jul 2025 12:41:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1502, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7e9edf5440112867feba4dfd", "medicine_id": "EMEA/H/C/005935", "medicine_name": "Sugammadex Amomed", "medicine_slug": "sugammadex-amomed", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-amomed-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-04", "first_observed_at": "2026-10-12T19:02:25Z", "last_observed_at": "2026-10-12T19:02:25Z", "sha256": "ae645c25161b6a41ea1078df5adc6903473670747f6e918de1e9cf3271e56a85", "format": "docx", "archive_key": "documents/ae645c25161b6a41ea1078df5adc6903473670747f6e918de1e9cf3271e56a85.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770220483\"", "last_modified": "Wed, 04 Feb 2026 15:54:43 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1673, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7f06bcf15955d01df9ebd779", "medicine_id": "EMEA/H/C/004248", "medicine_name": "Alunbrig", "medicine_slug": "alunbrig", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/alunbrig-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-04-25", "first_observed_at": "2026-10-12T19:45:32Z", "last_observed_at": "2026-10-12T19:45:32Z", "sha256": "ceeea3d080ec03592ddcd94f99b1a811906e8dff0f52cc9f5707ee2654f1a693", "format": "docx", "archive_key": "documents/ceeea3d080ec03592ddcd94f99b1a811906e8dff0f52cc9f5707ee2654f1a693.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1745594386\"", "last_modified": "Fri, 25 Apr 2025 15:19:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2848, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 10 }, "pipeline_version": "2.0.0" }, { "id": "source-7f08b7886dbefa50c9bbf715", "medicine_id": "EMEA/H/C/000481", "medicine_name": "Humira", "medicine_slug": "humira", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humira-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-08", "first_observed_at": "2026-10-12T19:05:51Z", "last_observed_at": "2026-10-12T19:05:51Z", "sha256": "0ecf37e08cb0de31151fecc637d8f3d6baf2f44a169e36dd20e9e3f3d348320c", "format": "docx", "archive_key": "documents/0ecf37e08cb0de31151fecc637d8f3d6baf2f44a169e36dd20e9e3f3d348320c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759932961\"", "last_modified": "Wed, 08 Oct 2025 14:16:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 19644, "changed_paragraphs": 5022, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-7f4d129b0a0fd2d3684d27c5", "medicine_id": "EMEA/H/C/006016", "medicine_name": "Imjudo", "medicine_slug": "imjudo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/imjudo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-14", "first_observed_at": "2026-10-12T19:16:18Z", "last_observed_at": "2026-10-12T19:16:18Z", "sha256": "2437ab76633f46c9eee5e002e5c7a7caba6367f59567d750be0eb67c74d1db4e", "format": "docx", "archive_key": "documents/2437ab76633f46c9eee5e002e5c7a7caba6367f59567d750be0eb67c74d1db4e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755183398\"", "last_modified": "Thu, 14 Aug 2025 14:56:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2525, "changed_paragraphs": 20, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8075e4298c10512552c265e3", "medicine_id": "EMEA/H/C/002755", "medicine_name": "Abilify Maintena", "medicine_slug": "abilify-maintena", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-28", "first_observed_at": "2026-10-12T19:04:26Z", "last_observed_at": "2026-10-12T19:04:26Z", "sha256": "d5a456363dc53f0ebe6b8dc0c37dce26959e56f243306d33d5f17dc7739cbc45", "format": "docx", "archive_key": "documents/d5a456363dc53f0ebe6b8dc0c37dce26959e56f243306d33d5f17dc7739cbc45.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761656911\"", "last_modified": "Tue, 28 Oct 2025 13:08:31 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5613, "changed_paragraphs": 99, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-80b0d9db881bf774bffb5d3c", "medicine_id": "EMEA/H/C/002022", "medicine_name": "Xaluprine (previously Mercaptopurine Nova Laboratories)", "medicine_slug": "xaluprine-previously-mercaptopurine-nova-laboratories", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xaluprine-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:08:02Z", "last_observed_at": "2026-10-12T19:08:02Z", "sha256": "a352706294cb9013c5ba158da50186f12673cdb6fb887d0033e1457d44698091", "format": "docx", "archive_key": "documents/a352706294cb9013c5ba158da50186f12673cdb6fb887d0033e1457d44698091.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758811623\"", "last_modified": "Thu, 25 Sep 2025 14:47:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1465, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8116ef89b641d9a73d218c68", "medicine_id": "EMEA/H/C/005984", "medicine_name": "Tocilizumab STADA (previously Tofidence)", "medicine_slug": "tocilizumab-stada-previously-tofidence", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tocilizumab-stada-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-20", "first_observed_at": "2026-10-12T17:26:06Z", "last_observed_at": "2026-10-12T17:26:06Z", "sha256": "e85a34cd8f287b1fcc1b295d47151ff1cdd43b6c5d781d465ebb56ee155cdbe3", "format": "docx", "archive_key": "documents/e85a34cd8f287b1fcc1b295d47151ff1cdd43b6c5d781d465ebb56ee155cdbe3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768900642\"", "last_modified": "Tue, 20 Jan 2026 09:17:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2561, "changed_paragraphs": 91, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-811e4641286f40b071017e0c", "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:02Z", "last_observed_at": "2026-10-12T19:09:02Z", "sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "format": "docx", "archive_key": "documents/8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758111235\"", "last_modified": "Wed, 17 Sep 2025 12:13:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4028, "changed_paragraphs": 22, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-813eb8c9e5f8c780c307d230", "medicine_id": "EMEA/H/C/004212", "medicine_name": "Amgevita", "medicine_slug": "amgevita", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/amgevita-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:38Z", "last_observed_at": "2026-10-12T13:39:38Z", "sha256": "6f92419b049d4385c724668fa5eb4e806bffd72b3d39fb7c8cd44fa9594fe783", "format": "docx", "archive_key": "documents/6f92419b049d4385c724668fa5eb4e806bffd72b3d39fb7c8cd44fa9594fe783.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776937404\"", "last_modified": "Thu, 23 Apr 2026 09:43:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12023, "changed_paragraphs": 167, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8141502273c64e6c1d988800", "medicine_id": "EMEA/H/C/005279", "medicine_name": "Rivaroxaban Accord", "medicine_slug": "rivaroxaban-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rivaroxaban-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-28", "first_observed_at": "2026-10-12T19:15:25Z", "last_observed_at": "2026-10-12T19:15:25Z", "sha256": "d3c9c2e0247ff6a62c75ce67f4969b0f6bfe5e35aaa2d6e825d93f844e6239f5", "format": "docx", "archive_key": "documents/d3c9c2e0247ff6a62c75ce67f4969b0f6bfe5e35aaa2d6e825d93f844e6239f5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756380054\"", "last_modified": "Thu, 28 Aug 2025 11:20:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8453, "changed_paragraphs": 15, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8175f531425e04cb590ef72c", "medicine_id": "EMEA/H/C/006046", "medicine_name": "Sugammadex Adroiq", "medicine_slug": "sugammadex-adroiq", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-adroiq-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:07:50Z", "last_observed_at": "2026-10-12T19:07:50Z", "sha256": "4f8f3382e28818ead35c9f666aed17ebc79074b43a1ec31a5d7e9fbe7cd6ed89", "format": "docx", "archive_key": "documents/4f8f3382e28818ead35c9f666aed17ebc79074b43a1ec31a5d7e9fbe7cd6ed89.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758789876\"", "last_modified": "Thu, 25 Sep 2025 08:44:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1645, "changed_paragraphs": 78, "unassigned_changed_paragraphs": 12 }, "pipeline_version": "2.0.0" }, { "id": "source-820cf6001aa1d241fbd68a85", "medicine_id": "EMEA/H/C/002697", "medicine_name": "Opsumit", "medicine_slug": "opsumit", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/opsumit-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:34Z", "last_observed_at": "2026-10-12T13:39:34Z", "sha256": "494af21fb5dc7c276172dddb7e206a3394382d7c59311813bde021d616f2ec59", "format": "docx", "archive_key": "documents/494af21fb5dc7c276172dddb7e206a3394382d7c59311813bde021d616f2ec59.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776940923\"", "last_modified": "Thu, 23 Apr 2026 10:42:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2528, "changed_paragraphs": 115, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-829e9ebd79c1d98e8a839547", "medicine_id": "EMEA/H/C/000619", "medicine_name": "Fosavance", "medicine_slug": "fosavance", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fosavance-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-12", "first_observed_at": "2026-10-12T19:01:48Z", "last_observed_at": "2026-10-12T19:01:48Z", "sha256": "37324165444dd93963c38ccfa569b0631b8d34d16c725b5a46b16dd7bb4cbbc2", "format": "docx", "archive_key": "documents/37324165444dd93963c38ccfa569b0631b8d34d16c725b5a46b16dd7bb4cbbc2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770891002\"", "last_modified": "Thu, 12 Feb 2026 10:10:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1327, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-83c0fdc326769f6bc39fbc44", "medicine_id": "EMEA/H/C/006199", "medicine_name": "Denbrayce", "medicine_slug": "denbrayce", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/denbrayce-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-24", "first_observed_at": "2026-10-12T17:30:41Z", "last_observed_at": "2026-10-12T17:30:41Z", "sha256": "f51ec503f06d59511692af7270ce02849f960a5c46c54a26062e8d75d770e1d9", "format": "docx", "archive_key": "documents/f51ec503f06d59511692af7270ce02849f960a5c46c54a26062e8d75d770e1d9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763978340\"", "last_modified": "Mon, 24 Nov 2025 09:59:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1648, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 13 }, "pipeline_version": "2.0.0" }, { "id": "source-8439a1a319b62d1bd67256a4", "medicine_id": "EMEA/H/C/000112", "medicine_name": "Twinrix Adult", "medicine_slug": "twinrix-adult", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/twinrix-adult-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-04", "first_observed_at": "2026-10-12T13:29:28Z", "last_observed_at": "2026-10-12T13:29:28Z", "sha256": "bc8ba3adecfe04d3079e5b502251cec982d6197257fe3b7ec3a22dc5f2ace654", "format": "docx", "archive_key": "documents/bc8ba3adecfe04d3079e5b502251cec982d6197257fe3b7ec3a22dc5f2ace654.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785832884\"", "last_modified": "Tue, 04 Aug 2026 08:41:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1055, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8445bbafd6717edf20828f78", "medicine_id": "EMEA/H/C/003899", "medicine_name": "Aripiprazole Zentiva", "medicine_slug": "aripiprazole-zentiva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aripiprazole-zentiva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:51Z", "last_observed_at": "2026-10-12T19:23:51Z", "sha256": "cbf2c8130eb0ea37140be1863f353578bd31b1aca62c69d84c430b16cc285999", "format": "docx", "archive_key": "documents/cbf2c8130eb0ea37140be1863f353578bd31b1aca62c69d84c430b16cc285999.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752755295\"", "last_modified": "Thu, 17 Jul 2025 12:28:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1938, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8590bc4749caea11f4c7f164", "medicine_id": "EMEA/H/C/004996", "medicine_name": "Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)", "medicine_slug": "clopidogrel-acetylsalicylic-acid-viatris-previously-clopidogrel-acetylsalicylic-acid-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/clopidogrel-acetylsalicylic-acid-viatris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-05", "first_observed_at": "2026-10-12T19:44:40Z", "last_observed_at": "2026-10-12T19:44:40Z", "sha256": "d524dd0e733e9d67db775a6656ebf05b617d41f55b6286958eb118ec6eeb6589", "format": "docx", "archive_key": "documents/d524dd0e733e9d67db775a6656ebf05b617d41f55b6286958eb118ec6eeb6589.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746437451\"", "last_modified": "Mon, 05 May 2025 09:30:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1814, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-85abb26f0759d5625654e285", "medicine_id": "EMEA/H/C/002489", "medicine_name": "Xalkori", "medicine_slug": "xalkori", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xalkori-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:36Z", "last_observed_at": "2026-10-12T19:08:36Z", "sha256": "7ca3417fe8bdc4805a1abe0d4110a7beb046b736225c647181a1102cb3560d68", "format": "docx", "archive_key": "documents/7ca3417fe8bdc4805a1abe0d4110a7beb046b736225c647181a1102cb3560d68.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758099996\"", "last_modified": "Wed, 17 Sep 2025 09:06:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3600, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-85d476f9ad959cc117ca8f1f", "medicine_id": "EMEA/H/C/002500", "medicine_name": "Pheburane", "medicine_slug": "pheburane", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pheburane-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-17", "first_observed_at": "2026-10-12T13:29:19Z", "last_observed_at": "2026-10-12T13:29:19Z", "sha256": "77586d0bea0858214b43b86e91abc2d2711733b96959ead5ed0b5ecbd8ed888a", "format": "docx", "archive_key": "documents/77586d0bea0858214b43b86e91abc2d2711733b96959ead5ed0b5ecbd8ed888a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1786955524\"", "last_modified": "Mon, 17 Aug 2026 08:32:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2025, "changed_paragraphs": 255, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-86834b025af0f621e97e14d8", "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:09Z", "last_observed_at": "2026-10-12T17:29:09Z", "sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "format": "docx", "archive_key": "documents/f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764775578\"", "last_modified": "Wed, 03 Dec 2025 15:26:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3318, "changed_paragraphs": 356, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-86de3472949b166b1d4d54f4", "medicine_id": "EMEA/H/C/000082", "medicine_name": "CellCept", "medicine_slug": "cellcept", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cellcept-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-07", "first_observed_at": "2026-10-12T13:38:57Z", "last_observed_at": "2026-10-12T13:38:57Z", "sha256": "c8dbc39eed3d12442357184af68533c965be0280448fc39a147e7024eb1c9f1d", "format": "docx", "archive_key": "documents/c8dbc39eed3d12442357184af68533c965be0280448fc39a147e7024eb1c9f1d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778156504\"", "last_modified": "Thu, 07 May 2026 12:21:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7193, "changed_paragraphs": 32, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8772f634d4bab1aee37e077b", "medicine_id": "EMEA/H/C/006294", "medicine_name": "Pomalidomide Zentiva", "medicine_slug": "pomalidomide-zentiva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pomalidomide-zentiva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:41:53Z", "last_observed_at": "2026-10-12T19:41:53Z", "sha256": "1498006111f952016760ee90cd943f95c9fcbfd3ed2a5e6e4f9a8c875c41c9be", "format": "docx", "archive_key": "documents/1498006111f952016760ee90cd943f95c9fcbfd3ed2a5e6e4f9a8c875c41c9be.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747052750\"", "last_modified": "Mon, 12 May 2025 12:25:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3267, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-877a982134b1168044106294", "medicine_id": "EMEA/H/C/001241", "medicine_name": "Brilique", "medicine_slug": "brilique", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/brilique-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:29:04Z", "last_observed_at": "2026-10-12T13:29:04Z", "sha256": "08300c6957dcf8b43144ffa1c7c21334caeda775dc350e656a4b69a26de9a9a0", "format": "docx", "archive_key": "documents/08300c6957dcf8b43144ffa1c7c21334caeda775dc350e656a4b69a26de9a9a0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787059749\"", "last_modified": "Tue, 18 Aug 2026 13:29:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4687, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-878eb702fff3865e274eac51", "medicine_id": "EMEA/H/C/005312", "medicine_name": "Cegfila (previously Pegfilgrastim Mundipharma)", "medicine_slug": "cegfila-previously-pegfilgrastim-mundipharma", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cegfila-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:47:30Z", "last_observed_at": "2026-10-12T13:47:30Z", "sha256": "dd41c573f3407f6620feeeb91d402c4e6ca914261a9adb23330819e3f620071e", "format": "docx", "archive_key": "documents/dd41c573f3407f6620feeeb91d402c4e6ca914261a9adb23330819e3f620071e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773820583\"", "last_modified": "Wed, 18 Mar 2026 07:56:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1446, "changed_paragraphs": 106, "unassigned_changed_paragraphs": 102 }, "pipeline_version": "2.0.0" }, { "id": "source-87944346b90e45c5490d562c", "medicine_id": "EMEA/H/C/000885", "medicine_name": "Bridion", "medicine_slug": "bridion", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/bridion-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-11-06", "first_observed_at": "2026-10-12T19:04:05Z", "last_observed_at": "2026-10-12T19:04:05Z", "sha256": "69e1e491421e7fb296b4743f4bc6b775866e6082a947dcbc93b1285d6503ab83", "format": "doc", "archive_key": "documents/69e1e491421e7fb296b4743f4bc6b775866e6082a947dcbc93b1285d6503ab83.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762443762\"", "last_modified": "Thu, 06 Nov 2025 15:42:42 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-87ea40f95d82cdfb5ba074b0", "medicine_id": "EMEA/H/C/002702", "medicine_name": "Hexacima", "medicine_slug": "hexacima", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/hexacima-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-29", "first_observed_at": "2026-10-12T19:07:06Z", "last_observed_at": "2026-10-12T19:07:06Z", "sha256": "b990725709f885f3f868e5da444393a40a54f89ba2f2d9b232d9c053493d1b03", "format": "docx", "archive_key": "documents/b990725709f885f3f868e5da444393a40a54f89ba2f2d9b232d9c053493d1b03.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759145794\"", "last_modified": "Mon, 29 Sep 2025 11:36:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2113, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-87ebc6ce7e018f0368638099", "medicine_id": "EMEA/H/C/004881", "medicine_name": "Seffalair Spiromax", "medicine_slug": "seffalair-spiromax", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/seffalair-spiromax-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-16", "first_observed_at": "2026-10-12T17:28:11Z", "last_observed_at": "2026-10-12T17:28:11Z", "sha256": "b400d80be8345a8bf3225fb16f1b348532237af04c82caaf20ff6e0cd46993e8", "format": "docx", "archive_key": "documents/b400d80be8345a8bf3225fb16f1b348532237af04c82caaf20ff6e0cd46993e8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765886328\"", "last_modified": "Tue, 16 Dec 2025 11:58:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2638, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-88119ecc6506c3a6e3aa3ad7", "medicine_id": "EMEA/H/C/003745", "medicine_name": "Duaklir Genuair", "medicine_slug": "duaklir-genuair", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/duaklir-genuair-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-07-29", "first_observed_at": "2026-10-12T19:20:02Z", "last_observed_at": "2026-10-12T19:20:02Z", "sha256": "fbd5e99e5a92359cfe4d36f7e5c2f6307288d4141ef365f8dd4cfe82e0b3ae30", "format": "doc", "archive_key": "documents/fbd5e99e5a92359cfe4d36f7e5c2f6307288d4141ef365f8dd4cfe82e0b3ae30.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753795708\"", "last_modified": "Tue, 29 Jul 2025 13:28:28 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-88ce3d618aa0fa7bd0a2344a", "medicine_id": "EMEA/H/C/002489", "medicine_name": "Xalkori", "medicine_slug": "xalkori", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xalkori-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:33Z", "last_observed_at": "2026-10-12T19:08:33Z", "sha256": "ef44dfaecb1d788d91296f191fa93284be4080e5e3ccdf0a2d2e35280911377f", "format": "docx", "archive_key": "documents/ef44dfaecb1d788d91296f191fa93284be4080e5e3ccdf0a2d2e35280911377f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758099995\"", "last_modified": "Wed, 17 Sep 2025 09:06:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3551, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-88dce3bb72007e55be4b1e89", "medicine_id": "EMEA/H/C/000716", "medicine_name": "Exforge", "medicine_slug": "exforge", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exforge-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-19", "first_observed_at": "2026-10-12T17:31:12Z", "last_observed_at": "2026-10-12T17:31:12Z", "sha256": "eff9f4b814acb93e747f1e86b787f2a503ffc73ea477c100cbd5ed274b56dfa3", "format": "docx", "archive_key": "documents/eff9f4b814acb93e747f1e86b787f2a503ffc73ea477c100cbd5ed274b56dfa3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763549621\"", "last_modified": "Wed, 19 Nov 2025 10:53:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2767, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-88ecf756a74bf162aa58c75a", "medicine_id": "EMEA/H/C/002737", "medicine_name": "Adempas", "medicine_slug": "adempas", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/adempas-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-22", "first_observed_at": "2026-10-12T13:36:27Z", "last_observed_at": "2026-10-12T13:36:27Z", "sha256": "3093e732540208856cb2992ea8ae6e038d4f781977b6d5add99346618903df39", "format": "docx", "archive_key": "documents/3093e732540208856cb2992ea8ae6e038d4f781977b6d5add99346618903df39.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1779452539\"", "last_modified": "Fri, 22 May 2026 12:22:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3991, "changed_paragraphs": 142, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-893d8c8f75e8ba4aa3d1dd5b", "medicine_id": "EMEA/H/C/001241", "medicine_name": "Brilique", "medicine_slug": "brilique", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/brilique-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:29:01Z", "last_observed_at": "2026-10-12T13:29:01Z", "sha256": "4e7acf88e1ec9568ec3afad6a97888101fee5eedba143df066668bb14696ac04", "format": "docx", "archive_key": "documents/4e7acf88e1ec9568ec3afad6a97888101fee5eedba143df066668bb14696ac04.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787059749\"", "last_modified": "Tue, 18 Aug 2026 13:29:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4503, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-896abba1d8391c918345d46b", "medicine_id": "EMEA/H/C/006047", "medicine_name": "Lacosamide Adroiq", "medicine_slug": "lacosamide-adroiq", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lacosamide-adroiq-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:07:59Z", "last_observed_at": "2026-10-12T19:07:59Z", "sha256": "cc83d966059d42856d0211a4f256b29b20d43593865704d6a9315aeb694f3c76", "format": "docx", "archive_key": "documents/cc83d966059d42856d0211a4f256b29b20d43593865704d6a9315aeb694f3c76.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758792881\"", "last_modified": "Thu, 25 Sep 2025 09:34:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1881, "changed_paragraphs": 69, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8a3c832cf29a23f02143eae7", "medicine_id": "EMEA/H/C/006206", "medicine_name": "Axitinib Accord", "medicine_slug": "axitinib-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/axitinib-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-22", "first_observed_at": "2026-10-12T19:23:23Z", "last_observed_at": "2026-10-12T19:23:23Z", "sha256": "86241fe7235d3c26d6e0ae1194d38f4cfc12e6847710f583a83089e26adb3657", "format": "docx", "archive_key": "documents/86241fe7235d3c26d6e0ae1194d38f4cfc12e6847710f583a83089e26adb3657.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753198741\"", "last_modified": "Tue, 22 Jul 2025 15:39:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2713, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 4 }, "pipeline_version": "2.0.0" }, { "id": "source-8b6d2cf3ce7af1f1302a515d", "medicine_id": "EMEA/H/C/005386", "medicine_name": "Phesgo", "medicine_slug": "phesgo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/phesgo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-28", "first_observed_at": "2026-10-12T19:04:35Z", "last_observed_at": "2026-10-12T19:04:35Z", "sha256": "c9e8c89f95f2ea2fe237554c3b911f0bcb896b6c3fc829d239d38c1ede2eead7", "format": "docx", "archive_key": "documents/c9e8c89f95f2ea2fe237554c3b911f0bcb896b6c3fc829d239d38c1ede2eead7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761661255\"", "last_modified": "Tue, 28 Oct 2025 14:20:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2463, "changed_paragraphs": 54, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-8b8098f2ccb2fed70d46a5e1", "medicine_id": "EMEA/H/C/000532", "medicine_name": "Kentera (previously Oxybutynin Nicobrand)", "medicine_slug": "kentera-previously-oxybutynin-nicobrand", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kentera-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-04-08", "first_observed_at": "2026-10-12T19:46:24Z", "last_observed_at": "2026-10-12T19:46:24Z", "sha256": "e3efc0fa9167ed8889b411dd6e2ac765b743fe2665b0a17071d58662f9d9944a", "format": "docx", "archive_key": "documents/e3efc0fa9167ed8889b411dd6e2ac765b743fe2665b0a17071d58662f9d9944a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1744112391\"", "last_modified": "Tue, 08 Apr 2025 11:39:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1380, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8b8c5fd6a02f0cde4cd826c2", "medicine_id": "EMEA/H/C/000762", "medicine_name": "Xelevia", "medicine_slug": "xelevia", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xelevia-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-12-01", "first_observed_at": "2026-10-12T17:29:40Z", "last_observed_at": "2026-10-12T17:29:40Z", "sha256": "20ee5f2cbd13a8f7b3e446e2a4ba275afc2ca44a20b636109f5b23f4fc629d27", "format": "doc", "archive_key": "documents/20ee5f2cbd13a8f7b3e446e2a4ba275afc2ca44a20b636109f5b23f4fc629d27.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764595969\"", "last_modified": "Mon, 01 Dec 2025 13:32:49 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-8c03650211fca31995d5527d", "medicine_id": "EMEA/H/C/005649", "medicine_name": "Abiraterone Krka", "medicine_slug": "abiraterone-krka", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/abiraterone-krka-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-16", "first_observed_at": "2026-10-12T17:26:58Z", "last_observed_at": "2026-10-12T17:26:58Z", "sha256": "3ef4a36cb06bedd9d158a8c32003e11ac91155f690eeb7252bb5e2bdc009a8c5", "format": "docx", "archive_key": "documents/3ef4a36cb06bedd9d158a8c32003e11ac91155f690eeb7252bb5e2bdc009a8c5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768569798\"", "last_modified": "Fri, 16 Jan 2026 13:23:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1343, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8c3e71c3fd252de918c18218", "medicine_id": "EMEA/H/C/004325", "medicine_name": "Nyxoid", "medicine_slug": "nyxoid", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nyxoid-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-12", "first_observed_at": "2026-10-12T19:36:44Z", "last_observed_at": "2026-10-12T19:36:44Z", "sha256": "049435742bf3f7d55a09a8a975d6e623e2e30098c387b0bb5c20772f64119914", "format": "docx", "archive_key": "documents/049435742bf3f7d55a09a8a975d6e623e2e30098c387b0bb5c20772f64119914.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749722705\"", "last_modified": "Thu, 12 Jun 2025 10:05:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1140, "changed_paragraphs": 58, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8c91d5b88138488f66453000", "medicine_id": "EMEA/H/C/000169", "medicine_name": "Exelon", "medicine_slug": "exelon", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exelon-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-24", "first_observed_at": "2026-10-12T19:01:21Z", "last_observed_at": "2026-10-12T19:01:21Z", "sha256": "686a5dc566c19ca30401c25f2fbf0ba55f3a488a95107bbee6977fc241a4e04b", "format": "docx", "archive_key": "documents/686a5dc566c19ca30401c25f2fbf0ba55f3a488a95107bbee6977fc241a4e04b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771923608\"", "last_modified": "Tue, 24 Feb 2026 09:00:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5465, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8cfbc5bdcf23531eac428df5", "medicine_id": "EMEA/H/C/000958", "medicine_name": "Stelara", "medicine_slug": "stelara", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/stelara-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:28:52Z", "last_observed_at": "2026-10-12T13:28:52Z", "sha256": "36cb13a54d5f0df5b6079c2519692ebf03eafdbb7ada52f141382055515c3f2d", "format": "docx", "archive_key": "documents/36cb13a54d5f0df5b6079c2519692ebf03eafdbb7ada52f141382055515c3f2d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787061225\"", "last_modified": "Tue, 18 Aug 2026 13:53:45 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7958, "changed_paragraphs": 203, "unassigned_changed_paragraphs": 8 }, "pipeline_version": "2.0.0" }, { "id": "source-8d2e6ef8cd058d95f7d0d8cc", "medicine_id": "EMEA/H/C/000726", "medicine_name": "Epoetin Alfa Hexal", "medicine_slug": "epoetin-alfa-hexal", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/epoetin-alfa-hexal-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:29:39Z", "last_observed_at": "2026-10-12T19:29:39Z", "sha256": "37ff6e4aa94771eaf523aaf26fab89a757d507d3ef05e6da5c56c6d5b187230c", "format": "docx", "archive_key": "documents/37ff6e4aa94771eaf523aaf26fab89a757d507d3ef05e6da5c56c6d5b187230c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752236350\"", "last_modified": "Fri, 11 Jul 2025 12:19:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3532, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8d7c3200418c650a002546aa", "medicine_id": "EMEA/H/C/002345", "medicine_name": "Revestive", "medicine_slug": "revestive", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/revestive-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-23", "first_observed_at": "2026-10-12T19:38:01Z", "last_observed_at": "2026-10-12T19:38:01Z", "sha256": "0125d033ce2f8805dc45ece9b8ffa34db6682b195448a3a560e6d2483a8982b4", "format": "docx", "archive_key": "documents/0125d033ce2f8805dc45ece9b8ffa34db6682b195448a3a560e6d2483a8982b4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747983692\"", "last_modified": "Fri, 23 May 2025 07:01:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2851, "changed_paragraphs": 125, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8dd88a3db45e564c959f66e5", "medicine_id": "EMEA/H/C/004104", "medicine_name": "Eptifibatide Accord", "medicine_slug": "eptifibatide-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eptifibatide-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-02", "first_observed_at": "2026-10-12T19:45:01Z", "last_observed_at": "2026-10-12T19:45:01Z", "sha256": "a45982959a207e1611cd67a6103370f86a234e3c45dfb3ab49b532886fe928cb", "format": "docx", "archive_key": "documents/a45982959a207e1611cd67a6103370f86a234e3c45dfb3ab49b532886fe928cb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746194515\"", "last_modified": "Fri, 02 May 2025 14:01:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1726, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8dfcfa3399f97d7dff936855", "medicine_id": "EMEA/H/C/006331", "medicine_name": "Sephience", "medicine_slug": "sephience", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sephience-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-22", "first_observed_at": "2026-10-12T13:36:32Z", "last_observed_at": "2026-10-12T13:36:32Z", "sha256": "67329cd08d9c2eabad565d3bea1c663f772dbaeae8bf9b4fc5a20f7821e84fbd", "format": "docx", "archive_key": "documents/67329cd08d9c2eabad565d3bea1c663f772dbaeae8bf9b4fc5a20f7821e84fbd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1779443736\"", "last_modified": "Fri, 22 May 2026 09:55:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1835, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8dfd14917c0bce8a02f32447", "medicine_id": "EMEA/H/C/006132", "medicine_name": "Wezenla", "medicine_slug": "wezenla", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/wezenla-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-01", "first_observed_at": "2026-10-12T13:33:47Z", "last_observed_at": "2026-10-12T13:33:47Z", "sha256": "98ed3f6ec1b7b67abb7889752d3ad5436b80b4d025384c0cf0266ec36ca6e462", "format": "docx", "archive_key": "documents/98ed3f6ec1b7b67abb7889752d3ad5436b80b4d025384c0cf0266ec36ca6e462.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782891119\"", "last_modified": "Wed, 01 Jul 2026 07:31:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6463, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8e262bfb8a6baf515c8b444e", "medicine_id": "EMEA/H/C/005476", "medicine_name": "Lyfnua", "medicine_slug": "lyfnua", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lyfnua-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-08", "first_observed_at": "2026-10-12T17:28:52Z", "last_observed_at": "2026-10-12T17:28:52Z", "sha256": "91b6417dc20a83c440581d108afd300a7574a4f84095e7593648531808ddd998", "format": "docx", "archive_key": "documents/91b6417dc20a83c440581d108afd300a7574a4f84095e7593648531808ddd998.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765183320\"", "last_modified": "Mon, 08 Dec 2025 08:42:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1272, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8e2f8c5e26cb2982fd0c656f", "medicine_id": "EMEA/H/C/000770", "medicine_name": "Avamys", "medicine_slug": "avamys", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/avamys-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-06-27", "first_observed_at": "2026-10-12T19:30:33Z", "last_observed_at": "2026-10-12T19:30:33Z", "sha256": "3247f6a8e691728cd732058ebdc4a674458760cde988779dc936a54c18e27afa", "format": "doc", "archive_key": "documents/3247f6a8e691728cd732058ebdc4a674458760cde988779dc936a54c18e27afa.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751030345\"", "last_modified": "Fri, 27 Jun 2025 13:19:05 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-8e6b65fc2d238ba8883b14a8", "medicine_id": "EMEA/H/C/002110", "medicine_name": "Trajenta", "medicine_slug": "trajenta", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/trajenta-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-25", "first_observed_at": "2026-10-12T13:34:05Z", "last_observed_at": "2026-10-12T13:34:05Z", "sha256": "f2afc108ff6cf8f75ded3bc575920302ca74908fd3287559b54ac20dbdc85dd3", "format": "docx", "archive_key": "documents/f2afc108ff6cf8f75ded3bc575920302ca74908fd3287559b54ac20dbdc85dd3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782399056\"", "last_modified": "Thu, 25 Jun 2026 14:50:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1112, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8eeaa27a9b641ece4cddb943", "medicine_id": "EMEA/H/C/002464", "medicine_name": "Jakavi", "medicine_slug": "jakavi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/jakavi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-10", "first_observed_at": "2026-10-12T19:03:51Z", "last_observed_at": "2026-10-12T19:03:51Z", "sha256": "1d5244dc7298d3e9d7b666910018e6048ac8aba3eecdf6d0581d293bc93a0809", "format": "docx", "archive_key": "documents/1d5244dc7298d3e9d7b666910018e6048ac8aba3eecdf6d0581d293bc93a0809.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762791039\"", "last_modified": "Mon, 10 Nov 2025 16:10:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5028, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8fa0c575edbf5bd4c0e6ac03", "medicine_id": "EMEA/H/C/000549", "medicine_name": "Pedea", "medicine_slug": "pedea", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pedea-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-25", "first_observed_at": "2026-10-12T17:30:20Z", "last_observed_at": "2026-10-12T17:30:20Z", "sha256": "b96fb2edd6bc9020520cccfda4ced68bd04fe64aa9e697eb6b067c7d3c233a35", "format": "docx", "archive_key": "documents/b96fb2edd6bc9020520cccfda4ced68bd04fe64aa9e697eb6b067c7d3c233a35.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764061985\"", "last_modified": "Tue, 25 Nov 2025 09:13:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 907, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-8fc14331f652f6a7e9217eb7", "medicine_id": "EMEA/H/C/006188", "medicine_name": "Buprenorphine Neuraxpharm", "medicine_slug": "buprenorphine-neuraxpharm", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/buprenorphine-neuraxpharm-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-16", "first_observed_at": "2026-10-12T19:39:14Z", "last_observed_at": "2026-10-12T19:39:14Z", "sha256": "f83300398ca578b6c52fe73b15e336e19057f193df5dbaa62822f3b6d9ea8f46", "format": "docx", "archive_key": "documents/f83300398ca578b6c52fe73b15e336e19057f193df5dbaa62822f3b6d9ea8f46.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747395509\"", "last_modified": "Fri, 16 May 2025 11:38:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1423, "changed_paragraphs": 20, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-906c67d52572caaa3055d717", "medicine_id": "EMEA/H/C/000266", "medicine_name": "DaTSCAN", "medicine_slug": "datscan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/datscan-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-02-25", "first_observed_at": "2026-10-12T19:01:07Z", "last_observed_at": "2026-10-12T19:01:07Z", "sha256": "f842a7d63a9e929625b7c8a862265193babc77a4c3e90a9a88b6e4aea5f0b180", "format": "doc", "archive_key": "documents/f842a7d63a9e929625b7c8a862265193babc77a4c3e90a9a88b6e4aea5f0b180.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772026317\"", "last_modified": "Wed, 25 Feb 2026 13:31:57 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-909ec548fb40d6d95e0573f5", "medicine_id": "EMEA/H/C/000791", "medicine_name": "Soliris", "medicine_slug": "soliris", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/soliris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-18", "first_observed_at": "2026-10-12T19:23:26Z", "last_observed_at": "2026-10-12T19:23:26Z", "sha256": "902ff1634bfba3f9a2fc0e3c21088235e72b900bf03fec3fc0c7dd7828d9d25c", "format": "docx", "archive_key": "documents/902ff1634bfba3f9a2fc0e3c21088235e72b900bf03fec3fc0c7dd7828d9d25c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752841194\"", "last_modified": "Fri, 18 Jul 2025 12:19:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2564, "changed_paragraphs": 31, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-90f1d81c87a1f941e5414311", "medicine_id": "EMEA/H/C/002211", "medicine_name": "Eklira Genuair", "medicine_slug": "eklira-genuair", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eklira-genuair-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-07-29", "first_observed_at": "2026-10-12T19:20:05Z", "last_observed_at": "2026-10-12T19:20:05Z", "sha256": "d1e322e0662f35891273f1e04e201aafbdd24630a1ceada57b16cf1085b0d886", "format": "doc", "archive_key": "documents/d1e322e0662f35891273f1e04e201aafbdd24630a1ceada57b16cf1085b0d886.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753796366\"", "last_modified": "Tue, 29 Jul 2025 13:39:26 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-9105b28b5d5490c8e2f01169", "medicine_id": "EMEA/H/C/002482", "medicine_name": "Zoledronic acid Mylan", "medicine_slug": "zoledronic-acid-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zoledronic-acid-mylan-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-03-31", "first_observed_at": "2026-10-12T13:45:04Z", "last_observed_at": "2026-10-12T13:45:04Z", "sha256": "db18571d321877a3838bd2e8579cf5ea2ceb67f5f9feb1d7a5a91771ddf920d1", "format": "doc", "archive_key": "documents/db18571d321877a3838bd2e8579cf5ea2ceb67f5f9feb1d7a5a91771ddf920d1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774956325\"", "last_modified": "Tue, 31 Mar 2026 11:25:25 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-91efe2c3ce20ff3bf6cd2173", "medicine_id": "EMEA/H/C/006016", "medicine_name": "Imjudo", "medicine_slug": "imjudo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imjudo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-14", "first_observed_at": "2026-10-12T19:16:15Z", "last_observed_at": "2026-10-12T19:16:15Z", "sha256": "82f0e8242ee995348d54ec34bfb83b1be80ea917a347d059c060033f40386298", "format": "docx", "archive_key": "documents/82f0e8242ee995348d54ec34bfb83b1be80ea917a347d059c060033f40386298.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755183398\"", "last_modified": "Thu, 14 Aug 2025 14:56:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2550, "changed_paragraphs": 38, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-92e1287a092cdea6cf21c67f", "medicine_id": "EMEA/H/C/000413", "medicine_name": "MicardisPlus", "medicine_slug": "micardisplus", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/micardisplus-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:06Z", "last_observed_at": "2026-10-12T13:39:06Z", "sha256": "03de31a4828fb4575f6bfc47b787007a94065a67b54b8052d0b76a581cf57072", "format": "docx", "archive_key": "documents/03de31a4828fb4575f6bfc47b787007a94065a67b54b8052d0b76a581cf57072.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777378431\"", "last_modified": "Tue, 28 Apr 2026 12:13:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4004, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-92e4aa7fa1045c3c6132c82f", "medicine_id": "EMEA/H/C/005751", "medicine_name": "Columvi", "medicine_slug": "columvi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/columvi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-24", "first_observed_at": "2026-10-12T19:05:11Z", "last_observed_at": "2026-10-12T19:05:11Z", "sha256": "8c420dd9ee7e80121ba9b9d392577b6dd81c89ebb969ff41d64f678017cd30b7", "format": "docx", "archive_key": "documents/8c420dd9ee7e80121ba9b9d392577b6dd81c89ebb969ff41d64f678017cd30b7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761306678\"", "last_modified": "Fri, 24 Oct 2025 11:51:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2455, "changed_paragraphs": 56, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-93035c199195b0e5ecae337e", "medicine_id": "EMEA/H/C/004978", "medicine_name": "Brukinsa", "medicine_slug": "brukinsa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/brukinsa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-10-07", "first_observed_at": "2026-10-12T13:27:22Z", "last_observed_at": "2026-10-12T13:27:22Z", "sha256": "2171ac5e589cf9527d9bc5ab2958997e970517f090a8425dfa56f9f4d9e6e96c", "format": "docx", "archive_key": "documents/2171ac5e589cf9527d9bc5ab2958997e970517f090a8425dfa56f9f4d9e6e96c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791375386\"", "last_modified": "Wed, 07 Oct 2026 12:16:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3743, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-93136fa9827038396e1dfeea", "medicine_id": "EMEA/H/C/000581", "medicine_name": "Kivexa", "medicine_slug": "kivexa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kivexa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:30Z", "last_observed_at": "2026-10-12T17:26:30Z", "sha256": "b5bcc7539b3a48d32926e9d370979fbf67a34aaab1f95d92ad4195ec9cc1bbd3", "format": "docx", "archive_key": "documents/b5bcc7539b3a48d32926e9d370979fbf67a34aaab1f95d92ad4195ec9cc1bbd3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768816143\"", "last_modified": "Mon, 19 Jan 2026 09:49:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2041, "changed_paragraphs": 27, "unassigned_changed_paragraphs": 4 }, "pipeline_version": "2.0.0" }, { "id": "source-932cddf94551092cf3ede460", "medicine_id": "EMEA/H/C/000222", "medicine_name": "CoAprovel", "medicine_slug": "coaprovel", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/coaprovel-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-25", "first_observed_at": "2026-10-12T19:08:11Z", "last_observed_at": "2026-10-12T19:08:11Z", "sha256": "7fca92510e077011e19aca492aa936baa4307855e1522dbead59a936f94769e5", "format": "docx", "archive_key": "documents/7fca92510e077011e19aca492aa936baa4307855e1522dbead59a936f94769e5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758800484\"", "last_modified": "Thu, 25 Sep 2025 11:41:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5487, "changed_paragraphs": 46, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-935a08bd1191dc79d38e9576", "medicine_id": "EMEA/H/C/000387", "medicine_name": "Vfend", "medicine_slug": "vfend", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vfend-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-21", "first_observed_at": "2026-10-12T13:31:11Z", "last_observed_at": "2026-10-12T13:31:11Z", "sha256": "9c7f227a3aae73a68130acbea1598b42c5ef6e2c21dffe73fa23a236b5156c75", "format": "docx", "archive_key": "documents/9c7f227a3aae73a68130acbea1598b42c5ef6e2c21dffe73fa23a236b5156c75.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1784618681\"", "last_modified": "Tue, 21 Jul 2026 07:24:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6558, "changed_paragraphs": 30, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-93c4809fbd8f82f8047ad6d8", "medicine_id": "EMEA/H/C/000603", "medicine_name": "Tysabri", "medicine_slug": "tysabri", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tysabri-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-29", "first_observed_at": "2026-10-12T13:36:21Z", "last_observed_at": "2026-10-12T13:36:21Z", "sha256": "612f2e983f6995504b7a744959b28ceae6eb2a9969a9c83f7591b2e6ce3c8cb0", "format": "docx", "archive_key": "documents/612f2e983f6995504b7a744959b28ceae6eb2a9969a9c83f7591b2e6ce3c8cb0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780060467\"", "last_modified": "Fri, 29 May 2026 13:14:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3401, "changed_paragraphs": 85, "unassigned_changed_paragraphs": 26 }, "pipeline_version": "2.0.0" }, { "id": "source-943fdbff633b0cace99de42c", "medicine_id": "EMEA/H/C/000252", "medicine_name": "Ziagen", "medicine_slug": "ziagen", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ziagen-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:26Z", "last_observed_at": "2026-10-12T17:26:26Z", "sha256": "54ca6b8e3e7fcc0ddb49a272f48cab559a099022ab851e806861d51c5ce042e7", "format": "docx", "archive_key": "documents/54ca6b8e3e7fcc0ddb49a272f48cab559a099022ab851e806861d51c5ce042e7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768832535\"", "last_modified": "Mon, 19 Jan 2026 14:22:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2883, "changed_paragraphs": 155, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-9602626838996ff4c1707059", "medicine_id": "EMEA/H/C/006056", "medicine_name": "Opuviz", "medicine_slug": "opuviz", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/opuviz-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:18Z", "last_observed_at": "2026-10-12T17:26:18Z", "sha256": "2c2be666a9b04d0af84a1d378a2c46c81f50e575f3332cae8a7fd3bd6e77ff36", "format": "docx", "archive_key": "documents/2c2be666a9b04d0af84a1d378a2c46c81f50e575f3332cae8a7fd3bd6e77ff36.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768837191\"", "last_modified": "Mon, 19 Jan 2026 15:39:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3688, "changed_paragraphs": 1085, "unassigned_changed_paragraphs": 5 }, "pipeline_version": "2.0.0" }, { "id": "source-967e58a055aaa321d30c17b5", "medicine_id": "EMEA/H/C/000638", "medicine_name": "Revatio", "medicine_slug": "revatio", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/revatio-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:51Z", "last_observed_at": "2026-10-12T19:08:51Z", "sha256": "3fdd820dcc75acdfd3ef6e1aa7aef33b64b7a935f6f4f525ffdcfe55fe376bcc", "format": "docx", "archive_key": "documents/3fdd820dcc75acdfd3ef6e1aa7aef33b64b7a935f6f4f525ffdcfe55fe376bcc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758110665\"", "last_modified": "Wed, 17 Sep 2025 12:04:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3554, "changed_paragraphs": 19, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-96f65d891051b574197708bc", "medicine_id": "EMEA/H/C/004728", "medicine_name": "Mvasi", "medicine_slug": "mvasi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/mvasi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-16", "first_observed_at": "2026-10-12T19:05:25Z", "last_observed_at": "2026-10-12T19:05:25Z", "sha256": "a52e278712552c88d687c789c8c0efa23c11f88e02e6d8914d109160079d55b7", "format": "docx", "archive_key": "documents/a52e278712552c88d687c789c8c0efa23c11f88e02e6d8914d109160079d55b7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760598994\"", "last_modified": "Thu, 16 Oct 2025 07:16:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3472, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-975f17cea1f76284ed13afe9", "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:56Z", "last_observed_at": "2026-10-12T19:02:56Z", "sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "format": "docx", "archive_key": "documents/722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769602107\"", "last_modified": "Wed, 28 Jan 2026 12:08:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3471, "changed_paragraphs": 50, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-98e966b83ef3359b0b17c1ac", "medicine_id": "EMEA/H/C/000115", "medicine_name": "Zyprexa", "medicine_slug": "zyprexa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zyprexa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:38Z", "last_observed_at": "2026-10-12T19:00:38Z", "sha256": "96e01e001292b1a1769f7b44a7c1edb9a4899be84b4aa53032b3c1c0e83d7cf0", "format": "docx", "archive_key": "documents/96e01e001292b1a1769f7b44a7c1edb9a4899be84b4aa53032b3c1c0e83d7cf0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772188138\"", "last_modified": "Fri, 27 Feb 2026 10:28:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2782, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-99c9a70fc482d61206acfd7e", "medicine_id": "EMEA/H/C/003787", "medicine_name": "Tadalafil Mylan", "medicine_slug": "tadalafil-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tadalafil-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-15", "first_observed_at": "2026-10-12T13:34:42Z", "last_observed_at": "2026-10-12T13:34:42Z", "sha256": "62bd2ba9c3567952782bfbfcc0332100da41fde20b4b034cd97caef4116f87a2", "format": "docx", "archive_key": "documents/62bd2ba9c3567952782bfbfcc0332100da41fde20b4b034cd97caef4116f87a2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781509852\"", "last_modified": "Mon, 15 Jun 2026 07:50:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3363, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 12 }, "pipeline_version": "2.0.0" }, { "id": "source-99f1e23086a54d8376a1bb52", "medicine_id": "EMEA/H/C/003834", "medicine_name": "Raxone", "medicine_slug": "raxone", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/raxone-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-20", "first_observed_at": "2026-10-12T19:16:09Z", "last_observed_at": "2026-10-12T19:16:09Z", "sha256": "a40c25bc9b88de4a3f9b4f2cd0c01f61082db69fffcf0a3823764ce0c0015e71", "format": "docx", "archive_key": "documents/a40c25bc9b88de4a3f9b4f2cd0c01f61082db69fffcf0a3823764ce0c0015e71.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755702419\"", "last_modified": "Wed, 20 Aug 2025 15:06:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1022, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9a0a280eec0ca5b6bae28852", "medicine_id": "EMEA/H/C/004076", "medicine_name": "Bortezomib Sun", "medicine_slug": "bortezomib-sun", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/bortezomib-sun-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-10-14", "first_observed_at": "2026-10-12T19:05:37Z", "last_observed_at": "2026-10-12T19:05:37Z", "sha256": "c4bd5baf6d4019a3849df6d052218e051bbd77a00e0defe1965760abc9903d5d", "format": "doc", "archive_key": "documents/c4bd5baf6d4019a3849df6d052218e051bbd77a00e0defe1965760abc9903d5d.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760455056\"", "last_modified": "Tue, 14 Oct 2025 15:17:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-9b05d28fe88db964e63adf77", "medicine_id": "EMEA/H/C/000406", "medicine_name": "Glivec", "medicine_slug": "glivec", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/glivec-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-12", "first_observed_at": "2026-10-12T19:03:41Z", "last_observed_at": "2026-10-12T19:03:41Z", "sha256": "0a7399d86623c6528f9f7bdca262048f57cb0f2cb325b4cb64a1012d75b5d47a", "format": "docx", "archive_key": "documents/0a7399d86623c6528f9f7bdca262048f57cb0f2cb325b4cb64a1012d75b5d47a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762955679\"", "last_modified": "Wed, 12 Nov 2025 13:54:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2402, "changed_paragraphs": 169, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9b3b80df91c091def757bfc9", "medicine_id": "EMEA/H/C/005061", "medicine_name": "Enerzair Breezhaler", "medicine_slug": "enerzair-breezhaler", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/enerzair-breezhaler-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-20", "first_observed_at": "2026-10-12T17:30:51Z", "last_observed_at": "2026-10-12T17:30:51Z", "sha256": "7f5bdc6bed95a4341cf397a11b1b8de7b3779753cbaeaed7b4024d0588187590", "format": "docx", "archive_key": "documents/7f5bdc6bed95a4341cf397a11b1b8de7b3779753cbaeaed7b4024d0588187590.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763636554\"", "last_modified": "Thu, 20 Nov 2025 11:02:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1956, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9b79f5c49331593b283034c4", "medicine_id": "EMEA/H/C/001088", "medicine_name": "Olazax Disperzi", "medicine_slug": "olazax-disperzi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olazax-disperzi-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-05-12", "first_observed_at": "2026-10-12T13:36:36Z", "last_observed_at": "2026-10-12T13:36:36Z", "sha256": "cac163e33ee5ce9610a3f6daf439a6ad57cd66ccb091d6762d3432d3eedeeb86", "format": "doc", "archive_key": "documents/cac163e33ee5ce9610a3f6daf439a6ad57cd66ccb091d6762d3432d3eedeeb86.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778572418\"", "last_modified": "Tue, 12 May 2026 07:53:38 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-9b98b8a63a7126a69f539d31", "medicine_id": "EMEA/H/C/000107", "medicine_name": "Epivir", "medicine_slug": "epivir", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/epivir-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:29Z", "last_observed_at": "2026-10-12T13:28:29Z", "sha256": "904a2bee5f9c3c7a487325fb08ed809c65fa98667b82cab8453987f0747cdd99", "format": "docx", "archive_key": "documents/904a2bee5f9c3c7a487325fb08ed809c65fa98667b82cab8453987f0747cdd99.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787233239\"", "last_modified": "Thu, 20 Aug 2026 13:40:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3489, "changed_paragraphs": 347, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9cd12e29a5eb6e86d0fd6587", "medicine_id": "EMEA/H/C/005087", "medicine_name": "Livogiva", "medicine_slug": "livogiva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/livogiva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-10", "first_observed_at": "2026-10-12T17:28:22Z", "last_observed_at": "2026-10-12T17:28:22Z", "sha256": "86d2dfbc0c005e572da806ef65fc36f237133b960bc59df48da6b8f4fb63a411", "format": "docx", "archive_key": "documents/86d2dfbc0c005e572da806ef65fc36f237133b960bc59df48da6b8f4fb63a411.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765376667\"", "last_modified": "Wed, 10 Dec 2025 14:24:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1230, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-9d1f1e17c888e8c5e5b171c3", "medicine_id": "EMEA/H/C/000233", "medicine_name": "Cetrotide", "medicine_slug": "cetrotide", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cetrotide-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:27:47Z", "last_observed_at": "2026-10-12T17:27:47Z", "sha256": "5d18abdd764867aa439779cae36dd92d76d95af5e69b1bf04f0ec3a40fa10ee1", "format": "docx", "archive_key": "documents/5d18abdd764867aa439779cae36dd92d76d95af5e69b1bf04f0ec3a40fa10ee1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766057691\"", "last_modified": "Thu, 18 Dec 2025 11:34:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 907, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9d1f6f559b2868cf1e70df29", "medicine_id": "EMEA/H/C/005896", "medicine_name": "Hyftor", "medicine_slug": "hyftor", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/hyftor-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-04", "first_observed_at": "2026-10-12T19:30:26Z", "last_observed_at": "2026-10-12T19:30:26Z", "sha256": "fdea0f8c8beb5c50cf6d54a5697063734a2b59911599ae4cbcdbe750e6151540", "format": "docx", "archive_key": "documents/fdea0f8c8beb5c50cf6d54a5697063734a2b59911599ae4cbcdbe750e6151540.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751647072\"", "last_modified": "Fri, 04 Jul 2025 16:37:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 946, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9e22e0e7bcb86d8e1dedf0f1", "medicine_id": "EMEA/H/C/006251", "medicine_name": "Dasatinib Accord Healthcare", "medicine_slug": "dasatinib-accord-healthcare", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/dasatinib-accord-healthcare-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-05", "first_observed_at": "2026-10-12T19:02:15Z", "last_observed_at": "2026-10-12T19:02:15Z", "sha256": "e13a7646ebab278a72a53434793d7181faab9ffa758b839f8b4c7b1a344a02b4", "format": "docx", "archive_key": "documents/e13a7646ebab278a72a53434793d7181faab9ffa758b839f8b4c7b1a344a02b4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770301331\"", "last_modified": "Thu, 05 Feb 2026 14:22:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3101, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9e33d5d566c95289f1a7e6a6", "medicine_id": "EMEA/H/C/004104", "medicine_name": "Eptifibatide Accord", "medicine_slug": "eptifibatide-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eptifibatide-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-02", "first_observed_at": "2026-10-12T19:45:11Z", "last_observed_at": "2026-10-12T19:45:11Z", "sha256": "c9be002148fa73331c72aadac205f927e043f3407cf695e63a1cbe715480600b", "format": "docx", "archive_key": "documents/c9be002148fa73331c72aadac205f927e043f3407cf695e63a1cbe715480600b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746194515\"", "last_modified": "Fri, 02 May 2025 14:01:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1667, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9e8fe7a5a159cd2be7897353", "medicine_id": "EMEA/H/C/004775", "medicine_name": "Givlaari", "medicine_slug": "givlaari", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/givlaari-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:41:33Z", "last_observed_at": "2026-10-12T19:41:33Z", "sha256": "57e1c2305cfbdf11403e66e8f74a3a0126a0ac78877008bff8d40e45b9c260b1", "format": "docx", "archive_key": "documents/57e1c2305cfbdf11403e66e8f74a3a0126a0ac78877008bff8d40e45b9c260b1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747047427\"", "last_modified": "Mon, 12 May 2025 10:57:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1212, "changed_paragraphs": 32, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9ec61c9d1156351893a29ca4", "medicine_id": "EMEA/H/C/003981", "medicine_name": "Duloxetine Viatris (previously Duloxetine Mylan)", "medicine_slug": "duloxetine-viatris-previously-duloxetine-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/duloxetine-viatris-previously-duloxetine-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-15", "first_observed_at": "2026-10-12T19:05:31Z", "last_observed_at": "2026-10-12T19:05:31Z", "sha256": "a3fcd41b075d15c850a0f367ebb6f0d92da2955806b88a6247a9bf6368228bcd", "format": "docx", "archive_key": "documents/a3fcd41b075d15c850a0f367ebb6f0d92da2955806b88a6247a9bf6368228bcd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760546267\"", "last_modified": "Wed, 15 Oct 2025 16:37:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2547, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-9ec91128981ab659e4649971", "medicine_id": "EMEA/H/C/000338", "medicine_name": "Trizivir", "medicine_slug": "trizivir", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trizivir-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:40Z", "last_observed_at": "2026-10-12T17:26:40Z", "sha256": "7b60528b5a9e0b2c4ab653d5cfe7aacd42662a265cb74e9eef5686e2d6eff4c8", "format": "docx", "archive_key": "documents/7b60528b5a9e0b2c4ab653d5cfe7aacd42662a265cb74e9eef5686e2d6eff4c8.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768816649\"", "last_modified": "Mon, 19 Jan 2026 09:57:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2007, "changed_paragraphs": 22, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-a0294e91260d3362898df4a1", "medicine_id": "EMEA/H/C/005178", "medicine_name": "Cabazitaxel Accord", "medicine_slug": "cabazitaxel-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cabazitaxel-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-07", "first_observed_at": "2026-10-12T17:27:10Z", "last_observed_at": "2026-10-12T17:27:10Z", "sha256": "a3b51f6135c2ac577a20e7a745c2fc827b441023fe0e7eb2866bf9bf7fd83d49", "format": "docx", "archive_key": "documents/a3b51f6135c2ac577a20e7a745c2fc827b441023fe0e7eb2866bf9bf7fd83d49.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1767801681\"", "last_modified": "Wed, 07 Jan 2026 16:01:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1954, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a0eb1b0c541fed5b530618e7", "medicine_id": "EMEA/H/C/000695", "medicine_name": "Circadin", "medicine_slug": "circadin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/circadin-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-07", "first_observed_at": "2026-10-12T19:30:12Z", "last_observed_at": "2026-10-12T19:30:12Z", "sha256": "8013697e7bd979b2aa97a7a73b435fd0f5d1c467cb0cdead18a103c8b4f947c3", "format": "docx", "archive_key": "documents/8013697e7bd979b2aa97a7a73b435fd0f5d1c467cb0cdead18a103c8b4f947c3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1751897653\"", "last_modified": "Mon, 07 Jul 2025 14:14:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1063, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-a194a1f72252edf05d415c89", "medicine_id": "EMEA/H/C/000179", "medicine_name": "Aldara", "medicine_slug": "aldara", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aldara-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-07-18", "first_observed_at": "2026-10-12T19:23:35Z", "last_observed_at": "2026-10-12T19:23:35Z", "sha256": "3b2cf9289455950d39ec16e24073ae6881faf24f4ae7692061252bd22e0d41f1", "format": "doc", "archive_key": "documents/3b2cf9289455950d39ec16e24073ae6881faf24f4ae7692061252bd22e0d41f1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752844836\"", "last_modified": "Fri, 18 Jul 2025 13:20:36 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-a1e85476de17f5a8664f7766", "medicine_id": "EMEA/H/C/001021", "medicine_name": "Adcirca (previously Tadalafil Lilly)", "medicine_slug": "adcirca-previously-tadalafil-lilly", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/adcirca-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:45Z", "last_observed_at": "2026-10-12T19:02:45Z", "sha256": "cdbefcd6143c93e81f3c826bea8d3d01bffc55652e0f792243097df75c452721", "format": "docx", "archive_key": "documents/cdbefcd6143c93e81f3c826bea8d3d01bffc55652e0f792243097df75c452721.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769602270\"", "last_modified": "Wed, 28 Jan 2026 12:11:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2596, "changed_paragraphs": 23, "unassigned_changed_paragraphs": 19 }, "pipeline_version": "2.0.0" }, { "id": "source-a214fce23bf43c3222026b3d", "medicine_id": "EMEA/H/C/004310", "medicine_name": "Daptomycin Hospira", "medicine_slug": "daptomycin-hospira", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/daptomycin-hospira-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:36Z", "last_observed_at": "2026-10-12T19:09:36Z", "sha256": "e544a64f1681af82ba143ddd0cfa7cca4ef0de691ed43076b92bb75f66ec7f7b", "format": "docx", "archive_key": "documents/e544a64f1681af82ba143ddd0cfa7cca4ef0de691ed43076b92bb75f66ec7f7b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758096393\"", "last_modified": "Wed, 17 Sep 2025 08:06:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2197, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a2dc64012a0e2142a7477fbb", "medicine_id": "EMEA/H/C/002640", "medicine_name": "Cometriq", "medicine_slug": "cometriq", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cometriq-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:48Z", "last_observed_at": "2026-10-12T19:00:48Z", "sha256": "9a013f64c372a20a7dfcfd0a30d84c365e558413e28c71df200098486d1db15b", "format": "docx", "archive_key": "documents/9a013f64c372a20a7dfcfd0a30d84c365e558413e28c71df200098486d1db15b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772184712\"", "last_modified": "Fri, 27 Feb 2026 09:31:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2263, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-a312e04389a52920b6e7e559", "medicine_id": "EMEA/H/C/002155", "medicine_name": "Tobi Podhaler", "medicine_slug": "tobi-podhaler", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tobi-podhaler-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-05-11", "first_observed_at": "2026-10-12T13:36:41Z", "last_observed_at": "2026-10-12T13:36:41Z", "sha256": "5cc26642b9e030f9233531f4a396f97cc48c19912f479d8ebfc2dd1e886eb02f", "format": "doc", "archive_key": "documents/5cc26642b9e030f9233531f4a396f97cc48c19912f479d8ebfc2dd1e886eb02f.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778512130\"", "last_modified": "Mon, 11 May 2026 15:08:50 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-a31ad98ca731add8030b2c11", "medicine_id": "EMEA/H/C/005155", "medicine_name": "Qdenga", "medicine_slug": "qdenga", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/qdenga-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:40Z", "last_observed_at": "2026-10-12T19:02:40Z", "sha256": "e569f524f020f028a35c6c220bddf3a6cc7a4f6893b39b6f03a30cff5b214377", "format": "docx", "archive_key": "documents/e569f524f020f028a35c6c220bddf3a6cc7a4f6893b39b6f03a30cff5b214377.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769758320\"", "last_modified": "Fri, 30 Jan 2026 07:32:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2387, "changed_paragraphs": 50, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a33d4e91086c5c029de837c3", "medicine_id": "EMEA/H/C/000258", "medicine_name": "NovoRapid", "medicine_slug": "novorapid", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/novorapid-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-17", "first_observed_at": "2026-10-12T19:05:17Z", "last_observed_at": "2026-10-12T19:05:17Z", "sha256": "1f523a448c243ca0c7f4a7a256aecf542f6d2937ca52c9e9a8051cbe652ac962", "format": "docx", "archive_key": "documents/1f523a448c243ca0c7f4a7a256aecf542f6d2937ca52c9e9a8051cbe652ac962.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1760696238\"", "last_modified": "Fri, 17 Oct 2025 10:17:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4502, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-a3ac25d4dd665180c4d94fd2", "medicine_id": "EMEA/H/C/005678", "medicine_name": "Sitagliptin / Metformin hydrochloride Mylan", "medicine_slug": "sitagliptin-metformin-hydrochloride-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sitagliptin-metformin-hydrochloride-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-15", "first_observed_at": "2026-10-12T13:34:19Z", "last_observed_at": "2026-10-12T13:34:19Z", "sha256": "20ae50aaca920987f329dc47da93ac2e6cbf64ebbf53248bee6257f89840f5f1", "format": "docx", "archive_key": "documents/20ae50aaca920987f329dc47da93ac2e6cbf64ebbf53248bee6257f89840f5f1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781510292\"", "last_modified": "Mon, 15 Jun 2026 07:58:12 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2465, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a3f8e8fed55de3f8530c3180", "medicine_id": "EMEA/H/C/005122", "medicine_name": "Omvoh", "medicine_slug": "omvoh", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/omvoh-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-03", "first_observed_at": "2026-10-12T19:15:18Z", "last_observed_at": "2026-10-12T19:15:18Z", "sha256": "6e00f061db2bf60e0816a005125e27a86eb7f7e42c539815e4593274e98f713a", "format": "docx", "archive_key": "documents/6e00f061db2bf60e0816a005125e27a86eb7f7e42c539815e4593274e98f713a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756906168\"", "last_modified": "Wed, 03 Sep 2025 13:29:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8809, "changed_paragraphs": 1037, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-a448ba148103c6e4f8bfa602", "medicine_id": "EMEA/H/C/004077", "medicine_name": "Darzalex", "medicine_slug": "darzalex", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/darzalex-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-27", "first_observed_at": "2026-10-12T19:04:45Z", "last_observed_at": "2026-10-12T19:04:45Z", "sha256": "ca7cec9127a023f1d64c4a23c66b64befc174186e07b1c71ff1195cffd627a2d", "format": "docx", "archive_key": "documents/ca7cec9127a023f1d64c4a23c66b64befc174186e07b1c71ff1195cffd627a2d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761566824\"", "last_modified": "Mon, 27 Oct 2025 12:07:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4571, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a4532d37153d2038ff9a86e8", "medicine_id": "EMEA/H/C/004649", "medicine_name": "Fulvestrant Mylan", "medicine_slug": "fulvestrant-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fulvestrant-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:54Z", "last_observed_at": "2026-10-12T13:35:54Z", "sha256": "b8e5c5784a26cd2bab82a1b1f2047cb0f2dca9b31e6d6e97564c17eca64312fe", "format": "docx", "archive_key": "documents/b8e5c5784a26cd2bab82a1b1f2047cb0f2dca9b31e6d6e97564c17eca64312fe.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781261495\"", "last_modified": "Fri, 12 Jun 2026 10:51:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1926, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a4621a49bcc40ac3f94d4939", "medicine_id": "EMEA/H/C/004361", "medicine_name": "Kanjinti", "medicine_slug": "kanjinti", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kanjinti-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:40:38Z", "last_observed_at": "2026-10-12T19:40:38Z", "sha256": "ea9ea0ca90af9dcbc236774255b0290bf3e784884d88a33522b45c8050f829cf", "format": "docx", "archive_key": "documents/ea9ea0ca90af9dcbc236774255b0290bf3e784884d88a33522b45c8050f829cf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747146648\"", "last_modified": "Tue, 13 May 2025 14:30:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2928, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a6036f92a16a3ab4b0d6ef76", "medicine_id": "EMEA/H/C/006152", "medicine_name": "Izamby", "medicine_slug": "izamby", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/izamby-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-02", "first_observed_at": "2026-10-12T17:29:38Z", "last_observed_at": "2026-10-12T17:29:38Z", "sha256": "1ccb5203c79bdc04e796d8657382378bf012badc733b877083ce1572b365f0ae", "format": "docx", "archive_key": "documents/1ccb5203c79bdc04e796d8657382378bf012badc733b877083ce1572b365f0ae.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764672247\"", "last_modified": "Tue, 02 Dec 2025 10:44:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1471, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 6 }, "pipeline_version": "2.0.0" }, { "id": "source-a658c1d18774a9ebd4afe18e", "medicine_id": "EMEA/H/C/005958", "medicine_name": "Omlyclo", "medicine_slug": "omlyclo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/omlyclo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-18", "first_observed_at": "2026-10-12T19:03:07Z", "last_observed_at": "2026-10-12T19:03:07Z", "sha256": "51a285c9095ff82e74e362f9d6741d9422455cfd2ca582a3fd8f12cf7d27d10a", "format": "docx", "archive_key": "documents/51a285c9095ff82e74e362f9d6741d9422455cfd2ca582a3fd8f12cf7d27d10a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763463076\"", "last_modified": "Tue, 18 Nov 2025 10:51:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8077, "changed_paragraphs": 924, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-a6a1147650e70c6696046075", "medicine_id": "EMEA/H/C/005124", "medicine_name": "Enhertu", "medicine_slug": "enhertu", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/enhertu-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:26Z", "last_observed_at": "2026-10-12T17:29:26Z", "sha256": "e85dac35c2cc16a38ee4f29d0b95d3e0f75165bc60e8283adccd27a78ccda432", "format": "docx", "archive_key": "documents/e85dac35c2cc16a38ee4f29d0b95d3e0f75165bc60e8283adccd27a78ccda432.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764772410\"", "last_modified": "Wed, 03 Dec 2025 14:33:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1907, "changed_paragraphs": 123, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-a6bf09d6be60fa69e08ca140", "medicine_id": "EMEA/H/C/004240", "medicine_name": "Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan", "medicine_slug": "efavirenz-emtricitabine-tenofovir-disoproxil-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/efavirenz-emtricitabine-tenofovir-disoproxil-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:36Z", "last_observed_at": "2026-10-12T13:35:36Z", "sha256": "b05a93fb60d054704516fe125d3f487de5110d2f458193666c1071a32ca9a361", "format": "docx", "archive_key": "documents/b05a93fb60d054704516fe125d3f487de5110d2f458193666c1071a32ca9a361.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781268050\"", "last_modified": "Fri, 12 Jun 2026 12:40:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3016, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a6e75dd529d9657c082cb659", "medicine_id": "EMEA/H/C/003819", "medicine_name": "Zykadia", "medicine_slug": "zykadia", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zykadia-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-26", "first_observed_at": "2026-10-12T19:15:39Z", "last_observed_at": "2026-10-12T19:15:39Z", "sha256": "4b3fd6d33cd626bcea8e944733f8421f83e3a0eb26201f68753431159b4715d2", "format": "docx", "archive_key": "documents/4b3fd6d33cd626bcea8e944733f8421f83e3a0eb26201f68753431159b4715d2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756210571\"", "last_modified": "Tue, 26 Aug 2025 12:16:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3826, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a79a7cba8bf5dbc72fd40574", "medicine_id": "EMEA/H/C/002434", "medicine_name": "Fycompa", "medicine_slug": "fycompa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fycompa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-10", "first_observed_at": "2026-10-12T13:32:00Z", "last_observed_at": "2026-10-12T13:32:00Z", "sha256": "3ff8cd4d67d22ba799aa348aeda944d6d896a16dcf54b030db101cbc095fc8ad", "format": "docx", "archive_key": "documents/3ff8cd4d67d22ba799aa348aeda944d6d896a16dcf54b030db101cbc095fc8ad.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783665224\"", "last_modified": "Fri, 10 Jul 2026 06:33:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3543, "changed_paragraphs": 32, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a7a56afe8c7c3d12f12413ba", "medicine_id": "EMEA/H/C/004881", "medicine_name": "Seffalair Spiromax", "medicine_slug": "seffalair-spiromax", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/seffalair-spiromax-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-16", "first_observed_at": "2026-10-12T17:28:07Z", "last_observed_at": "2026-10-12T17:28:07Z", "sha256": "7eff81949b3d672e4e4d45be072c05d86664a74a9352fa76df2a19e6260c69b3", "format": "docx", "archive_key": "documents/7eff81949b3d672e4e4d45be072c05d86664a74a9352fa76df2a19e6260c69b3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765886328\"", "last_modified": "Tue, 16 Dec 2025 11:58:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2549, "changed_paragraphs": 27, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a7dd2dd81f4bb5f7de078b9c", "medicine_id": "EMEA/H/C/000258", "medicine_name": "NovoRapid", "medicine_slug": "novorapid", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/novorapid-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-17", "first_observed_at": "2026-10-12T19:05:20Z", "last_observed_at": "2026-10-12T19:05:20Z", "sha256": "7a2e275dc85e326e218371029d27a1433946e84b3ea473376b27254ac744b108", "format": "docx", "archive_key": "documents/7a2e275dc85e326e218371029d27a1433946e84b3ea473376b27254ac744b108.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1748451841\"", "last_modified": "Wed, 28 May 2025 17:04:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4461, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-a91ac33cdc893a4fbfb3ad37", "medicine_id": "EMEA/H/C/002173", "medicine_name": "Xgeva", "medicine_slug": "xgeva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xgeva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-30", "first_observed_at": "2026-10-12T13:34:02Z", "last_observed_at": "2026-10-12T13:34:02Z", "sha256": "47551aac60917b2ed3f8c2e52c27dd3450c19003b7f0c7922ab6afa6357572e5", "format": "docx", "archive_key": "documents/47551aac60917b2ed3f8c2e52c27dd3450c19003b7f0c7922ab6afa6357572e5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782821250\"", "last_modified": "Tue, 30 Jun 2026 12:07:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2303, "changed_paragraphs": 21, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-a97cf967f33828327919bcac", "medicine_id": "EMEA/H/C/001088", "medicine_name": "Olazax Disperzi", "medicine_slug": "olazax-disperzi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olazax-disperzi-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-05-12", "first_observed_at": "2026-10-12T13:36:38Z", "last_observed_at": "2026-10-12T13:36:38Z", "sha256": "bb2453d3037dd102a6989bb5bf056c4205496d8eaf4a915dd5ad2e9cd50cebd3", "format": "doc", "archive_key": "documents/bb2453d3037dd102a6989bb5bf056c4205496d8eaf4a915dd5ad2e9cd50cebd3.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778572418\"", "last_modified": "Tue, 12 May 2026 07:53:38 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-aa7828f4c415e8fade66f4fc", "medicine_id": "EMEA/H/C/002198", "medicine_name": "Temozolomide Sun", "medicine_slug": "temozolomide-sun", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/temozolomide-sun-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:29:41Z", "last_observed_at": "2026-10-12T19:29:41Z", "sha256": "360a0c2f818e361f16f41af225e41b64991004a3c5deeb058657a5b883de7347", "format": "docx", "archive_key": "documents/360a0c2f818e361f16f41af225e41b64991004a3c5deeb058657a5b883de7347.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752143890\"", "last_modified": "Thu, 10 Jul 2025 10:38:10 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2063, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ac204c9b89b97110ab8ba72f", "medicine_id": "EMEA/H/C/000278", "medicine_name": "Herceptin", "medicine_slug": "herceptin", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/herceptin-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-25", "first_observed_at": "2026-10-12T17:30:27Z", "last_observed_at": "2026-10-12T17:30:27Z", "sha256": "7058a11a8433a5e8fa7a7faad348278fda238cc952f0f8ab4ee40da0821c02b2", "format": "docx", "archive_key": "documents/7058a11a8433a5e8fa7a7faad348278fda238cc952f0f8ab4ee40da0821c02b2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764063847\"", "last_modified": "Tue, 25 Nov 2025 09:44:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4740, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-aca2eb2a074bdefb15189a8a", "medicine_id": "EMEA/H/C/001136", "medicine_name": "Clopidogrel TAD", "medicine_slug": "clopidogrel-tad", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/clopidogrel-tad-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:41:00Z", "last_observed_at": "2026-10-12T19:41:00Z", "sha256": "ee6ae8cacfb8b975d0540bc6fb939a17d6b2e929f257fdfe526eedfd3cbc837e", "format": "docx", "archive_key": "documents/ee6ae8cacfb8b975d0540bc6fb939a17d6b2e929f257fdfe526eedfd3cbc837e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747147131\"", "last_modified": "Tue, 13 May 2025 14:38:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1286, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-acb656ad31eb3184c264b4cd", "medicine_id": "EMEA/H/C/006459", "medicine_name": "Eltrombopag Accord", "medicine_slug": "eltrombopag-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eltrombopag-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-20", "first_observed_at": "2026-10-12T19:38:33Z", "last_observed_at": "2026-10-12T19:38:33Z", "sha256": "4dba9ba2d13e28b9b00b5cee0ebfe8b72ef357d185dbbf0def82cb05d9f63530", "format": "docx", "archive_key": "documents/4dba9ba2d13e28b9b00b5cee0ebfe8b72ef357d185dbbf0def82cb05d9f63530.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747743019\"", "last_modified": "Tue, 20 May 2025 12:10:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3253, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ad69d09363ca0e5d3cfc40d1", "medicine_id": "EMEA/H/C/001085", "medicine_name": "Olanzapine Glenmark", "medicine_slug": "olanzapine-glenmark", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olanzapine-glenmark-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:36:50Z", "last_observed_at": "2026-10-12T13:36:50Z", "sha256": "f76071d3b0e50c8cc29006729404ad089053f401e88f2e0f8677c4d648b7d6d5", "format": "doc", "archive_key": "documents/f76071d3b0e50c8cc29006729404ad089053f401e88f2e0f8677c4d648b7d6d5.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778248298\"", "last_modified": "Fri, 08 May 2026 13:51:38 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-ad7452ae7b0a9ad4a381b842", "medicine_id": "EMEA/H/C/000425", "medicine_name": "Forsteo", "medicine_slug": "forsteo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/forsteo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:52Z", "last_observed_at": "2026-10-12T19:02:52Z", "sha256": "297d0b4a748fdf292c9e00a9b78fa327c674036dbcc625fdb126df326d5bd57c", "format": "docx", "archive_key": "documents/297d0b4a748fdf292c9e00a9b78fa327c674036dbcc625fdb126df326d5bd57c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769601934\"", "last_modified": "Wed, 28 Jan 2026 12:05:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1245, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-ae325f069ae857fd9d1753a6", "medicine_id": "EMEA/H/C/002649", "medicine_name": "Invokana", "medicine_slug": "invokana", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/invokana-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:27:33Z", "last_observed_at": "2026-10-12T17:27:33Z", "sha256": "a1af6612347748b5da8c154ebcce6e2aad0bb4a764a46fc2142143b05661d165", "format": "docx", "archive_key": "documents/a1af6612347748b5da8c154ebcce6e2aad0bb4a764a46fc2142143b05661d165.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766044981\"", "last_modified": "Thu, 18 Dec 2025 08:03:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1936, "changed_paragraphs": 85, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-aebb85fdcfabf97d656c392b", "medicine_id": "EMEA/H/C/006544", "medicine_name": "Otulfi", "medicine_slug": "otulfi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/otulfi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:54Z", "last_observed_at": "2026-10-12T13:46:54Z", "sha256": "ece109f16cfe4c05bf75ddee59c98963b7c47d3cc16e993089a750fc077ccfc9", "format": "docx", "archive_key": "documents/ece109f16cfe4c05bf75ddee59c98963b7c47d3cc16e993089a750fc077ccfc9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774449266\"", "last_modified": "Wed, 25 Mar 2026 14:34:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6725, "changed_paragraphs": 1697, "unassigned_changed_paragraphs": 765 }, "pipeline_version": "2.0.0" }, { "id": "source-aef9ae0f8e0087d897d1f70f", "medicine_id": "EMEA/H/C/002737", "medicine_name": "Adempas", "medicine_slug": "adempas", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/adempas-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-22", "first_observed_at": "2026-10-12T13:36:29Z", "last_observed_at": "2026-10-12T13:36:29Z", "sha256": "4ed86370c90529467e65d9f8fefeb73bd06a694419a72ca009c08d841e1be751", "format": "docx", "archive_key": "documents/4ed86370c90529467e65d9f8fefeb73bd06a694419a72ca009c08d841e1be751.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1779452672\"", "last_modified": "Fri, 22 May 2026 12:24:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4089, "changed_paragraphs": 146, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b00606528adcfef988a48937", "medicine_id": "EMEA/H/C/005958", "medicine_name": "Omlyclo", "medicine_slug": "omlyclo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/omlyclo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-18", "first_observed_at": "2026-10-12T19:03:03Z", "last_observed_at": "2026-10-12T19:03:03Z", "sha256": "c5b129d66e832e67fa5d74ee1658655b9c29b120328d9407b39581f4691582ea", "format": "docx", "archive_key": "documents/c5b129d66e832e67fa5d74ee1658655b9c29b120328d9407b39581f4691582ea.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763463075\"", "last_modified": "Tue, 18 Nov 2025 10:51:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7520, "changed_paragraphs": 876, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-b025a12dbaa7a90fd46746e6", "medicine_id": "EMEA/H/C/003787", "medicine_name": "Tadalafil Mylan", "medicine_slug": "tadalafil-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tadalafil-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-15", "first_observed_at": "2026-10-12T13:34:55Z", "last_observed_at": "2026-10-12T13:34:55Z", "sha256": "bc61cb8c8056c968db6506a44c96076e600dfa4f0c8bb04bc5a3bf4a99b412bc", "format": "docx", "archive_key": "documents/bc61cb8c8056c968db6506a44c96076e600dfa4f0c8bb04bc5a3bf4a99b412bc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781509853\"", "last_modified": "Mon, 15 Jun 2026 07:50:53 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3653, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b0f20ac76a50bccfd2108205", "medicine_id": "EMEA/H/C/002790", "medicine_name": "Ongentys", "medicine_slug": "ongentys", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ongentys-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-05-07", "first_observed_at": "2026-10-12T19:43:17Z", "last_observed_at": "2026-10-12T19:43:17Z", "sha256": "7eb1c0118a3833eef91b4d4c4f3bd5bab6afe95fbc2c901b2be812cd4fbd2dd1", "format": "doc", "archive_key": "documents/7eb1c0118a3833eef91b4d4c4f3bd5bab6afe95fbc2c901b2be812cd4fbd2dd1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746614017\"", "last_modified": "Wed, 07 May 2025 10:33:37 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-b117901a8036012dde2ca350", "medicine_id": "EMEA/H/C/000690", "medicine_name": "Nexavar", "medicine_slug": "nexavar", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/nexavar-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-03-28", "first_observed_at": "2026-10-12T19:46:57Z", "last_observed_at": "2026-10-12T19:46:57Z", "sha256": "453fff219cfe53ce95d40f8a77054887fe751af6807a8563eebfcfdb01b634d9", "format": "docx", "archive_key": "documents/453fff219cfe53ce95d40f8a77054887fe751af6807a8563eebfcfdb01b634d9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1743171860\"", "last_modified": "Fri, 28 Mar 2025 14:24:20 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1403, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-b1925a54bfeff5c1398e0f30", "medicine_id": "EMEA/H/C/004164", "medicine_name": "Alecensa", "medicine_slug": "alecensa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/alecensa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:36Z", "last_observed_at": "2026-10-12T19:00:36Z", "sha256": "83ee6e171c0e05bd6ab2daf5408dcacb676175e21156c6f5251ff1b3290852d9", "format": "docx", "archive_key": "documents/83ee6e171c0e05bd6ab2daf5408dcacb676175e21156c6f5251ff1b3290852d9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772186583\"", "last_modified": "Fri, 27 Feb 2026 10:03:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2070, "changed_paragraphs": 187, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b1eaab6445cfa827e3b1481b", "medicine_id": "EMEA/H/C/003984", "medicine_name": "Bortezomib Accord", "medicine_slug": "bortezomib-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/bortezomib-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:47:12Z", "last_observed_at": "2026-10-12T13:47:12Z", "sha256": "e4aac937241121e8ad1e32b40b1007fb58398035928568a7e60a65074b0efb36", "format": "docx", "archive_key": "documents/e4aac937241121e8ad1e32b40b1007fb58398035928568a7e60a65074b0efb36.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774424316\"", "last_modified": "Wed, 25 Mar 2026 07:38:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4840, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b244d7f3125eed79d9ce0ddd", "medicine_id": "EMEA/H/C/005738", "medicine_name": "Vildagliptin / Metformin hydrochloride Accord", "medicine_slug": "vildagliptin-metformin-hydrochloride-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vildagliptin-metformin-hydrochloride-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-25", "first_observed_at": "2026-10-12T19:22:53Z", "last_observed_at": "2026-10-12T19:22:53Z", "sha256": "8af4b85f8fc545f4d9ccb58e44882e3cb9e9ba5608168c162c8b2eeaba88f8ec", "format": "docx", "archive_key": "documents/8af4b85f8fc545f4d9ccb58e44882e3cb9e9ba5608168c162c8b2eeaba88f8ec.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753458624\"", "last_modified": "Fri, 25 Jul 2025 15:50:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1472, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b2ca94c523be35c37d5bab91", "medicine_id": "EMEA/H/C/000115", "medicine_name": "Zyprexa", "medicine_slug": "zyprexa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zyprexa-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:40Z", "last_observed_at": "2026-10-12T19:00:40Z", "sha256": "8bbd2395830e95c62f438e1801d3fefa0030a0c494e29ef48b0c7e88a6c84c8f", "format": "doc", "archive_key": "documents/8bbd2395830e95c62f438e1801d3fefa0030a0c494e29ef48b0c7e88a6c84c8f.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772188226\"", "last_modified": "Fri, 27 Feb 2026 10:30:26 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-b2fdd9a7f3718161026d4f23", "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:14Z", "last_observed_at": "2026-10-12T17:29:14Z", "sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "format": "docx", "archive_key": "documents/aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764775578\"", "last_modified": "Wed, 03 Dec 2025 15:26:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3322, "changed_paragraphs": 356, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b2fe72bcd921651203a0ff2e", "medicine_id": "EMEA/H/C/003904", "medicine_name": "Evotaz", "medicine_slug": "evotaz", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/evotaz-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-10", "first_observed_at": "2026-10-12T19:30:04Z", "last_observed_at": "2026-10-12T19:30:04Z", "sha256": "1aa5801b5983595d59ac5834392591fabad217600cd1f35ffe8622c2f2623e51", "format": "docx", "archive_key": "documents/1aa5801b5983595d59ac5834392591fabad217600cd1f35ffe8622c2f2623e51.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752140308\"", "last_modified": "Thu, 10 Jul 2025 09:38:28 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1989, "changed_paragraphs": 209, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-b3535d23eee1e8a9a1fb5da5", "medicine_id": "EMEA/H/C/000833", "medicine_name": "Effentora", "medicine_slug": "effentora", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/effentora-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-18", "first_observed_at": "2026-10-12T17:31:19Z", "last_observed_at": "2026-10-12T17:31:19Z", "sha256": "749511f6aeff319ec9a05c6e648fabc7d4309775f4c125aa9cf90c2000243ff9", "format": "docx", "archive_key": "documents/749511f6aeff319ec9a05c6e648fabc7d4309775f4c125aa9cf90c2000243ff9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763457333\"", "last_modified": "Tue, 18 Nov 2025 09:15:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2101, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-b448791bb92ba28dddf18f38", "medicine_id": "EMEA/H/C/005818", "medicine_name": "Uplizna", "medicine_slug": "uplizna", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/uplizna-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-27", "first_observed_at": "2026-10-12T17:29:49Z", "last_observed_at": "2026-10-12T17:29:49Z", "sha256": "0db94362a185a887b81cbb54301ebcfb41d52b85a7ab3c0ed8ba9dbc344aa808", "format": "docx", "archive_key": "documents/0db94362a185a887b81cbb54301ebcfb41d52b85a7ab3c0ed8ba9dbc344aa808.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764241885\"", "last_modified": "Thu, 27 Nov 2025 11:11:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1583, "changed_paragraphs": 314, "unassigned_changed_paragraphs": 8 }, "pipeline_version": "2.0.0" }, { "id": "source-b520aa5e0de169ff511a0886", "medicine_id": "EMEA/H/C/004119", "medicine_name": "Besponsa", "medicine_slug": "besponsa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/besponsa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:07Z", "last_observed_at": "2026-10-12T19:09:07Z", "sha256": "6d89a22d429cadde10d322835417e2b03c0f21e4352c135009a9e68729bc6299", "format": "docx", "archive_key": "documents/6d89a22d429cadde10d322835417e2b03c0f21e4352c135009a9e68729bc6299.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758096008\"", "last_modified": "Wed, 17 Sep 2025 08:00:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1582, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b5626359fbb77de0c67bbc56", "medicine_id": "EMEA/H/C/000314", "medicine_name": "Neoclarityn", "medicine_slug": "neoclarityn", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/neoclarityn-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:25Z", "last_observed_at": "2026-10-12T13:47:25Z", "sha256": "25896e98eab63098c1d9838e445dacbb3a7ac7671e4bd73ccf2164e00bde12d6", "format": "docx", "archive_key": "documents/25896e98eab63098c1d9838e445dacbb3a7ac7671e4bd73ccf2164e00bde12d6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773917134\"", "last_modified": "Thu, 19 Mar 2026 10:45:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1874, "changed_paragraphs": 43, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b5c20248b25e68dad88cd7a4", "medicine_id": "EMEA/H/C/005851", "medicine_name": "Veoza", "medicine_slug": "veoza", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/veoza-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:48:48Z", "last_observed_at": "2026-10-12T13:48:48Z", "sha256": "32d33ff5f62383f563052f0346f0c0d0da4a6cd155d73013929520f493bef788", "format": "docx", "archive_key": "documents/32d33ff5f62383f563052f0346f0c0d0da4a6cd155d73013929520f493bef788.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773827829\"", "last_modified": "Wed, 18 Mar 2026 09:57:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 992, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b5de155abfc26fe489dd1b33", "medicine_id": "EMEA/H/C/005005", "medicine_name": "Posaconazole Accord", "medicine_slug": "posaconazole-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/posaconazole-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:44:30Z", "last_observed_at": "2026-10-12T19:44:30Z", "sha256": "307cc53ed0048509787bc0b73f2040c678b1df3cc6f8e722f513a205cc3e6baa", "format": "docx", "archive_key": "documents/307cc53ed0048509787bc0b73f2040c678b1df3cc6f8e722f513a205cc3e6baa.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746515591\"", "last_modified": "Tue, 06 May 2025 07:13:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1589, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-b71aeee5a07abebc34c02e28", "medicine_id": "EMEA/H/C/000582", "medicine_name": "Avastin", "medicine_slug": "avastin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avastin-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-19", "first_observed_at": "2026-10-12T17:27:18Z", "last_observed_at": "2026-10-12T17:27:18Z", "sha256": "89a938df5e41f86548301270084e3d1ecf171802e24b5429f62e3bede7ee32dd", "format": "docx", "archive_key": "documents/89a938df5e41f86548301270084e3d1ecf171802e24b5429f62e3bede7ee32dd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766158920\"", "last_modified": "Fri, 19 Dec 2025 15:42:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3438, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b733ef9ed87c8e65b7c8787f", "medicine_id": "EMEA/H/C/000389", "medicine_name": "Invanz", "medicine_slug": "invanz", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/invanz-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-11-21", "first_observed_at": "2026-10-12T17:30:48Z", "last_observed_at": "2026-10-12T17:30:48Z", "sha256": "213456c3b17bcd6a1c8715c4d7a68d159582f67dcd463d676f9c9ade90323d72", "format": "doc", "archive_key": "documents/213456c3b17bcd6a1c8715c4d7a68d159582f67dcd463d676f9c9ade90323d72.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763734352\"", "last_modified": "Fri, 21 Nov 2025 14:12:32 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-b78e4755810e7b8c53ac3cfe", "medicine_id": "EMEA/H/C/005408", "medicine_name": "Abiraterone Accord", "medicine_slug": "abiraterone-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/abiraterone-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-06", "first_observed_at": "2026-10-12T19:44:09Z", "last_observed_at": "2026-10-12T19:44:09Z", "sha256": "ff046e9b6e51c18964c4a214f12c91fd62769cb80a6dd556982b7827553cd10a", "format": "docx", "archive_key": "documents/ff046e9b6e51c18964c4a214f12c91fd62769cb80a6dd556982b7827553cd10a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746513758\"", "last_modified": "Tue, 06 May 2025 06:42:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2478, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b7e818c20a738636f06f7a00", "medicine_id": "EMEA/H/C/001179", "medicine_name": "Daxas", "medicine_slug": "daxas", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/daxas-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:14Z", "last_observed_at": "2026-10-12T19:06:14Z", "sha256": "51573d3273887901d699c87dba7c52b81c1185180f5c00a525c68be2e058db68", "format": "docx", "archive_key": "documents/51573d3273887901d699c87dba7c52b81c1185180f5c00a525c68be2e058db68.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759829796\"", "last_modified": "Tue, 07 Oct 2025 09:36:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1998, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b80332502302d166824a0193", "medicine_id": "EMEA/H/C/003745", "medicine_name": "Duaklir Genuair", "medicine_slug": "duaklir-genuair", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/duaklir-genuair-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-07-29", "first_observed_at": "2026-10-12T19:19:59Z", "last_observed_at": "2026-10-12T19:19:59Z", "sha256": "d8b501a5004ab8ad3adce453e17e6641baac219ea6fd211ef1eab560410b3fe2", "format": "doc", "archive_key": "documents/d8b501a5004ab8ad3adce453e17e6641baac219ea6fd211ef1eab560410b3fe2.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753795707\"", "last_modified": "Tue, 29 Jul 2025 13:28:27 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-b81b59fb1db742037cab80d6", "medicine_id": "EMEA/H/C/001136", "medicine_name": "Clopidogrel TAD", "medicine_slug": "clopidogrel-tad", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/clopidogrel-tad-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-13", "first_observed_at": "2026-10-12T19:40:49Z", "last_observed_at": "2026-10-12T19:40:49Z", "sha256": "f688cd18a108dfe948012d5534bb0d48e1142e08f8c4090f92bcc1b7fb75e3f9", "format": "docx", "archive_key": "documents/f688cd18a108dfe948012d5534bb0d48e1142e08f8c4090f92bcc1b7fb75e3f9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747147131\"", "last_modified": "Tue, 13 May 2025 14:38:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1277, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b82019883364cb81ebd14037", "medicine_id": "EMEA/H/C/005725", "medicine_name": "Vydura", "medicine_slug": "vydura", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vydura-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-26", "first_observed_at": "2026-10-12T19:01:04Z", "last_observed_at": "2026-10-12T19:01:04Z", "sha256": "0be43b11854b2722eb5a55712c9872dbbbce4d0f91acb566c03ee6dfd288abc0", "format": "docx", "archive_key": "documents/0be43b11854b2722eb5a55712c9872dbbbce4d0f91acb566c03ee6dfd288abc0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772095515\"", "last_modified": "Thu, 26 Feb 2026 08:45:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1270, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b884a1ac04d0992ef27f8d83", "medicine_id": "EMEA/H/C/000150", "medicine_name": "Quadramet", "medicine_slug": "quadramet", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/quadramet-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-06", "first_observed_at": "2026-10-12T19:03:58Z", "last_observed_at": "2026-10-12T19:03:58Z", "sha256": "14e2ad0fbbfd646c637558259828d008457ab7ef3679c62fc1f9badc23c958f7", "format": "docx", "archive_key": "documents/14e2ad0fbbfd646c637558259828d008457ab7ef3679c62fc1f9badc23c958f7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762436139\"", "last_modified": "Thu, 06 Nov 2025 13:35:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1078, "changed_paragraphs": 290, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b92342d26cc66c69fd923acf", "medicine_id": "EMEA/H/C/001110", "medicine_name": "Revolade", "medicine_slug": "revolade", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/revolade-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-26", "first_observed_at": "2026-10-12T19:00:59Z", "last_observed_at": "2026-10-12T19:00:59Z", "sha256": "beb4f19a3e0f616ed443c376a57c0d045cc0d750999f91d3b3f42e67268b1226", "format": "docx", "archive_key": "documents/beb4f19a3e0f616ed443c376a57c0d045cc0d750999f91d3b3f42e67268b1226.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772096117\"", "last_modified": "Thu, 26 Feb 2026 08:55:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5871, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b945bbd7373f05db1379ceb4", "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-27", "first_observed_at": "2026-10-12T13:28:11Z", "last_observed_at": "2026-10-12T13:28:11Z", "sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "format": "docx", "archive_key": "documents/8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787837497\"", "last_modified": "Thu, 27 Aug 2026 13:31:37 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3864, "changed_paragraphs": 107, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-b97c331d23a7a0f19aebfb61", "medicine_id": "EMEA/H/C/000725", "medicine_name": "Binocrit", "medicine_slug": "binocrit", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/binocrit-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-11", "first_observed_at": "2026-10-12T19:28:20Z", "last_observed_at": "2026-10-12T19:28:20Z", "sha256": "b2bb40c100cab3babee14bbe20cc7718cb73ac1bbb3971dfd487c4f10a0e6478", "format": "docx", "archive_key": "documents/b2bb40c100cab3babee14bbe20cc7718cb73ac1bbb3971dfd487c4f10a0e6478.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752235789\"", "last_modified": "Fri, 11 Jul 2025 12:09:49 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3587, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ba46e119957a3ca29a915015", "medicine_id": "EMEA/H/C/005106", "medicine_name": "Aybintio", "medicine_slug": "aybintio", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aybintio-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-09-11", "first_observed_at": "2026-10-12T13:27:42Z", "last_observed_at": "2026-10-12T13:27:42Z", "sha256": "fba935554f03156639cf5f78cbde9b08cd3489bf366e599397ae71b670ba5459", "format": "docx", "archive_key": "documents/fba935554f03156639cf5f78cbde9b08cd3489bf366e599397ae71b670ba5459.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1789137855\"", "last_modified": "Fri, 11 Sep 2026 14:44:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3418, "changed_paragraphs": 148, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ba6ed4f3231b4e78449367be", "medicine_id": "EMEA/H/C/006196", "medicine_name": "Avtozma", "medicine_slug": "avtozma", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avtozma-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-24", "first_observed_at": "2026-10-12T19:08:15Z", "last_observed_at": "2026-10-12T19:08:15Z", "sha256": "ba4e9a32d5db265220ea443856f682f3a2420f7a8beaf9b7631d5fb62e8f4ccc", "format": "docx", "archive_key": "documents/ba4e9a32d5db265220ea443856f682f3a2420f7a8beaf9b7631d5fb62e8f4ccc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758704879\"", "last_modified": "Wed, 24 Sep 2025 09:07:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7678, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 11 }, "pipeline_version": "2.0.0" }, { "id": "source-babdd4d5cda2bfe61022989f", "medicine_id": "EMEA/H/C/000626", "medicine_name": "Neupro", "medicine_slug": "neupro", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/neupro-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-07", "first_observed_at": "2026-10-12T13:40:40Z", "last_observed_at": "2026-10-12T13:40:40Z", "sha256": "28dfd09ebf3cb726cbb061c6be0aebe13c29b657d728805c77cdae9c28e01a25", "format": "docx", "archive_key": "documents/28dfd09ebf3cb726cbb061c6be0aebe13c29b657d728805c77cdae9c28e01a25.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775560316\"", "last_modified": "Tue, 07 Apr 2026 11:11:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7189, "changed_paragraphs": 40, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bad0c29e627b46c44aa55163", "medicine_id": "EMEA/H/C/004996", "medicine_name": "Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)", "medicine_slug": "clopidogrel-acetylsalicylic-acid-viatris-previously-clopidogrel-acetylsalicylic-acid-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/clopidogrel-acetylsalicylic-acid-viatris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-05", "first_observed_at": "2026-10-12T19:44:51Z", "last_observed_at": "2026-10-12T19:44:51Z", "sha256": "294593741d9397e19ae02a3bbca30fc6728316afe71021d138998bb4b75122cd", "format": "docx", "archive_key": "documents/294593741d9397e19ae02a3bbca30fc6728316afe71021d138998bb4b75122cd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1746437451\"", "last_modified": "Mon, 05 May 2025 09:30:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1715, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bb1b3bad89ae8fb8d3480e7d", "medicine_id": "EMEA/H/C/000715", "medicine_name": "Lucentis", "medicine_slug": "lucentis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lucentis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-10-08", "first_observed_at": "2026-10-12T12:55:10Z", "last_observed_at": "2026-10-12T12:56:37Z", "sha256": "612293565adc0504c607d89baf03ff2fc1b364a1fa3d139f8647ac4ebe52cf1b", "format": "docx", "archive_key": "documents/612293565adc0504c607d89baf03ff2fc1b364a1fa3d139f8647ac4ebe52cf1b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791453645\"", "last_modified": "Thu, 08 Oct 2026 10:00:45 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3941, "changed_paragraphs": 24, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bb326613adf807c5b764ea97", "medicine_id": "EMEA/H/C/001056", "medicine_name": "Clopidogrel Krka", "medicine_slug": "clopidogrel-krka", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/clopidogrel-krka-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:39:57Z", "last_observed_at": "2026-10-12T19:39:57Z", "sha256": "fc58c0c60752e32d1ee5cb3e437d1b03516774943253a275fc1019bc4278dbce", "format": "docx", "archive_key": "documents/fc58c0c60752e32d1ee5cb3e437d1b03516774943253a275fc1019bc4278dbce.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747217573\"", "last_modified": "Wed, 14 May 2025 10:12:53 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1296, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bb3cde635cf7cd6bb8b16e4e", "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-18", "first_observed_at": "2026-10-12T19:31:05Z", "last_observed_at": "2026-10-12T19:31:05Z", "sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "format": "docx", "archive_key": "documents/3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750238581\"", "last_modified": "Wed, 18 Jun 2025 09:23:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1032, "changed_paragraphs": 23, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bb736e6d90be96a990172ed5", "medicine_id": "EMEA/H/C/000917", "medicine_name": "Zarzio", "medicine_slug": "zarzio", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zarzio-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-05", "first_observed_at": "2026-10-12T13:36:13Z", "last_observed_at": "2026-10-12T13:36:13Z", "sha256": "968afffa2a72df6dda240602dfb44e50ec1ab7fb854d6d777ac92e19cd52fe6f", "format": "docx", "archive_key": "documents/968afffa2a72df6dda240602dfb44e50ec1ab7fb854d6d777ac92e19cd52fe6f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780667435\"", "last_modified": "Fri, 05 Jun 2026 13:50:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1811, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bbbb3e2a4c9c34fc45c2d878", "medicine_id": "EMEA/H/C/000833", "medicine_name": "Effentora", "medicine_slug": "effentora", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/effentora-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-18", "first_observed_at": "2026-10-12T17:31:17Z", "last_observed_at": "2026-10-12T17:31:17Z", "sha256": "8bbb8aec7f74b22ceeb1c1ce8073bbfd444f4d8b71f50c6c906fc7698d909a35", "format": "docx", "archive_key": "documents/8bbb8aec7f74b22ceeb1c1ce8073bbfd444f4d8b71f50c6c906fc7698d909a35.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763457333\"", "last_modified": "Tue, 18 Nov 2025 09:15:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2102, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-bcb3676dba9be6c6cf96c0a5", "medicine_id": "EMEA/H/C/003825", "medicine_name": "Kovaltry", "medicine_slug": "kovaltry", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kovaltry-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:24Z", "last_observed_at": "2026-10-12T19:16:24Z", "sha256": "5e15909c5973231a552c6cf2654a0e17ec7d8842211fc387cadbc79c08520f46", "format": "docx", "archive_key": "documents/5e15909c5973231a552c6cf2654a0e17ec7d8842211fc387cadbc79c08520f46.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755092404\"", "last_modified": "Wed, 13 Aug 2025 13:40:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3096, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bde764e81be214f69d4b1874", "medicine_id": "EMEA/H/C/002783", "medicine_name": "Levetiracetam Hospira", "medicine_slug": "levetiracetam-hospira", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/levetiracetam-hospira-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:38Z", "last_observed_at": "2026-10-12T19:09:38Z", "sha256": "a6c8c211893c8f350f269f108fc2d662ebd91c173aeb7213531c08901ecf57b3", "format": "docx", "archive_key": "documents/a6c8c211893c8f350f269f108fc2d662ebd91c173aeb7213531c08901ecf57b3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758097154\"", "last_modified": "Wed, 17 Sep 2025 08:19:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1429, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-be92f595218ee3147a428a7e", "medicine_id": "EMEA/H/C/002148", "medicine_name": "Eliquis", "medicine_slug": "eliquis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eliquis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-10", "first_observed_at": "2026-10-12T13:40:29Z", "last_observed_at": "2026-10-12T13:40:29Z", "sha256": "c3f0c80aee334b4c8664a503814ebac43e36c3eb969908b2b42ff943fbe6f521", "format": "docx", "archive_key": "documents/c3f0c80aee334b4c8664a503814ebac43e36c3eb969908b2b42ff943fbe6f521.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775807731\"", "last_modified": "Fri, 10 Apr 2026 07:55:31 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8241, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-bf3b935325b63167ece5cf78", "medicine_id": "EMEA/H/C/004106", "medicine_name": "Venclyxto", "medicine_slug": "venclyxto", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/venclyxto-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-08", "first_observed_at": "2026-10-12T13:33:38Z", "last_observed_at": "2026-10-12T13:33:38Z", "sha256": "4339a0529b02e90af2a0c2d03806e7f0684faad347537bb326ff692f4b227f03", "format": "docx", "archive_key": "documents/4339a0529b02e90af2a0c2d03806e7f0684faad347537bb326ff692f4b227f03.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783506922\"", "last_modified": "Wed, 08 Jul 2026 10:35:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3780, "changed_paragraphs": 418, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-bf4b610d144f9037b863201d", "medicine_id": "EMEA/H/C/000762", "medicine_name": "Xelevia", "medicine_slug": "xelevia", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xelevia-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-12-01", "first_observed_at": "2026-10-12T17:29:44Z", "last_observed_at": "2026-10-12T17:29:44Z", "sha256": "2dd7c1d3d28ade5d19ab3f09db4c29d493fbfabddfb589487e7887531281690e", "format": "doc", "archive_key": "documents/2dd7c1d3d28ade5d19ab3f09db4c29d493fbfabddfb589487e7887531281690e.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764595969\"", "last_modified": "Mon, 01 Dec 2025 13:32:49 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-bf7e95a529cab2f0ef511cbf", "medicine_id": "EMEA/H/C/002018", "medicine_name": "Jevtana", "medicine_slug": "jevtana", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/jevtana-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-09-30", "first_observed_at": "2026-10-12T19:06:30Z", "last_observed_at": "2026-10-12T19:06:30Z", "sha256": "5a10c9919b8c914d80634b50b79a91f7da17dbea368893e0fc8e09e7bfed2bfa", "format": "doc", "archive_key": "documents/5a10c9919b8c914d80634b50b79a91f7da17dbea368893e0fc8e09e7bfed2bfa.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759233748\"", "last_modified": "Tue, 30 Sep 2025 12:02:28 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-c039759811db82b93f72f698", "medicine_id": "EMEA/H/C/000175", "medicine_name": "Iscover", "medicine_slug": "iscover", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/iscover-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-26", "first_observed_at": "2026-10-12T19:15:48Z", "last_observed_at": "2026-10-12T19:15:48Z", "sha256": "00dc989d8d8f12826acb51303c928c50b57110f1ebd721c19a022f7f86bf2b9b", "format": "docx", "archive_key": "documents/00dc989d8d8f12826acb51303c928c50b57110f1ebd721c19a022f7f86bf2b9b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756217148\"", "last_modified": "Tue, 26 Aug 2025 14:05:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1933, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c03fb6f08190e30934edc22f", "medicine_id": "EMEA/H/C/000709", "medicine_name": "Sprycel", "medicine_slug": "sprycel", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sprycel-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-10-02", "first_observed_at": "2026-10-12T13:27:33Z", "last_observed_at": "2026-10-12T13:27:33Z", "sha256": "7b2a270ca60f948a69940b5bd26552042c4c20cae01b420ad781477ba43b0fe9", "format": "docx", "archive_key": "documents/7b2a270ca60f948a69940b5bd26552042c4c20cae01b420ad781477ba43b0fe9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1790943274\"", "last_modified": "Fri, 02 Oct 2026 12:14:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5541, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-c0cfff56629ca53898dd4709", "medicine_id": "EMEA/H/C/004700", "medicine_name": "Pelmeg", "medicine_slug": "pelmeg", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pelmeg-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:47:36Z", "last_observed_at": "2026-10-12T13:47:36Z", "sha256": "b2be0edbf6bc3269641de1889e40a199aac2620ad26bd538c7d647e7fd351f7a", "format": "docx", "archive_key": "documents/b2be0edbf6bc3269641de1889e40a199aac2620ad26bd538c7d647e7fd351f7a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773819968\"", "last_modified": "Wed, 18 Mar 2026 07:46:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1502, "changed_paragraphs": 123, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c0f060f1f49c5b66ccef691b", "medicine_id": "EMEA/H/C/003970", "medicine_name": "Pemetrexed Pfizer (previously Pemetrexed Hospira)", "medicine_slug": "pemetrexed-pfizer-previously-pemetrexed-hospira", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/pemetrexed-pfizer-previously-pemetrexed-hospira-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:10:43Z", "last_observed_at": "2026-10-12T19:10:43Z", "sha256": "ee812f293ab0cd8ae2485dfcd9049196e32f90fb7e28b6fe60ca25886307c018", "format": "docx", "archive_key": "documents/ee812f293ab0cd8ae2485dfcd9049196e32f90fb7e28b6fe60ca25886307c018.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758097819\"", "last_modified": "Wed, 17 Sep 2025 08:30:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3272, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c11aa9e32420f125a88005bc", "medicine_id": "EMEA/H/C/003746", "medicine_name": "Otezla", "medicine_slug": "otezla", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/otezla-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-04", "first_observed_at": "2026-10-12T19:00:31Z", "last_observed_at": "2026-10-12T19:00:31Z", "sha256": "9ac80b0d56ebad4970f7a8335a177613af59ef25517bcd0bdd3397c207cc1bac", "format": "docx", "archive_key": "documents/9ac80b0d56ebad4970f7a8335a177613af59ef25517bcd0bdd3397c207cc1bac.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772619964\"", "last_modified": "Wed, 04 Mar 2026 10:26:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2754, "changed_paragraphs": 30, "unassigned_changed_paragraphs": 9 }, "pipeline_version": "2.0.0" }, { "id": "source-c1f946bc2e5fe3cb93eeefd0", "medicine_id": "EMEA/H/C/001059", "medicine_name": "Grepid", "medicine_slug": "grepid", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-06-23", "first_observed_at": "2026-10-12T19:30:51Z", "last_observed_at": "2026-10-12T19:30:51Z", "sha256": "56db361d5765222728933c181fe90880f87d89958699de25742065532a24d8f1", "format": "doc", "archive_key": "documents/56db361d5765222728933c181fe90880f87d89958699de25742065532a24d8f1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750678335\"", "last_modified": "Mon, 23 Jun 2025 11:32:15 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-c30fe67c2557a065282a6da8", "medicine_id": "EMEA/H/C/002638", "medicine_name": "Ibandronic acid Accord", "medicine_slug": "ibandronic-acid-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ibandronic-acid-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-26", "first_observed_at": "2026-10-12T19:07:40Z", "last_observed_at": "2026-10-12T19:07:40Z", "sha256": "a3b3d803b1a906929e401c159eaaf927d145b081c8d5b2f4e2a0f6ba1bb870de", "format": "docx", "archive_key": "documents/a3b3d803b1a906929e401c159eaaf927d145b081c8d5b2f4e2a0f6ba1bb870de.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758898739\"", "last_modified": "Fri, 26 Sep 2025 14:58:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2406, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-c3d00ba2ce4a575e719f9f80", "medicine_id": "EMEA/H/C/001086", "medicine_name": "Olanzapine Glenmark Europe", "medicine_slug": "olanzapine-glenmark-europe", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olanzapine-glenmark-europe-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:36:57Z", "last_observed_at": "2026-10-12T13:36:57Z", "sha256": "8d437f950e609156a235acf87f401e31b62b87c62d3eb69a08b83f375245d1d4", "format": "doc", "archive_key": "documents/8d437f950e609156a235acf87f401e31b62b87c62d3eb69a08b83f375245d1d4.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778248876\"", "last_modified": "Fri, 08 May 2026 14:01:16 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-c456b260a6ea2676dbd096d9", "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:36:04Z", "last_observed_at": "2026-10-12T13:36:04Z", "sha256": "6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5", "format": "docx", "archive_key": "documents/6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781264698\"", "last_modified": "Fri, 12 Jun 2026 11:44:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1861, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c4e1e345673be2109418f4dc", "medicine_id": "EMEA/H/C/001179", "medicine_name": "Daxas", "medicine_slug": "daxas", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/daxas-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:09Z", "last_observed_at": "2026-10-12T19:06:09Z", "sha256": "5a46f173703a8685205dd61d80eb3f1ec4682dddeec32928c7ecab73f8f7da95", "format": "docx", "archive_key": "documents/5a46f173703a8685205dd61d80eb3f1ec4682dddeec32928c7ecab73f8f7da95.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759829795\"", "last_modified": "Tue, 07 Oct 2025 09:36:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2016, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c502f5a07564cf8070079339", "medicine_id": "EMEA/H/C/000955", "medicine_name": "RoActemra", "medicine_slug": "roactemra", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/roactemra-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:41:18Z", "last_observed_at": "2026-10-12T13:41:18Z", "sha256": "cf4a91213ae92233c428a558204a83d1068aed134fdda1b1071732f361531aa2", "format": "docx", "archive_key": "documents/cf4a91213ae92233c428a558204a83d1068aed134fdda1b1071732f361531aa2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775037438\"", "last_modified": "Wed, 01 Apr 2026 09:57:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6978, "changed_paragraphs": 1182, "unassigned_changed_paragraphs": 29 }, "pipeline_version": "2.0.0" }, { "id": "source-c58e019b5bec1fb24569e83e", "medicine_id": "EMEA/H/C/004025", "medicine_name": "Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan)", "medicine_slug": "lopinavir-ritonavir-viatris-previously-ritonavir-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lopinavir-ritonavir-viatris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-08", "first_observed_at": "2026-10-12T19:12:46Z", "last_observed_at": "2026-10-12T19:12:46Z", "sha256": "3e30663f02732816ed8779d7a929d500c824ae15aeaee9144ca6eef11900e273", "format": "docx", "archive_key": "documents/3e30663f02732816ed8779d7a929d500c824ae15aeaee9144ca6eef11900e273.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757337480\"", "last_modified": "Mon, 08 Sep 2025 13:18:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3543, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c5d611345a78fc66578cac91", "medicine_id": "EMEA/H/C/006544", "medicine_name": "Otulfi", "medicine_slug": "otulfi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/otulfi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:51Z", "last_observed_at": "2026-10-12T13:46:51Z", "sha256": "21733c42932f8afacd2a370dff3fc774710fba9afbc924b4f5e1a0e5a75b6acd", "format": "docx", "archive_key": "documents/21733c42932f8afacd2a370dff3fc774710fba9afbc924b4f5e1a0e5a75b6acd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774449266\"", "last_modified": "Wed, 25 Mar 2026 14:34:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6563, "changed_paragraphs": 1690, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-c61e101124b1602f426640c9", "medicine_id": "EMEA/H/C/005516", "medicine_name": "Bemrist Breezhaler", "medicine_slug": "bemrist-breezhaler", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/bemrist-breezhaler-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:15Z", "last_observed_at": "2026-10-12T19:06:15Z", "sha256": "d0a24545348cc4d57ccdf15aa42a878a53742f44ea06085bfa7d51764d3f699e", "format": "docx", "archive_key": "documents/d0a24545348cc4d57ccdf15aa42a878a53742f44ea06085bfa7d51764d3f699e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759846298\"", "last_modified": "Tue, 07 Oct 2025 14:11:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2791, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c6638e859752c15372f87005", "medicine_id": "EMEA/H/C/000169", "medicine_name": "Exelon", "medicine_slug": "exelon", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exelon-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-24", "first_observed_at": "2026-10-12T19:01:24Z", "last_observed_at": "2026-10-12T19:01:24Z", "sha256": "10448efb132df712675ff13816466027d858e2c2ed8784b5d30b4c3face2d119", "format": "docx", "archive_key": "documents/10448efb132df712675ff13816466027d858e2c2ed8784b5d30b4c3face2d119.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771923608\"", "last_modified": "Tue, 24 Feb 2026 09:00:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5447, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c6766690c7b668e9ed97ac25", "medicine_id": "EMEA/H/C/002464", "medicine_name": "Jakavi", "medicine_slug": "jakavi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/jakavi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-10", "first_observed_at": "2026-10-12T19:03:48Z", "last_observed_at": "2026-10-12T19:03:48Z", "sha256": "61869ebfe2680776654fa74d3c8410b0979ca573d1bd47d9bd6bc38201c69007", "format": "docx", "archive_key": "documents/61869ebfe2680776654fa74d3c8410b0979ca573d1bd47d9bd6bc38201c69007.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762791039\"", "last_modified": "Mon, 10 Nov 2025 16:10:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5034, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c7a810dd21f94cd2d273f0da", "medicine_id": "EMEA/H/C/002097", "medicine_name": "Fampyra", "medicine_slug": "fampyra", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fampyra-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-21", "first_observed_at": "2026-10-12T19:16:07Z", "last_observed_at": "2026-10-12T19:16:07Z", "sha256": "a0c3ba8d58d6a43a809ecc3d142a78b10c2bd7f0b9f3a3553df2617d87daec1f", "format": "docx", "archive_key": "documents/a0c3ba8d58d6a43a809ecc3d142a78b10c2bd7f0b9f3a3553df2617d87daec1f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755781911\"", "last_modified": "Thu, 21 Aug 2025 13:11:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1641, "changed_paragraphs": 193, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c7f1d27d710651a01c0c1c6a", "medicine_id": "EMEA/H/C/006199", "medicine_name": "Denbrayce", "medicine_slug": "denbrayce", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/denbrayce-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-24", "first_observed_at": "2026-10-12T17:30:39Z", "last_observed_at": "2026-10-12T17:30:39Z", "sha256": "7aec92539e38d6a35a948dd8af777fe2fa290d7c53f1bc8753c739d81fc9d6af", "format": "docx", "archive_key": "documents/7aec92539e38d6a35a948dd8af777fe2fa290d7c53f1bc8753c739d81fc9d6af.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763978340\"", "last_modified": "Mon, 24 Nov 2025 09:59:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1375, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c82011ce70fd8dc89bfaf777", "medicine_id": "EMEA/H/C/006157", "medicine_name": "Osenvelt", "medicine_slug": "osenvelt", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/osenvelt-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:18Z", "last_observed_at": "2026-10-12T13:47:18Z", "sha256": "dc7eaabd6c9a06b5d41aa4a8b497d436aef070eb74e54893adce691602be4759", "format": "docx", "archive_key": "documents/dc7eaabd6c9a06b5d41aa4a8b497d436aef070eb74e54893adce691602be4759.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773932556\"", "last_modified": "Thu, 19 Mar 2026 15:02:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1407, "changed_paragraphs": 18, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c8b17db176ebb33561bb1413", "medicine_id": "EMEA/H/C/004164", "medicine_name": "Alecensa", "medicine_slug": "alecensa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/alecensa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:33Z", "last_observed_at": "2026-10-12T19:00:33Z", "sha256": "815d015f485abccb366cc8b59bef3ff2b7589fb9206cca47f8f889f776e1f3af", "format": "docx", "archive_key": "documents/815d015f485abccb366cc8b59bef3ff2b7589fb9206cca47f8f889f776e1f3af.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772186583\"", "last_modified": "Fri, 27 Feb 2026 10:03:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1934, "changed_paragraphs": 253, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-c94e79c8ab6d9bd96d244a9e", "medicine_id": "EMEA/H/C/002755", "medicine_name": "Abilify Maintena", "medicine_slug": "abilify-maintena", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-28", "first_observed_at": "2026-10-12T19:04:31Z", "last_observed_at": "2026-10-12T19:04:31Z", "sha256": "e68935b240432e3b0e600e29c572100ee68b3319db490cb703e63933c28de5c7", "format": "docx", "archive_key": "documents/e68935b240432e3b0e600e29c572100ee68b3319db490cb703e63933c28de5c7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761656911\"", "last_modified": "Tue, 28 Oct 2025 13:08:31 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5597, "changed_paragraphs": 97, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-c96321ac7577e21fc0d40119", "medicine_id": "EMEA/H/C/005600", "medicine_name": "Rivaroxaban Viatris (previously Rivaroxaban Mylan)", "medicine_slug": "rivaroxaban-viatris-previously-rivaroxaban-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rivaroxaban-viatris-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-04", "first_observed_at": "2026-10-12T19:36:56Z", "last_observed_at": "2026-10-12T19:36:56Z", "sha256": "23e12930e87dfb1e4ff35978713886b95f3ffda265129f4e22fc85df9f4aff16", "format": "docx", "archive_key": "documents/23e12930e87dfb1e4ff35978713886b95f3ffda265129f4e22fc85df9f4aff16.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749040054\"", "last_modified": "Wed, 04 Jun 2025 12:27:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9361, "changed_paragraphs": 59, "unassigned_changed_paragraphs": 5 }, "pipeline_version": "2.0.0" }, { "id": "source-c9bc5eeae7a25ae2ec1f2cb9", "medicine_id": "EMEA/H/C/004691", "medicine_name": "Bylvay", "medicine_slug": "bylvay", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/bylvay-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:37:52Z", "last_observed_at": "2026-10-12T13:37:52Z", "sha256": "3a21680f2ea7dee4e55919ae65d86e8961d918f20c350fe2fd7e3b43ca47dcac", "format": "docx", "archive_key": "documents/3a21680f2ea7dee4e55919ae65d86e8961d918f20c350fe2fd7e3b43ca47dcac.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778243233\"", "last_modified": "Fri, 08 May 2026 12:27:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2175, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 17 }, "pipeline_version": "2.0.0" }, { "id": "source-cad1a6dc874ba9ace6d4f00a", "medicine_id": "EMEA/H/C/002110", "medicine_name": "Trajenta", "medicine_slug": "trajenta", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trajenta-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-25", "first_observed_at": "2026-10-12T13:34:04Z", "last_observed_at": "2026-10-12T13:34:04Z", "sha256": "6790e47dfc837185d06a0b7a6588fc5e50a5d434b1cfef165a082115248399e6", "format": "docx", "archive_key": "documents/6790e47dfc837185d06a0b7a6588fc5e50a5d434b1cfef165a082115248399e6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782399057\"", "last_modified": "Thu, 25 Jun 2026 14:50:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1132, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-cba4680b7fbd2c536884abd8", "medicine_id": "EMEA/H/C/003984", "medicine_name": "Bortezomib Accord", "medicine_slug": "bortezomib-accord", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/bortezomib-accord-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:47:15Z", "last_observed_at": "2026-10-12T13:47:15Z", "sha256": "150a191aaf0a1e169e9d5fa2530f0eccb4e3d46509faf5ec5ee975a2e67788c4", "format": "docx", "archive_key": "documents/150a191aaf0a1e169e9d5fa2530f0eccb4e3d46509faf5ec5ee975a2e67788c4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774424316\"", "last_modified": "Wed, 25 Mar 2026 07:38:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4881, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-cc371d7c2b53a38bdc313831", "medicine_id": "EMEA/H/C/002154", "medicine_name": "Esbriet", "medicine_slug": "esbriet", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/esbriet-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-10", "first_observed_at": "2026-10-12T13:33:24Z", "last_observed_at": "2026-10-12T13:33:24Z", "sha256": "2df13b23112defceb5fd947a2f85070f36906347957fd848cc53d6f2710df187", "format": "docx", "archive_key": "documents/2df13b23112defceb5fd947a2f85070f36906347957fd848cc53d6f2710df187.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783689265\"", "last_modified": "Fri, 10 Jul 2026 13:14:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2679, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ccb701a21a3ac0566cd64d01", "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:08:57Z", "last_observed_at": "2026-10-12T19:08:57Z", "sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "format": "docx", "archive_key": "documents/23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758111235\"", "last_modified": "Wed, 17 Sep 2025 12:13:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4022, "changed_paragraphs": 27, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-ccd6e4297624ea024166e969", "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:36:03Z", "last_observed_at": "2026-10-12T13:36:03Z", "sha256": "3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0", "format": "docx", "archive_key": "documents/3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781264672\"", "last_modified": "Fri, 12 Jun 2026 11:44:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1831, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-cd4d5cdd1491321c9fafe27b", "medicine_id": "EMEA/H/C/004085", "medicine_name": "Olumiant", "medicine_slug": "olumiant", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olumiant-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-19", "first_observed_at": "2026-10-12T17:27:28Z", "last_observed_at": "2026-10-12T17:27:28Z", "sha256": "9049552843769a05b49a25684fff9b60d7f008e41b645e511bc2f49211970f77", "format": "docx", "archive_key": "documents/9049552843769a05b49a25684fff9b60d7f008e41b645e511bc2f49211970f77.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766152127\"", "last_modified": "Fri, 19 Dec 2025 13:48:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2746, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-cd502a3f414a9d6f9af63a04", "medicine_id": "EMEA/H/C/004061", "medicine_name": "Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau)", "medicine_slug": "chenodeoxycholic-acid-leadiant-previously-chenodeoxycholic-acid-sigma-tau", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/chenodeoxycholic-acid-leadiant-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:27Z", "last_observed_at": "2026-10-12T19:16:27Z", "sha256": "ca9ef6dea237401ee41664dfa7cc3179745982308f78ee4dc956edd74de72901", "format": "docx", "archive_key": "documents/ca9ef6dea237401ee41664dfa7cc3179745982308f78ee4dc956edd74de72901.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755075015\"", "last_modified": "Wed, 13 Aug 2025 08:50:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 883, "changed_paragraphs": 22, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-cdaecb76df7734b3152e3f0f", "medicine_id": "EMEA/H/C/006113", "medicine_name": "Emblaveo", "medicine_slug": "emblaveo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/emblaveo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:12:01Z", "last_observed_at": "2026-10-12T19:12:01Z", "sha256": "2c21d31348fa478f5de5b4a663016755d5452d037826559853c0254f572d415a", "format": "docx", "archive_key": "documents/2c21d31348fa478f5de5b4a663016755d5452d037826559853c0254f572d415a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758095701\"", "last_modified": "Wed, 17 Sep 2025 07:55:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1413, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ce69c9b3b68f8e08caa5cad7", "medicine_id": "EMEA/H/C/005868", "medicine_name": "Vyloy", "medicine_slug": "vyloy", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyloy-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-01", "first_observed_at": "2026-10-12T19:17:10Z", "last_observed_at": "2026-10-12T19:17:10Z", "sha256": "c93454dc72f115df0831a12bc882b9c931c4fddd687e6fb15d25c299cd26748e", "format": "docx", "archive_key": "documents/c93454dc72f115df0831a12bc882b9c931c4fddd687e6fb15d25c299cd26748e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1754044775\"", "last_modified": "Fri, 01 Aug 2025 10:39:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1387, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ce77e606b3e62d5f6fef575d", "medicine_id": "EMEA/H/C/004085", "medicine_name": "Olumiant", "medicine_slug": "olumiant", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olumiant-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-19", "first_observed_at": "2026-10-12T17:27:24Z", "last_observed_at": "2026-10-12T17:27:24Z", "sha256": "b4ca079a8e59619a86bb4d5c48f047c56c3216b31a07e1e31daf02679a924865", "format": "docx", "archive_key": "documents/b4ca079a8e59619a86bb4d5c48f047c56c3216b31a07e1e31daf02679a924865.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766152127\"", "last_modified": "Fri, 19 Dec 2025 13:48:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2757, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-ceac28ec8dc121bb19f69142", "medicine_id": "EMEA/H/C/000574", "medicine_name": "Azilect", "medicine_slug": "azilect", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/azilect-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-04-08", "first_observed_at": "2026-10-12T19:46:03Z", "last_observed_at": "2026-10-12T19:46:03Z", "sha256": "d2af7459c0f51816cb926b860b6cc9dee51d42709381dfd0f23ec41c396171ec", "format": "docx", "archive_key": "documents/d2af7459c0f51816cb926b860b6cc9dee51d42709381dfd0f23ec41c396171ec.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1744111707\"", "last_modified": "Tue, 08 Apr 2025 11:28:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1371, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-cf28c695dfc5d2d050f95285", "medicine_id": "EMEA/H/C/005516", "medicine_name": "Bemrist Breezhaler", "medicine_slug": "bemrist-breezhaler", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/bemrist-breezhaler-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-10-07", "first_observed_at": "2026-10-12T19:06:19Z", "last_observed_at": "2026-10-12T19:06:19Z", "sha256": "5f0012a578cd881ab97415e33afca4a210635c0e983f8e71e80bae88a39cb6ae", "format": "docx", "archive_key": "documents/5f0012a578cd881ab97415e33afca4a210635c0e983f8e71e80bae88a39cb6ae.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759846298\"", "last_modified": "Tue, 07 Oct 2025 14:11:38 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2792, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-cf44b18b0f2e35a10b60bf11", "medicine_id": "EMEA/H/C/002604", "medicine_name": "Tafinlar", "medicine_slug": "tafinlar", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tafinlar-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-23", "first_observed_at": "2026-10-12T19:23:07Z", "last_observed_at": "2026-10-12T19:23:07Z", "sha256": "229821b3be7df6566aa28b6f643c9593070e8314d71718e3b4c3607303637f72", "format": "docx", "archive_key": "documents/229821b3be7df6566aa28b6f643c9593070e8314d71718e3b4c3607303637f72.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753284916\"", "last_modified": "Wed, 23 Jul 2025 15:35:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3581, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d048afc32da0f78e0d39551b", "medicine_id": "EMEA/H/C/000463", "medicine_name": "Ebixa", "medicine_slug": "ebixa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ebixa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-08", "first_observed_at": "2026-10-12T13:33:30Z", "last_observed_at": "2026-10-12T13:33:30Z", "sha256": "022348f0cfd991bd9ed352df20a2ba266618b479dc412738a5d020523e83042f", "format": "docx", "archive_key": "documents/022348f0cfd991bd9ed352df20a2ba266618b479dc412738a5d020523e83042f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783518399\"", "last_modified": "Wed, 08 Jul 2026 13:46:39 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3951, "changed_paragraphs": 188, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d0ae0bf14568ab5adf79e44a", "medicine_id": "EMEA/H/C/002576", "medicine_name": "Remsima", "medicine_slug": "remsima", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/remsima-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-08", "first_observed_at": "2026-10-12T13:37:58Z", "last_observed_at": "2026-10-12T13:37:58Z", "sha256": "27bfb864f98f7738217c7e9f79f4efc6d3f2f4fd07bff1d83fcc454a50626dee", "format": "docx", "archive_key": "documents/27bfb864f98f7738217c7e9f79f4efc6d3f2f4fd07bff1d83fcc454a50626dee.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778245890\"", "last_modified": "Fri, 08 May 2026 13:11:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9495, "changed_paragraphs": 640, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d10ea7497b831a802d8ae623", "medicine_id": "EMEA/H/C/004837", "medicine_name": "Xromi", "medicine_slug": "xromi", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xromi-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-17", "first_observed_at": "2026-10-12T19:31:37Z", "last_observed_at": "2026-10-12T19:31:37Z", "sha256": "5e9826d3dd1edc48d9eb87b57c4ee7e70574bc6ce1c841b5477a3de3b9950a1e", "format": "docx", "archive_key": "documents/5e9826d3dd1edc48d9eb87b57c4ee7e70574bc6ce1c841b5477a3de3b9950a1e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750152672\"", "last_modified": "Tue, 17 Jun 2025 09:31:12 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1314, "changed_paragraphs": 42, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-d143f566b93e470166b2b4f3", "medicine_id": "EMEA/H/C/004240", "medicine_name": "Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan", "medicine_slug": "efavirenz-emtricitabine-tenofovir-disoproxil-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/efavirenz-emtricitabine-tenofovir-disoproxil-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:34Z", "last_observed_at": "2026-10-12T13:35:34Z", "sha256": "223e825c84e4f295da7ebf5574a88f09198b0a5ae258c643cee5369de2f2791d", "format": "docx", "archive_key": "documents/223e825c84e4f295da7ebf5574a88f09198b0a5ae258c643cee5369de2f2791d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781268033\"", "last_modified": "Fri, 12 Jun 2026 12:40:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3012, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d144ad176164190cc939e14a", "medicine_id": "EMEA/H/C/000277", "medicine_name": "Keppra", "medicine_slug": "keppra", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/keppra-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:40:52Z", "last_observed_at": "2026-10-12T13:40:52Z", "sha256": "31cb6d1cec335f2b192c26e7ca21b7c079076535dc90ed2027aa025c50888301", "format": "docx", "archive_key": "documents/31cb6d1cec335f2b192c26e7ca21b7c079076535dc90ed2027aa025c50888301.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775058839\"", "last_modified": "Wed, 01 Apr 2026 15:53:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7040, "changed_paragraphs": 31, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d18fcb2b829040991e58066f", "medicine_id": "EMEA/H/C/005183", "medicine_name": "Klisyri", "medicine_slug": "klisyri", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/klisyri-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:32Z", "last_observed_at": "2026-10-12T19:01:32Z", "sha256": "f290085082e51cc285b7c92b831407ceed02d32baba5acd4efe73b1a3978f7ff", "format": "docx", "archive_key": "documents/f290085082e51cc285b7c92b831407ceed02d32baba5acd4efe73b1a3978f7ff.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771512875\"", "last_modified": "Thu, 19 Feb 2026 14:54:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 942, "changed_paragraphs": 50, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d241ab0ffe1e9faa1ddf6c7e", "medicine_id": "EMEA/H/C/000626", "medicine_name": "Neupro", "medicine_slug": "neupro", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/neupro-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-04-07", "first_observed_at": "2026-10-12T13:40:39Z", "last_observed_at": "2026-10-12T13:40:39Z", "sha256": "f777dcaaa35d72a236da383b170522a5a117317b9b4fbce0cc4955f0dd6f0a34", "format": "doc", "archive_key": "documents/f777dcaaa35d72a236da383b170522a5a117317b9b4fbce0cc4955f0dd6f0a34.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775560315\"", "last_modified": "Tue, 07 Apr 2026 11:11:55 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-d244904ed5734d59afbbdeea", "medicine_id": "EMEA/H/C/000229", "medicine_name": "Temodal", "medicine_slug": "temodal", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/temodal-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:29:09Z", "last_observed_at": "2026-10-12T13:29:09Z", "sha256": "7a0f4edca25a87307b3f79eb3b20278437df85acae9f08407579e07b880d9509", "format": "docx", "archive_key": "documents/7a0f4edca25a87307b3f79eb3b20278437df85acae9f08407579e07b880d9509.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787043685\"", "last_modified": "Tue, 18 Aug 2026 09:01:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3323, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d2fba3c0f90382bddd977500", "medicine_id": "EMEA/H/C/002639", "medicine_name": "Xtandi", "medicine_slug": "xtandi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xtandi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-29", "first_observed_at": "2026-10-12T13:30:45Z", "last_observed_at": "2026-10-12T13:30:45Z", "sha256": "146d50d0de682089206c8c6edbc55f169388489efc96d97e9722ea592ba66301", "format": "docx", "archive_key": "documents/146d50d0de682089206c8c6edbc55f169388489efc96d97e9722ea592ba66301.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785331043\"", "last_modified": "Wed, 29 Jul 2026 13:17:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3053, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d3a74c78199734b597a22403", "medicine_id": "EMEA/H/C/000425", "medicine_name": "Forsteo", "medicine_slug": "forsteo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/forsteo-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-01-28", "first_observed_at": "2026-10-12T19:02:54Z", "last_observed_at": "2026-10-12T19:02:54Z", "sha256": "2f5435d6969b643a6c2fe67ba260cf76a1938244af63929ef57dae505bdca729", "format": "doc", "archive_key": "documents/2f5435d6969b643a6c2fe67ba260cf76a1938244af63929ef57dae505bdca729.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769601934\"", "last_modified": "Wed, 28 Jan 2026 12:05:34 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-d3b9fefcc6f7183b8f9f5011", "medicine_id": "EMEA/H/C/005122", "medicine_name": "Omvoh", "medicine_slug": "omvoh", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/omvoh-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-03", "first_observed_at": "2026-10-12T19:15:15Z", "last_observed_at": "2026-10-12T19:15:15Z", "sha256": "8bd34a050de946ede8fdc795a824452b6ee781f43952c3eff84a7ccca4d371b5", "format": "docx", "archive_key": "documents/8bd34a050de946ede8fdc795a824452b6ee781f43952c3eff84a7ccca4d371b5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756906167\"", "last_modified": "Wed, 03 Sep 2025 13:29:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8669, "changed_paragraphs": 1055, "unassigned_changed_paragraphs": 5 }, "pipeline_version": "2.0.0" }, { "id": "source-d3dc2424089c088062be259f", "medicine_id": "EMEA/H/C/004646", "medicine_name": "Lorviqua", "medicine_slug": "lorviqua", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lorviqua-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-15", "first_observed_at": "2026-10-12T13:40:21Z", "last_observed_at": "2026-10-12T13:40:21Z", "sha256": "60dc172f08ea3d561119e0d5bda985db037f78b0a16e1e39ca300b1f129588f1", "format": "docx", "archive_key": "documents/60dc172f08ea3d561119e0d5bda985db037f78b0a16e1e39ca300b1f129588f1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776248509\"", "last_modified": "Wed, 15 Apr 2026 10:21:49 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1792, "changed_paragraphs": 5, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d3e7f3c36aa95bc8c85b73a2", "medicine_id": "EMEA/H/C/000810", "medicine_name": "Olanzapine Teva", "medicine_slug": "olanzapine-teva", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olanzapine-teva-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-12", "first_observed_at": "2026-10-12T19:42:26Z", "last_observed_at": "2026-10-12T19:42:26Z", "sha256": "7f449f68053d07f4feb24f4e83f1cf34716b7b32f9f16bb16ea19984c7832d7a", "format": "docx", "archive_key": "documents/7f449f68053d07f4feb24f4e83f1cf34716b7b32f9f16bb16ea19984c7832d7a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747053683\"", "last_modified": "Mon, 12 May 2025 12:41:23 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4417, "changed_paragraphs": 434, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d40b8fbffadab288bc50975e", "medicine_id": "EMEA/H/C/004049", "medicine_name": "Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan)", "medicine_slug": "tenofovir-disoproxil-viatris-previously-tenofovir-disoproxil-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tenofovir-disoproxil-viatris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-09", "first_observed_at": "2026-10-12T19:12:43Z", "last_observed_at": "2026-10-12T19:12:43Z", "sha256": "9c02775909ab052141f22035bdd3baedf89ee4eddc3856275c0063049e1b415d", "format": "docx", "archive_key": "documents/9c02775909ab052141f22035bdd3baedf89ee4eddc3856275c0063049e1b415d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757406013\"", "last_modified": "Tue, 09 Sep 2025 08:20:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2914, "changed_paragraphs": 12, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d4207f26791cfe9b2d3504f0", "medicine_id": "EMEA/H/C/004119", "medicine_name": "Besponsa", "medicine_slug": "besponsa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/besponsa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:05Z", "last_observed_at": "2026-10-12T19:09:05Z", "sha256": "f16726d749587b6bdb2bef8e0d6b8e5bc35aa5b09965f91046cf2e4ca0161de2", "format": "docx", "archive_key": "documents/f16726d749587b6bdb2bef8e0d6b8e5bc35aa5b09965f91046cf2e4ca0161de2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758096008\"", "last_modified": "Wed, 17 Sep 2025 08:00:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1590, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d42fc0e0a8619babd97fa932", "medicine_id": "EMEA/H/C/005279", "medicine_name": "Rivaroxaban Accord", "medicine_slug": "rivaroxaban-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rivaroxaban-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-28", "first_observed_at": "2026-10-12T19:15:22Z", "last_observed_at": "2026-10-12T19:15:22Z", "sha256": "0a294e3769148ecf189ee36da82fee02c1245f5717d49279d965cef29f7c41e5", "format": "docx", "archive_key": "documents/0a294e3769148ecf189ee36da82fee02c1245f5717d49279d965cef29f7c41e5.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756380053\"", "last_modified": "Thu, 28 Aug 2025 11:20:53 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9211, "changed_paragraphs": 15, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d44fd57709b8f42bd1785b41", "medicine_id": "EMEA/H/C/003834", "medicine_name": "Raxone", "medicine_slug": "raxone", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/raxone-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-20", "first_observed_at": "2026-10-12T19:16:11Z", "last_observed_at": "2026-10-12T19:16:11Z", "sha256": "3c9106f28c895cd4529e4e66d50ab94bd3fc5a59a122fe743109596f56a68266", "format": "docx", "archive_key": "documents/3c9106f28c895cd4529e4e66d50ab94bd3fc5a59a122fe743109596f56a68266.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755702420\"", "last_modified": "Wed, 20 Aug 2025 15:07:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1012, "changed_paragraphs": 26, "unassigned_changed_paragraphs": 25 }, "pipeline_version": "2.0.0" }, { "id": "source-d485be5d9060fd557be910b2", "medicine_id": "EMEA/H/C/005246", "medicine_name": "Byfavo", "medicine_slug": "byfavo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/byfavo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-26", "first_observed_at": "2026-10-12T13:28:14Z", "last_observed_at": "2026-10-12T13:28:14Z", "sha256": "92a178ceb705631219efa40b1d0da73ebe6dfa866bc1b24d7e4dab9ded8a6861", "format": "docx", "archive_key": "documents/92a178ceb705631219efa40b1d0da73ebe6dfa866bc1b24d7e4dab9ded8a6861.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787729457\"", "last_modified": "Wed, 26 Aug 2026 07:30:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2792, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-d50540d38928bb1394806d33", "medicine_id": "EMEA/H/C/003726", "medicine_name": "Lynparza", "medicine_slug": "lynparza", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lynparza-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:39Z", "last_observed_at": "2026-10-12T19:01:39Z", "sha256": "52d814da6f8b7161a526fd18e83ae853843edbc11afe6dfa288fffe156616571", "format": "docx", "archive_key": "documents/52d814da6f8b7161a526fd18e83ae853843edbc11afe6dfa288fffe156616571.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771514654\"", "last_modified": "Thu, 19 Feb 2026 15:24:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3364, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-d54923d2bac122806513e823", "medicine_id": "EMEA/H/C/000791", "medicine_name": "Soliris", "medicine_slug": "soliris", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/soliris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-18", "first_observed_at": "2026-10-12T19:23:29Z", "last_observed_at": "2026-10-12T19:23:29Z", "sha256": "0fc0e097adbcd65db3b76f09ad49275310be0e959d35cd4587132f4c367e5aed", "format": "docx", "archive_key": "documents/0fc0e097adbcd65db3b76f09ad49275310be0e959d35cd4587132f4c367e5aed.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752841195\"", "last_modified": "Fri, 18 Jul 2025 12:19:55 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2454, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d550d93fac79de1f5b70960c", "medicine_id": "EMEA/H/C/006208", "medicine_name": "Apremilast Accord", "medicine_slug": "apremilast-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/apremilast-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:22Z", "last_observed_at": "2026-10-12T13:35:22Z", "sha256": "44b70b9a1fd874ed98cea13d0fd85ccf5a6fa48b2ccee7eb5831113607b98a04", "format": "docx", "archive_key": "documents/44b70b9a1fd874ed98cea13d0fd85ccf5a6fa48b2ccee7eb5831113607b98a04.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781252287\"", "last_modified": "Fri, 12 Jun 2026 08:18:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2444, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d57a5483e2d598a45f189cfa", "medicine_id": "EMEA/H/C/005791", "medicine_name": "Spikevax (previously COVID-19 Vaccine Moderna)", "medicine_slug": "spikevax-previously-covid-19-vaccine-moderna", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/spikevax-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-25", "first_observed_at": "2026-10-12T19:21:27Z", "last_observed_at": "2026-10-12T19:21:27Z", "sha256": "ee7712f3bea6ed1e7adb7ff4b59495e4c6961b92481d32d6b60668695c2bd753", "format": "docx", "archive_key": "documents/ee7712f3bea6ed1e7adb7ff4b59495e4c6961b92481d32d6b60668695c2bd753.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753460061\"", "last_modified": "Fri, 25 Jul 2025 16:14:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 13251, "changed_paragraphs": 219, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d684029453f166d2ccdd69d9", "medicine_id": "EMEA/H/C/000240", "medicine_name": "Remicade", "medicine_slug": "remicade", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/remicade-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-12-15", "first_observed_at": "2026-10-12T17:28:15Z", "last_observed_at": "2026-10-12T17:28:15Z", "sha256": "51ff8890d4b3613958af1b34989b6ef5c83ac642cdf5326e987653049302ffa1", "format": "docx", "archive_key": "documents/51ff8890d4b3613958af1b34989b6ef5c83ac642cdf5326e987653049302ffa1.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765799231\"", "last_modified": "Mon, 15 Dec 2025 11:47:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2441, "changed_paragraphs": 31, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d72301bcacfad26e0875b6a6", "medicine_id": "EMEA/H/C/000278", "medicine_name": "Herceptin", "medicine_slug": "herceptin", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/herceptin-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-25", "first_observed_at": "2026-10-12T17:30:23Z", "last_observed_at": "2026-10-12T17:30:23Z", "sha256": "09a04dbee9db2f235a3127ff90ac6ec06374497b999abfed523e6e0367981977", "format": "docx", "archive_key": "documents/09a04dbee9db2f235a3127ff90ac6ec06374497b999abfed523e6e0367981977.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764063847\"", "last_modified": "Tue, 25 Nov 2025 09:44:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4656, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d7e0f3276633f5a4a1cef1a4", "medicine_id": "EMEA/H/C/006459", "medicine_name": "Eltrombopag Accord", "medicine_slug": "eltrombopag-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eltrombopag-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-20", "first_observed_at": "2026-10-12T19:38:22Z", "last_observed_at": "2026-10-12T19:38:22Z", "sha256": "0485f44a0e25bf9e0f930e8ce8c053598ed2a48f78476ffafefb66d9fb3e8d89", "format": "docx", "archive_key": "documents/0485f44a0e25bf9e0f930e8ce8c053598ed2a48f78476ffafefb66d9fb3e8d89.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747743019\"", "last_modified": "Tue, 20 May 2025 12:10:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3253, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d7ee296bef62b33bf153220e", "medicine_id": "EMEA/H/C/004050", "medicine_name": "Emtricitabine/Tenofovir disoproxil Mylan", "medicine_slug": "emtricitabine-tenofovir-disoproxil-mylan", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/emtricitabine-tenofovir-disoproxil-mylan-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:35:50Z", "last_observed_at": "2026-10-12T13:35:50Z", "sha256": "e39cc7ad47f03eb2ce2ca3a7ee4cb611318362a7f95910dcfd88b0802fb8b704", "format": "docx", "archive_key": "documents/e39cc7ad47f03eb2ce2ca3a7ee4cb611318362a7f95910dcfd88b0802fb8b704.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781271543\"", "last_modified": "Fri, 12 Jun 2026 13:39:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2664, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d808ecdcc36d20bcbcc9522b", "medicine_id": "EMEA/H/C/004443", "medicine_name": "Lacosamide Accord", "medicine_slug": "lacosamide-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lacosamide-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-28", "first_observed_at": "2026-10-12T19:37:18Z", "last_observed_at": "2026-10-12T19:37:18Z", "sha256": "9545e0873b112a71b2e986007eb48a83c9a8dbc1f9b46e449dc293355632f678", "format": "docx", "archive_key": "documents/9545e0873b112a71b2e986007eb48a83c9a8dbc1f9b46e449dc293355632f678.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1748442944\"", "last_modified": "Wed, 28 May 2025 14:35:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4985, "changed_paragraphs": 28, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d85ced16d4719c906781e81c", "medicine_id": "EMEA/H/C/000233", "medicine_name": "Cetrotide", "medicine_slug": "cetrotide", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cetrotide-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:28:04Z", "last_observed_at": "2026-10-12T17:28:04Z", "sha256": "89d004f7601b8a9380386ff1b89ed00c999b773b8e823e5c4c6e181d4a2f4a5b", "format": "docx", "archive_key": "documents/89d004f7601b8a9380386ff1b89ed00c999b773b8e823e5c4c6e181d4a2f4a5b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766057691\"", "last_modified": "Thu, 18 Dec 2025 11:34:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 911, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d86357b928da66e696014503", "medicine_id": "EMEA/H/C/000388", "medicine_name": "Trisenox", "medicine_slug": "trisenox", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trisenox-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:27Z", "last_observed_at": "2026-10-12T19:02:27Z", "sha256": "b5ada3476b5436cdde0bd6dbc7e49908b8720c4e91b27923152641fdd73a2d5c", "format": "docx", "archive_key": "documents/b5ada3476b5436cdde0bd6dbc7e49908b8720c4e91b27923152641fdd73a2d5c.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769781406\"", "last_modified": "Fri, 30 Jan 2026 13:56:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1619, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d8c400cd5cb9c5e2404ceb92", "medicine_id": "EMEA/H/C/004077", "medicine_name": "Darzalex", "medicine_slug": "darzalex", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/darzalex-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-27", "first_observed_at": "2026-10-12T19:04:42Z", "last_observed_at": "2026-10-12T19:04:42Z", "sha256": "8c36ebbab8d2aa40602da934a729cc4f66032e3fc0f846c0bd7d789721c39d9a", "format": "docx", "archive_key": "documents/8c36ebbab8d2aa40602da934a729cc4f66032e3fc0f846c0bd7d789721c39d9a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761566824\"", "last_modified": "Mon, 27 Oct 2025 12:07:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4505, "changed_paragraphs": 21, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-d947f88d235e99a2a8da7343", "medicine_id": "EMEA/H/C/005061", "medicine_name": "Enerzair Breezhaler", "medicine_slug": "enerzair-breezhaler", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/enerzair-breezhaler-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-20", "first_observed_at": "2026-10-12T17:30:54Z", "last_observed_at": "2026-10-12T17:30:54Z", "sha256": "0771876d802fc6fa85eee64097a6dcfec1dcd56f1e1be95ed39939822d76f9be", "format": "docx", "archive_key": "documents/0771876d802fc6fa85eee64097a6dcfec1dcd56f1e1be95ed39939822d76f9be.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763636554\"", "last_modified": "Thu, 20 Nov 2025 11:02:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1965, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-d9fbf4f63431ce85865e00e5", "medicine_id": "EMEA/H/C/001056", "medicine_name": "Clopidogrel Krka", "medicine_slug": "clopidogrel-krka", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/clopidogrel-krka-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:39:46Z", "last_observed_at": "2026-10-12T19:39:46Z", "sha256": "2686a703ac2fddc64f2bae6fbf31dd2f23f6dd174bea9bbe2c3601e82cb5630d", "format": "docx", "archive_key": "documents/2686a703ac2fddc64f2bae6fbf31dd2f23f6dd174bea9bbe2c3601e82cb5630d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747217573\"", "last_modified": "Wed, 14 May 2025 10:12:53 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1280, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-daf056a6bbdaca441184b155", "medicine_id": "EMEA/H/C/000252", "medicine_name": "Ziagen", "medicine_slug": "ziagen", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ziagen-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:24Z", "last_observed_at": "2026-10-12T17:26:24Z", "sha256": "be2d4dbb728f57d6645c0048c9a25207c8ef4f19637e74e4ed93b99e28098ec4", "format": "docx", "archive_key": "documents/be2d4dbb728f57d6645c0048c9a25207c8ef4f19637e74e4ed93b99e28098ec4.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768832535\"", "last_modified": "Mon, 19 Jan 2026 14:22:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2860, "changed_paragraphs": 31, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-db0404d96833d8f373e1421a", "medicine_id": "EMEA/H/C/000603", "medicine_name": "Tysabri", "medicine_slug": "tysabri", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tysabri-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-29", "first_observed_at": "2026-10-12T13:36:24Z", "last_observed_at": "2026-10-12T13:36:24Z", "sha256": "21f5eb6f564bf2e923bae5d7adef2aaedcf76b2455d7245ad0c9f3c596ef2d2f", "format": "docx", "archive_key": "documents/21f5eb6f564bf2e923bae5d7adef2aaedcf76b2455d7245ad0c9f3c596ef2d2f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780060636\"", "last_modified": "Fri, 29 May 2026 13:17:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3467, "changed_paragraphs": 56, "unassigned_changed_paragraphs": 19 }, "pipeline_version": "2.0.0" }, { "id": "source-db23eeace3f23f652cf98bac", "medicine_id": "EMEA/H/C/002387", "medicine_name": "Zyclara", "medicine_slug": "zyclara", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zyclara-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-07-22", "first_observed_at": "2026-10-12T19:23:14Z", "last_observed_at": "2026-10-12T19:23:14Z", "sha256": "c02787946c100b974be10bccda29c793d5b9e1987328cd6bcd27c4a38dbba706", "format": "doc", "archive_key": "documents/c02787946c100b974be10bccda29c793d5b9e1987328cd6bcd27c4a38dbba706.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753194111\"", "last_modified": "Tue, 22 Jul 2025 14:21:51 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-dc2c74fa095e5ff275eeb144", "medicine_id": "EMEA/H/C/002514", "medicine_name": "Aubagio", "medicine_slug": "aubagio", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aubagio-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-12-09", "first_observed_at": "2026-10-12T17:28:41Z", "last_observed_at": "2026-10-12T17:28:41Z", "sha256": "ab7c6261f6fd68040f3dc43ff3d58e967ca4d2dc4b02d12f3c93b9fbfa6d5fa6", "format": "doc", "archive_key": "documents/ab7c6261f6fd68040f3dc43ff3d58e967ca4d2dc4b02d12f3c93b9fbfa6d5fa6.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1765271902\"", "last_modified": "Tue, 09 Dec 2025 09:18:22 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-dd100ba88d58dedcc7a4d9ed", "medicine_id": "EMEA/H/C/002202", "medicine_name": "Gilenya", "medicine_slug": "gilenya", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/gilenya-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-30", "first_observed_at": "2026-10-12T13:30:27Z", "last_observed_at": "2026-10-12T13:30:27Z", "sha256": "83f3661e0a3bbe5c73439ed4ae1f26511ae4bd38a7233fa0d5bdc0d8d330a97e", "format": "docx", "archive_key": "documents/83f3661e0a3bbe5c73439ed4ae1f26511ae4bd38a7233fa0d5bdc0d8d330a97e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785412227\"", "last_modified": "Thu, 30 Jul 2026 11:50:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2632, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-dd26eb8615d8c18bd80c1f6a", "medicine_id": "EMEA/H/C/005246", "medicine_name": "Byfavo", "medicine_slug": "byfavo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/byfavo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-26", "first_observed_at": "2026-10-12T13:28:16Z", "last_observed_at": "2026-10-12T13:28:16Z", "sha256": "61243a969f979f690fe718e414ceaeb66438c1faa31101ba25187d2f9ea662fd", "format": "docx", "archive_key": "documents/61243a969f979f690fe718e414ceaeb66438c1faa31101ba25187d2f9ea662fd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787729457\"", "last_modified": "Wed, 26 Aug 2026 07:30:57 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2878, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-dd55abaf2041fe4e618fed75", "medicine_id": "EMEA/H/C/004106", "medicine_name": "Venclyxto", "medicine_slug": "venclyxto", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/venclyxto-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-08", "first_observed_at": "2026-10-12T13:33:36Z", "last_observed_at": "2026-10-12T13:33:36Z", "sha256": "cb909b1e026c92fa2c7a68aafb5af7a7a6dc62c5e45faa62a526c1c85bfd9f82", "format": "docx", "archive_key": "documents/cb909b1e026c92fa2c7a68aafb5af7a7a6dc62c5e45faa62a526c1c85bfd9f82.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783506922\"", "last_modified": "Wed, 08 Jul 2026 10:35:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3686, "changed_paragraphs": 380, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-dd56ffc2c8535636439f2eff", "medicine_id": "EMEA/H/C/004248", "medicine_name": "Alunbrig", "medicine_slug": "alunbrig", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/alunbrig-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-04-25", "first_observed_at": "2026-10-12T19:45:22Z", "last_observed_at": "2026-10-12T19:45:22Z", "sha256": "4e301ec6306300d48577788c7c0dfc3b5252d58e41c6a1fef7b451f840163d80", "format": "docx", "archive_key": "documents/4e301ec6306300d48577788c7c0dfc3b5252d58e41c6a1fef7b451f840163d80.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1745594385\"", "last_modified": "Fri, 25 Apr 2025 15:19:45 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2854, "changed_paragraphs": 13, "unassigned_changed_paragraphs": 11 }, "pipeline_version": "2.0.0" }, { "id": "source-dd7a18b7c210239223fa10ad", "medicine_id": "EMEA/H/C/004310", "medicine_name": "Daptomycin Hospira", "medicine_slug": "daptomycin-hospira", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/daptomycin-hospira-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:09:33Z", "last_observed_at": "2026-10-12T19:09:33Z", "sha256": "3242bb93d94dc3b7e86b89af5160c6986e8caa2e4f8d73bf8a634a557420452a", "format": "docx", "archive_key": "documents/3242bb93d94dc3b7e86b89af5160c6986e8caa2e4f8d73bf8a634a557420452a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758096393\"", "last_modified": "Wed, 17 Sep 2025 08:06:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2186, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-dd9e51b4974ed4fb6da5159a", "medicine_id": "EMEA/H/C/000463", "medicine_name": "Ebixa", "medicine_slug": "ebixa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ebixa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-08", "first_observed_at": "2026-10-12T13:33:33Z", "last_observed_at": "2026-10-12T13:33:33Z", "sha256": "46238dbbc8dd8870e4f7514702aff97252ca1067dfb0fa3e66ca745fc549ae75", "format": "docx", "archive_key": "documents/46238dbbc8dd8870e4f7514702aff97252ca1067dfb0fa3e66ca745fc549ae75.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783518400\"", "last_modified": "Wed, 08 Jul 2026 13:46:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3942, "changed_paragraphs": 188, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-dda6e6b6ebdd9dd261001d78", "medicine_id": "EMEA/H/C/002669", "medicine_name": "Voriconazole Accord", "medicine_slug": "voriconazole-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/voriconazole-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-28", "first_observed_at": "2026-10-12T19:20:13Z", "last_observed_at": "2026-10-12T19:20:13Z", "sha256": "452fcfca61b9ba27a14214c8d04e8fd3d752d77f305cba7a3e743c6e4cecb83a", "format": "docx", "archive_key": "documents/452fcfca61b9ba27a14214c8d04e8fd3d752d77f305cba7a3e743c6e4cecb83a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753701596\"", "last_modified": "Mon, 28 Jul 2025 11:19:56 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2488, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-dda7a9536e6e3b6e820a6139", "medicine_id": "EMEA/H/C/000273", "medicine_name": "Rapamune", "medicine_slug": "rapamune", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rapamune-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-04", "first_observed_at": "2026-10-12T13:39:00Z", "last_observed_at": "2026-10-12T13:39:00Z", "sha256": "5ec17411e4c1a81999ea8a4a3fb0ca56fd42f205f10b55b04218801cee6c6cfa", "format": "docx", "archive_key": "documents/5ec17411e4c1a81999ea8a4a3fb0ca56fd42f205f10b55b04218801cee6c6cfa.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777881495\"", "last_modified": "Mon, 04 May 2026 07:58:15 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3066, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-de146a0e9f79699d73e1a000", "medicine_id": "EMEA/H/C/003726", "medicine_name": "Lynparza", "medicine_slug": "lynparza", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lynparza-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:36Z", "last_observed_at": "2026-10-12T19:01:36Z", "sha256": "7cf7b7c56bc485f74bc07cd3ebc31178ad23b3dd41bcadb2ed3d4351c4650b3a", "format": "docx", "archive_key": "documents/7cf7b7c56bc485f74bc07cd3ebc31178ad23b3dd41bcadb2ed3d4351c4650b3a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771514654\"", "last_modified": "Thu, 19 Feb 2026 15:24:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3505, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-de59fe9b3c9310d9b2f8606e", "medicine_id": "EMEA/H/C/005553", "medicine_name": "Aspaveli", "medicine_slug": "aspaveli", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aspaveli-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-10", "first_observed_at": "2026-10-12T19:03:44Z", "last_observed_at": "2026-10-12T19:03:44Z", "sha256": "cbb36c4bf3fbb1cb92b778a55d4e26d7afb99f7aaa2b5faa3bcf1c82ba3e82d7", "format": "docx", "archive_key": "documents/cbb36c4bf3fbb1cb92b778a55d4e26d7afb99f7aaa2b5faa3bcf1c82ba3e82d7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1762774186\"", "last_modified": "Mon, 10 Nov 2025 11:29:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1623, "changed_paragraphs": 65, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-dee8a41344a3dee694607b38", "medicine_id": "EMEA/H/C/005764", "medicine_name": "Fabhalta", "medicine_slug": "fabhalta", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fabhalta-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:21Z", "last_observed_at": "2026-10-12T19:04:21Z", "sha256": "9b0d37cd0e6bfe1f6a2eb8636cc3df4f77d2f3897f85555fc7f0b3b17733fcbe", "format": "docx", "archive_key": "documents/9b0d37cd0e6bfe1f6a2eb8636cc3df4f77d2f3897f85555fc7f0b3b17733fcbe.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761751352\"", "last_modified": "Wed, 29 Oct 2025 15:22:32 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1884, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-df254fe130ff8f48a014660f", "medicine_id": "EMEA/H/C/000778", "medicine_name": "Abraxane", "medicine_slug": "abraxane", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abraxane-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-01-21", "first_observed_at": "2026-10-12T19:03:01Z", "last_observed_at": "2026-10-12T19:03:01Z", "sha256": "5db4e07eaa50eb884a5b1af9bcf17ec8daf2a553d6c6e2505e0031b7ec286e27", "format": "docx", "archive_key": "documents/5db4e07eaa50eb884a5b1af9bcf17ec8daf2a553d6c6e2505e0031b7ec286e27.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768990882\"", "last_modified": "Wed, 21 Jan 2026 10:21:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2237, "changed_paragraphs": 106, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-dfdf6861216bffe1c095176b", "medicine_id": "EMEA/H/C/002618", "medicine_name": "Nexium Control", "medicine_slug": "nexium-control", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nexium-control-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-03", "first_observed_at": "2026-10-12T13:36:16Z", "last_observed_at": "2026-10-12T13:36:16Z", "sha256": "266d567343c3811aa2034b1a0d89c81f2a39f87634c27e040eddf35f3f1f5cac", "format": "docx", "archive_key": "documents/266d567343c3811aa2034b1a0d89c81f2a39f87634c27e040eddf35f3f1f5cac.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780482096\"", "last_modified": "Wed, 03 Jun 2026 10:21:36 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2021, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e0090d8c53f6053132f4f706", "medicine_id": "EMEA/H/C/001087", "medicine_name": "Olazax", "medicine_slug": "olazax", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/olazax-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-05-11", "first_observed_at": "2026-10-12T13:36:49Z", "last_observed_at": "2026-10-12T13:36:49Z", "sha256": "e2e219f7c7d5cabcb557c3a20d8bc9738a7aeb24d8e0f1ba4b963b755920b6a7", "format": "doc", "archive_key": "documents/e2e219f7c7d5cabcb557c3a20d8bc9738a7aeb24d8e0f1ba4b963b755920b6a7.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778507306\"", "last_modified": "Mon, 11 May 2026 13:48:26 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-e05739a15a0532954ee45dd4", "medicine_id": "EMEA/H/C/000980", "medicine_name": "Samsca", "medicine_slug": "samsca", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/samsca-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-08-20", "first_observed_at": "2026-10-12T13:28:24Z", "last_observed_at": "2026-10-12T13:28:24Z", "sha256": "3080d919225c2a98f20aec84d5803b3fde6e1b64f323055c46d098625f4ad301", "format": "docx", "archive_key": "documents/3080d919225c2a98f20aec84d5803b3fde6e1b64f323055c46d098625f4ad301.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787214364\"", "last_modified": "Thu, 20 Aug 2026 08:26:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1382, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e1483193b0b9d09390e42214", "medicine_id": "EMEA/H/C/000860", "medicine_name": "Isentress", "medicine_slug": "isentress", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/isentress-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:40:07Z", "last_observed_at": "2026-10-12T19:40:07Z", "sha256": "a9b418aa769dc4369e48054e196f1b9897429b216bba1f2d1ec4e084b1bc26e5", "format": "doc", "archive_key": "documents/a9b418aa769dc4369e48054e196f1b9897429b216bba1f2d1ec4e084b1bc26e5.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747226309\"", "last_modified": "Wed, 14 May 2025 12:38:29 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-e192d7ce131e1645eace610a", "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-05", "first_observed_at": "2026-10-12T19:02:19Z", "last_observed_at": "2026-10-12T19:02:19Z", "sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "format": "docx", "archive_key": "documents/f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770301859\"", "last_modified": "Thu, 05 Feb 2026 14:30:59 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3946, "changed_paragraphs": 16, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e1ce1adb0d4bf10d339d6315", "medicine_id": "EMEA/H/C/000388", "medicine_name": "Trisenox", "medicine_slug": "trisenox", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/trisenox-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-30", "first_observed_at": "2026-10-12T19:02:30Z", "last_observed_at": "2026-10-12T19:02:30Z", "sha256": "84d471b5142e7e1ef0a02035323924afb35918affe0d882315f04168b49b86d6", "format": "docx", "archive_key": "documents/84d471b5142e7e1ef0a02035323924afb35918affe0d882315f04168b49b86d6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1769781407\"", "last_modified": "Fri, 30 Jan 2026 13:56:47 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1619, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e21f95b53d2aa18de4317935", "medicine_id": "EMEA/H/C/002155", "medicine_name": "Tobi Podhaler", "medicine_slug": "tobi-podhaler", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/tobi-podhaler-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-05-11", "first_observed_at": "2026-10-12T13:36:44Z", "last_observed_at": "2026-10-12T13:36:44Z", "sha256": "06a4703867edf25b7eb790890f81f2a271bb399a711447341c922ccdabc9031e", "format": "docx", "archive_key": "documents/06a4703867edf25b7eb790890f81f2a271bb399a711447341c922ccdabc9031e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778512130\"", "last_modified": "Mon, 11 May 2026 15:08:50 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1710, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e30d3e2fd3dc3a6a3a25ab2a", "medicine_id": "EMEA/H/C/000082", "medicine_name": "CellCept", "medicine_slug": "cellcept", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cellcept-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-05-07", "first_observed_at": "2026-10-12T13:38:54Z", "last_observed_at": "2026-10-12T13:38:54Z", "sha256": "8b2aad8e85cb4815da49aa0e2ba42355e2e18c8a8c0122148e93ae68ceb44205", "format": "docx", "archive_key": "documents/8b2aad8e85cb4815da49aa0e2ba42355e2e18c8a8c0122148e93ae68ceb44205.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778156504\"", "last_modified": "Thu, 07 May 2026 12:21:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 7218, "changed_paragraphs": 32, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e3932a928cf90bf8fb14f02f", "medicine_id": "EMEA/H/C/002434", "medicine_name": "Fycompa", "medicine_slug": "fycompa", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fycompa-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-10", "first_observed_at": "2026-10-12T13:31:53Z", "last_observed_at": "2026-10-12T13:31:53Z", "sha256": "ea71588767c01ec0d963dcff1ec8339ebd7d99fd9f25439a3c9d9c86ca3ea916", "format": "docx", "archive_key": "documents/ea71588767c01ec0d963dcff1ec8339ebd7d99fd9f25439a3c9d9c86ca3ea916.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783665224\"", "last_modified": "Fri, 10 Jul 2026 06:33:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3454, "changed_paragraphs": 42, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e47ad1eb70eea40ffe6f630a", "medicine_id": "EMEA/H/C/000262", "medicine_name": "Enbrel", "medicine_slug": "enbrel", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/enbrel-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-13", "first_observed_at": "2026-10-12T19:16:40Z", "last_observed_at": "2026-10-12T19:16:40Z", "sha256": "a41dac2fc5e8b417985556dd3387a9d48be01703fe6cadaaa44d436826c3fb06", "format": "docx", "archive_key": "documents/a41dac2fc5e8b417985556dd3387a9d48be01703fe6cadaaa44d436826c3fb06.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755069484\"", "last_modified": "Wed, 13 Aug 2025 07:18:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12470, "changed_paragraphs": 160, "unassigned_changed_paragraphs": 15 }, "pipeline_version": "2.0.0" }, { "id": "source-e4f1d7cc9ec32637ea4dab98", "medicine_id": "EMEA/H/C/002036", "medicine_name": "Rivastigmine Actavis", "medicine_slug": "rivastigmine-actavis", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rivastigmine-actavis-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-13", "first_observed_at": "2026-10-12T19:35:40Z", "last_observed_at": "2026-10-12T19:35:40Z", "sha256": "6b737beef96eb51218b255a06528670449f27251eca6788fca29bc0450313d54", "format": "docx", "archive_key": "documents/6b737beef96eb51218b255a06528670449f27251eca6788fca29bc0450313d54.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1749820240\"", "last_modified": "Fri, 13 Jun 2025 13:10:40 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2633, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e4fa0b9c95a2e427d4c95a33", "medicine_id": "EMEA/H/C/002640", "medicine_name": "Cometriq", "medicine_slug": "cometriq", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cometriq-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-27", "first_observed_at": "2026-10-12T19:00:55Z", "last_observed_at": "2026-10-12T19:00:55Z", "sha256": "c7f8aa8da9127064263770c4aed5506128bacd0c40693b863c48a757d735203e", "format": "docx", "archive_key": "documents/c7f8aa8da9127064263770c4aed5506128bacd0c40693b863c48a757d735203e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772184712\"", "last_modified": "Fri, 27 Feb 2026 09:31:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2221, "changed_paragraphs": 9, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-e56383168f778128e02c2b2e", "medicine_id": "EMEA/H/C/000389", "medicine_name": "Invanz", "medicine_slug": "invanz", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/invanz-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-21", "first_observed_at": "2026-10-12T17:30:44Z", "last_observed_at": "2026-10-12T17:30:44Z", "sha256": "a9208c117495d2d6c465ba196e4dbbb3d498b27d747df3b2d0145b0549743e4b", "format": "docx", "archive_key": "documents/a9208c117495d2d6c465ba196e4dbbb3d498b27d747df3b2d0145b0549743e4b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763734353\"", "last_modified": "Fri, 21 Nov 2025 14:12:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1276, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e57a12d699a4610a3b7c43b5", "medicine_id": "EMEA/H/C/001192", "medicine_name": "Topotecan Hospira", "medicine_slug": "topotecan-hospira", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/topotecan-hospira-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-31", "first_observed_at": "2026-10-12T13:46:30Z", "last_observed_at": "2026-10-12T13:46:30Z", "sha256": "5321cb7f2f2b642daaa6a57ec40154a0f5690218626179527ae4ba5077fc621e", "format": "docx", "archive_key": "documents/5321cb7f2f2b642daaa6a57ec40154a0f5690218626179527ae4ba5077fc621e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774959141\"", "last_modified": "Tue, 31 Mar 2026 12:12:21 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1205, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e58329b521b2e223a700355b", "medicine_id": "EMEA/H/C/006469", "medicine_name": "Emtricitabine / Tenofovir alafenamide Viatris", "medicine_slug": "emtricitabine-tenofovir-alafenamide-viatris", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/emtricitabine-tenofovir-alafenamide-viatris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-16", "first_observed_at": "2026-10-12T13:40:17Z", "last_observed_at": "2026-10-12T13:40:17Z", "sha256": "f756470c4d010c80a3cc0e1d2d813c1c039c3ca68b113594de79e065fdc70412", "format": "docx", "archive_key": "documents/f756470c4d010c80a3cc0e1d2d813c1c039c3ca68b113594de79e065fdc70412.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776339002\"", "last_modified": "Thu, 16 Apr 2026 11:30:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2271, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e59bd285182e4acde2b7f377", "medicine_id": "EMEA/H/C/002389", "medicine_name": "Kadcyla", "medicine_slug": "kadcyla", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/kadcyla-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-03-26", "first_observed_at": "2026-10-12T19:47:07Z", "last_observed_at": "2026-10-12T19:47:07Z", "sha256": "a10449e9a2a08dc425c5d6d0dbdcf6b9060c46025a72dea95454c9a9fda57a75", "format": "docx", "archive_key": "documents/a10449e9a2a08dc425c5d6d0dbdcf6b9060c46025a72dea95454c9a9fda57a75.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1742989877\"", "last_modified": "Wed, 26 Mar 2025 11:51:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1977, "changed_paragraphs": 351, "unassigned_changed_paragraphs": 10 }, "pipeline_version": "2.0.0" }, { "id": "source-e5fe1986f77f9e93b3fefd24", "medicine_id": "EMEA/H/C/000606", "medicine_name": "Xolair", "medicine_slug": "xolair", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/xolair-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-05-28", "first_observed_at": "2026-10-12T19:37:51Z", "last_observed_at": "2026-10-12T19:37:51Z", "sha256": "704c69c96cf5db1d067b68163d9912e82fd9d7a67320b120383df0a0657ec624", "format": "docx", "archive_key": "documents/704c69c96cf5db1d067b68163d9912e82fd9d7a67320b120383df0a0657ec624.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1748445425\"", "last_modified": "Wed, 28 May 2025 15:17:05 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12636, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e647a485d96e8825cde41cd9", "medicine_id": "EMEA/H/C/006056", "medicine_name": "Opuviz", "medicine_slug": "opuviz", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/opuviz-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:21Z", "last_observed_at": "2026-10-12T17:26:21Z", "sha256": "71608478f2904ae317c73d22f8ca527cf83b7bc506528a92e9483522c4b663f9", "format": "docx", "archive_key": "documents/71608478f2904ae317c73d22f8ca527cf83b7bc506528a92e9483522c4b663f9.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768837192\"", "last_modified": "Mon, 19 Jan 2026 15:39:52 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3970, "changed_paragraphs": 1091, "unassigned_changed_paragraphs": 96 }, "pipeline_version": "2.0.0" }, { "id": "source-e64874e5407ad189f5c05219", "medicine_id": "EMEA/H/C/005620", "medicine_name": "Mounjaro", "medicine_slug": "mounjaro", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/mounjaro-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-28", "first_observed_at": "2026-10-12T13:28:03Z", "last_observed_at": "2026-10-12T13:28:03Z", "sha256": "f9ecf49efbd04c7f3ce29bff2d32addd62cf0100de9def6715ecaeb822880540", "format": "docx", "archive_key": "documents/f9ecf49efbd04c7f3ce29bff2d32addd62cf0100de9def6715ecaeb822880540.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787922262\"", "last_modified": "Fri, 28 Aug 2026 13:04:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 10333, "changed_paragraphs": 76, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-e6cadd30a86c6c9b1c0915b2", "medicine_id": "EMEA/H/C/006444", "medicine_name": "Yesintek", "medicine_slug": "yesintek", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/yesintek-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-16", "first_observed_at": "2026-10-12T19:01:45Z", "last_observed_at": "2026-10-12T19:01:45Z", "sha256": "8c2b3e8345d1587a65069bc2ed38a32860a843ac07d78bef733b8e208f95a8f7", "format": "docx", "archive_key": "documents/8c2b3e8345d1587a65069bc2ed38a32860a843ac07d78bef733b8e208f95a8f7.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771234001\"", "last_modified": "Mon, 16 Feb 2026 09:26:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6981, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 24 }, "pipeline_version": "2.0.0" }, { "id": "source-e6e3f95ea79f1192dbdf1e10", "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-13", "first_observed_at": "2026-10-12T13:31:32Z", "last_observed_at": "2026-10-12T13:31:32Z", "sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "format": "docx", "archive_key": "documents/eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783950548\"", "last_modified": "Mon, 13 Jul 2026 13:49:08 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 9812, "changed_paragraphs": 568, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-e77cc60882241e43025a486c", "medicine_id": "EMEA/H/C/000839", "medicine_name": "Volibris", "medicine_slug": "volibris", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/volibris-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-04-22", "first_observed_at": "2026-10-12T13:40:12Z", "last_observed_at": "2026-10-12T13:40:12Z", "sha256": "52f9d2bc39e6662be65cc88f654aa4da50ee17f0d4982d4be7b4921ee2fee56a", "format": "doc", "archive_key": "documents/52f9d2bc39e6662be65cc88f654aa4da50ee17f0d4982d4be7b4921ee2fee56a.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776864817\"", "last_modified": "Wed, 22 Apr 2026 13:33:37 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-e9a7fba8f244847c29cc319b", "medicine_id": "EMEA/H/C/005738", "medicine_name": "Vildagliptin / Metformin hydrochloride Accord", "medicine_slug": "vildagliptin-metformin-hydrochloride-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vildagliptin-metformin-hydrochloride-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-25", "first_observed_at": "2026-10-12T19:22:37Z", "last_observed_at": "2026-10-12T19:22:37Z", "sha256": "5901bd392b2e877663eb3a5cb0af7e11311068ea94fda488d31a0cbfddaa765d", "format": "docx", "archive_key": "documents/5901bd392b2e877663eb3a5cb0af7e11311068ea94fda488d31a0cbfddaa765d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753458624\"", "last_modified": "Fri, 25 Jul 2025 15:50:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1460, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-e9ff2713d3df6640fcfa0428", "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-03", "first_observed_at": "2026-10-12T17:29:22Z", "last_observed_at": "2026-10-12T17:29:22Z", "sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "format": "docx", "archive_key": "documents/711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764765556\"", "last_modified": "Wed, 03 Dec 2025 12:39:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2145, "changed_paragraphs": 36, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ea5c43e2783a68c84a69e47d", "medicine_id": "EMEA/H/C/006251", "medicine_name": "Dasatinib Accord Healthcare", "medicine_slug": "dasatinib-accord-healthcare", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/dasatinib-accord-healthcare-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-05", "first_observed_at": "2026-10-12T19:02:16Z", "last_observed_at": "2026-10-12T19:02:16Z", "sha256": "eca8ba22f8dd4eba48fe7a21980c67d7ba9a4ed58ecce51bd42baf8fc0b3bb92", "format": "docx", "archive_key": "documents/eca8ba22f8dd4eba48fe7a21980c67d7ba9a4ed58ecce51bd42baf8fc0b3bb92.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1770301331\"", "last_modified": "Thu, 05 Feb 2026 14:22:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3101, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-eaab20b66f37ed2a83bf6050", "medicine_id": "EMEA/H/C/005306", "medicine_name": "Lenalidomide Mylan", "medicine_slug": "lenalidomide-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lenalidomide-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-06-12", "first_observed_at": "2026-10-12T13:36:00Z", "last_observed_at": "2026-10-12T13:36:00Z", "sha256": "284a211ae1e378772905f47f912ad76e2359aedbb04aefb942aeab3dde51b7fd", "format": "docx", "archive_key": "documents/284a211ae1e378772905f47f912ad76e2359aedbb04aefb942aeab3dde51b7fd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1781263664\"", "last_modified": "Fri, 12 Jun 2026 11:27:44 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4706, "changed_paragraphs": 3, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-eb7f35580ad6fca2853daf7a", "medicine_id": "EMEA/H/C/000722", "medicine_name": "Januvia", "medicine_slug": "januvia", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/januvia-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-10-31", "first_observed_at": "2026-10-12T19:04:09Z", "last_observed_at": "2026-10-12T19:04:09Z", "sha256": "b7d432828c500c4877cd8c7e7a29eb438e9c7b279312cd703f297f786ab17b42", "format": "doc", "archive_key": "documents/b7d432828c500c4877cd8c7e7a29eb438e9c7b279312cd703f297f786ab17b42.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761905552\"", "last_modified": "Fri, 31 Oct 2025 10:12:32 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-eca3b84d4b35beb839da3a24", "medicine_id": "EMEA/H/C/006113", "medicine_name": "Emblaveo", "medicine_slug": "emblaveo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/emblaveo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:10:52Z", "last_observed_at": "2026-10-12T19:10:52Z", "sha256": "47da8b56a52154a1ea0f0d0dd6719b6c928bc9734442ee70d1f66c0fc57ede1e", "format": "docx", "archive_key": "documents/47da8b56a52154a1ea0f0d0dd6719b6c928bc9734442ee70d1f66c0fc57ede1e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758095701\"", "last_modified": "Wed, 17 Sep 2025 07:55:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1425, "changed_paragraphs": 10, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ecd1373044751ffb95a74e7d", "medicine_id": "EMEA/H/C/000313", "medicine_name": "Aerius", "medicine_slug": "aerius", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aerius-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:21Z", "last_observed_at": "2026-10-12T13:47:21Z", "sha256": "43d4d2570e3f779a989b1a5737f419e2d3c0856cd6f669e029d53be57a3447a3", "format": "docx", "archive_key": "documents/43d4d2570e3f779a989b1a5737f419e2d3c0856cd6f669e029d53be57a3447a3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773917894\"", "last_modified": "Thu, 19 Mar 2026 10:58:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1877, "changed_paragraphs": 43, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ed7290a0fd9a4c75168f5a4d", "medicine_id": "EMEA/H/C/000266", "medicine_name": "DaTSCAN", "medicine_slug": "datscan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/datscan-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2026-02-25", "first_observed_at": "2026-10-12T19:01:08Z", "last_observed_at": "2026-10-12T19:01:08Z", "sha256": "291b05419a221d15000b6803e798a52be80cd7fa357c639d46c00f36f07b82e2", "format": "doc", "archive_key": "documents/291b05419a221d15000b6803e798a52be80cd7fa357c639d46c00f36f07b82e2.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772026317\"", "last_modified": "Wed, 25 Feb 2026 13:31:57 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-ed9cf7f9565341980ec10144", "medicine_id": "EMEA/H/C/003819", "medicine_name": "Zykadia", "medicine_slug": "zykadia", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zykadia-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-08-26", "first_observed_at": "2026-10-12T19:15:42Z", "last_observed_at": "2026-10-12T19:15:42Z", "sha256": "6b3aae395a85be44f16072cecfe58c284c9a0870255b00cbc21a8e89708a50ae", "format": "docx", "archive_key": "documents/6b3aae395a85be44f16072cecfe58c284c9a0870255b00cbc21a8e89708a50ae.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756210571\"", "last_modified": "Tue, 26 Aug 2025 12:16:11 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3876, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-eec4301358a1191a19e95d17", "medicine_id": "EMEA/H/C/003794", "medicine_name": "Strensiq", "medicine_slug": "strensiq", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/strensiq-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:52:06Z", "last_observed_at": "2026-10-12T13:52:06Z", "sha256": "6161d5b8e2abd4c33834351f5f07062f042278ab73aeb30e92df378cfe895d23", "format": "docx", "archive_key": "documents/6161d5b8e2abd4c33834351f5f07062f042278ab73aeb30e92df378cfe895d23.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773842767\"", "last_modified": "Wed, 18 Mar 2026 14:06:07 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2270, "changed_paragraphs": 194, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ef0557ef1f102cd71af48fe8", "medicine_id": "EMEA/H/C/000581", "medicine_name": "Kivexa", "medicine_slug": "kivexa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kivexa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:35Z", "last_observed_at": "2026-10-12T17:26:35Z", "sha256": "a7cf008d527366df09bbf426532e5f421d5e2d34f7c924e13e368ce21a46e6de", "format": "docx", "archive_key": "documents/a7cf008d527366df09bbf426532e5f421d5e2d34f7c924e13e368ce21a46e6de.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768816144\"", "last_modified": "Mon, 19 Jan 2026 09:49:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2090, "changed_paragraphs": 157, "unassigned_changed_paragraphs": 5 }, "pipeline_version": "2.0.0" }, { "id": "source-f0325a3c201a452d28365286", "medicine_id": "EMEA/H/C/004143", "medicine_name": "Tecentriq", "medicine_slug": "tecentriq", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tecentriq-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:09Z", "last_observed_at": "2026-10-12T13:39:09Z", "sha256": "1e899bb8c08414476b9a3db79362c49ed20173c7da1e7a986cc47192067eccc3", "format": "docx", "archive_key": "documents/1e899bb8c08414476b9a3db79362c49ed20173c7da1e7a986cc47192067eccc3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777370386\"", "last_modified": "Tue, 28 Apr 2026 09:59:46 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6749, "changed_paragraphs": 49, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f0f93eac2429d0d09a8d9b8d", "medicine_id": "EMEA/H/C/003916", "medicine_name": "Terrosa", "medicine_slug": "terrosa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/terrosa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-23", "first_observed_at": "2026-10-12T13:39:31Z", "last_observed_at": "2026-10-12T13:39:31Z", "sha256": "3592d072525ce11938f51086292e3c38e99222a1bf24f3425d6dc450b4800681", "format": "docx", "archive_key": "documents/3592d072525ce11938f51086292e3c38e99222a1bf24f3425d6dc450b4800681.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785505198\"", "last_modified": "Fri, 31 Jul 2026 13:39:58 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2536, "changed_paragraphs": 44, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f0fbcc6f8fb76ac82d15ddb0", "medicine_id": "EMEA/H/C/002839", "medicine_name": "Odomzo", "medicine_slug": "odomzo", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/odomzo-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-17", "first_observed_at": "2026-10-12T19:03:12Z", "last_observed_at": "2026-10-12T19:03:12Z", "sha256": "7f5b0430359bd63f3eeadf9b1fe28ca85960b0bb5d6b974c806d7ae096822ea2", "format": "docx", "archive_key": "documents/7f5b0430359bd63f3eeadf9b1fe28ca85960b0bb5d6b974c806d7ae096822ea2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763390764\"", "last_modified": "Mon, 17 Nov 2025 14:46:04 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1460, "changed_paragraphs": 0, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f17f3851e8eda9452c21fbe7", "medicine_id": "EMEA/H/C/005454", "medicine_name": "Rybrevant", "medicine_slug": "rybrevant", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rybrevant-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-29", "first_observed_at": "2026-10-12T19:04:12Z", "last_observed_at": "2026-10-12T19:04:12Z", "sha256": "9aa934a48518b69f018f71c82168012a9f9d72adc1ba01912c663610d73a23fb", "format": "docx", "archive_key": "documents/9aa934a48518b69f018f71c82168012a9f9d72adc1ba01912c663610d73a23fb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761737118\"", "last_modified": "Wed, 29 Oct 2025 11:25:18 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3834, "changed_paragraphs": 22, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f1d16a06ac4c68f0e5ff9294", "medicine_id": "EMEA/H/C/002679", "medicine_name": "Ultibro Breezhaler", "medicine_slug": "ultibro-breezhaler", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/ultibro-breezhaler-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-25", "first_observed_at": "2026-10-12T19:22:54Z", "last_observed_at": "2026-10-12T19:22:54Z", "sha256": "1534af9e5e3a20baf83a63b142c8f06cb96a21d3d33ab5c9ae9334dd02433392", "format": "docx", "archive_key": "documents/1534af9e5e3a20baf83a63b142c8f06cb96a21d3d33ab5c9ae9334dd02433392.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753433062\"", "last_modified": "Fri, 25 Jul 2025 08:44:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1933, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f1eb4a92e0b38587fb4bd033", "medicine_id": "EMEA/H/C/000690", "medicine_name": "Nexavar", "medicine_slug": "nexavar", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nexavar-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-03-28", "first_observed_at": "2026-10-12T19:46:46Z", "last_observed_at": "2026-10-12T19:46:46Z", "sha256": "f674c06ce762276be6432e22856bfdc4bf30bfd2dddba754df81a1696f1fda82", "format": "docx", "archive_key": "documents/f674c06ce762276be6432e22856bfdc4bf30bfd2dddba754df81a1696f1fda82.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1743404133\"", "last_modified": "Mon, 31 Mar 2025 06:55:33 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1400, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-f20a60110d1f8fef5225317d", "medicine_id": "EMEA/H/C/003746", "medicine_name": "Otezla", "medicine_slug": "otezla", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/otezla-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-04", "first_observed_at": "2026-10-12T19:00:30Z", "last_observed_at": "2026-10-12T19:00:30Z", "sha256": "35ab6716aa09492c14ac6849111486ec47235c0bc65ef055350de950f316c5e6", "format": "docx", "archive_key": "documents/35ab6716aa09492c14ac6849111486ec47235c0bc65ef055350de950f316c5e6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772619963\"", "last_modified": "Wed, 04 Mar 2026 10:26:03 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2381, "changed_paragraphs": 29, "unassigned_changed_paragraphs": 16 }, "pipeline_version": "2.0.0" }, { "id": "source-f214103729c0fbdc694704c3", "medicine_id": "EMEA/H/C/002211", "medicine_name": "Eklira Genuair", "medicine_slug": "eklira-genuair", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eklira-genuair-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-07-29", "first_observed_at": "2026-10-12T19:20:08Z", "last_observed_at": "2026-10-12T19:20:08Z", "sha256": "c5b8c9c366a8549f659f4f4d33d5264ec342ab8de1bb678068aa787a18ff0cd1", "format": "doc", "archive_key": "documents/c5b8c9c366a8549f659f4f4d33d5264ec342ab8de1bb678068aa787a18ff0cd1.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753796366\"", "last_modified": "Tue, 29 Jul 2025 13:39:26 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-f2349fd2163f253f870bf7c6", "medicine_id": "EMEA/H/C/000829", "medicine_name": "Pradaxa", "medicine_slug": "pradaxa", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pradaxa-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-24", "first_observed_at": "2026-10-12T17:30:35Z", "last_observed_at": "2026-10-12T17:30:35Z", "sha256": "d276833360d6cae8a9547acda5aba26bb28d75f09a11023b2bbed7a00329c7d6", "format": "docx", "archive_key": "documents/d276833360d6cae8a9547acda5aba26bb28d75f09a11023b2bbed7a00329c7d6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763975202\"", "last_modified": "Mon, 24 Nov 2025 09:06:42 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 11021, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f24662fc62565b2f69d88192", "medicine_id": "EMEA/H/C/003970", "medicine_name": "Pemetrexed Pfizer (previously Pemetrexed Hospira)", "medicine_slug": "pemetrexed-pfizer-previously-pemetrexed-hospira", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/pemetrexed-pfizer-previously-pemetrexed-hospira-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-17", "first_observed_at": "2026-10-12T19:10:48Z", "last_observed_at": "2026-10-12T19:10:48Z", "sha256": "746d924df56a85ae9d78d8d14e8959d8c0998bb9cab53f5372d8d9e2d9a28758", "format": "docx", "archive_key": "documents/746d924df56a85ae9d78d8d14e8959d8c0998bb9cab53f5372d8d9e2d9a28758.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758097819\"", "last_modified": "Wed, 17 Sep 2025 08:30:19 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3292, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f253dfba07352f7dfac1b8d5", "medicine_id": "EMEA/H/C/004008", "medicine_name": "Aripiprazole Sandoz", "medicine_slug": "aripiprazole-sandoz", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aripiprazole-sandoz-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-13", "first_observed_at": "2026-10-12T13:40:24Z", "last_observed_at": "2026-10-12T13:40:24Z", "sha256": "f37989cf0022eda124c29183d5f5f16cecbd0193cbe3f6751427982688c92a40", "format": "docx", "archive_key": "documents/f37989cf0022eda124c29183d5f5f16cecbd0193cbe3f6751427982688c92a40.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776077574\"", "last_modified": "Mon, 13 Apr 2026 10:52:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2592, "changed_paragraphs": 34, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f25d8f37d303c556083a8ab6", "medicine_id": "EMEA/H/C/001087", "medicine_name": "Olazax", "medicine_slug": "olazax", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olazax-epar-product-information-tracked-changes_en.doc", "source_updated_at": "2026-05-11", "first_observed_at": "2026-10-12T13:36:46Z", "last_observed_at": "2026-10-12T13:36:46Z", "sha256": "ce5c5a9e7ca151d7405d86429822e85afdbbe2b0ce35086b30b8ca5ca630de01", "format": "doc", "archive_key": "documents/ce5c5a9e7ca151d7405d86429822e85afdbbe2b0ce35086b30b8ca5ca630de01.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1778507305\"", "last_modified": "Mon, 11 May 2026 13:48:25 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-f2d8ec77d7be334b947183c9", "medicine_id": "EMEA/H/C/000435", "medicine_name": "Zavesca", "medicine_slug": "zavesca", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zavesca-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-09", "first_observed_at": "2026-10-12T13:33:28Z", "last_observed_at": "2026-10-12T13:33:28Z", "sha256": "dae1a59376c1452382419127cec319aba0ec1962b31891c00977a1f854e61c01", "format": "docx", "archive_key": "documents/dae1a59376c1452382419127cec319aba0ec1962b31891c00977a1f854e61c01.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1783603009\"", "last_modified": "Thu, 09 Jul 2026 13:16:49 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1024, "changed_paragraphs": 141, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-f2ddc26a0327bdd9c5fbb681", "medicine_id": "EMEA/H/C/002202", "medicine_name": "Gilenya", "medicine_slug": "gilenya", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/gilenya-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-07-30", "first_observed_at": "2026-10-12T13:30:10Z", "last_observed_at": "2026-10-12T13:30:10Z", "sha256": "053aa2713a90977cd5ae2327e9eac4493b27f05184691e9500a3630c2a86d105", "format": "docx", "archive_key": "documents/053aa2713a90977cd5ae2327e9eac4493b27f05184691e9500a3630c2a86d105.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785412226\"", "last_modified": "Thu, 30 Jul 2026 11:50:26 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2628, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-f34b78f381a5e027cfbe1fe6", "medicine_id": "EMEA/H/C/002547", "medicine_name": "Perjeta", "medicine_slug": "perjeta", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/perjeta-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-28", "first_observed_at": "2026-10-12T13:39:17Z", "last_observed_at": "2026-10-12T13:39:17Z", "sha256": "cb28465c58604d0b3ae410ab4b7f20b7947f60bdf7475f845ec18185037e8ea6", "format": "docx", "archive_key": "documents/cb28465c58604d0b3ae410ab4b7f20b7947f60bdf7475f845ec18185037e8ea6.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1777364388\"", "last_modified": "Tue, 28 Apr 2026 08:19:48 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1784, "changed_paragraphs": 81, "unassigned_changed_paragraphs": 7 }, "pipeline_version": "2.0.0" }, { "id": "source-f49c10868b6a3660618b0126", "medicine_id": "EMEA/H/C/005818", "medicine_name": "Uplizna", "medicine_slug": "uplizna", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/uplizna-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-11-27", "first_observed_at": "2026-10-12T17:29:53Z", "last_observed_at": "2026-10-12T17:29:53Z", "sha256": "fdcad64e4130a5cab6d12eb2ae37e0c3ca0c811f827d999a8cd90e40ff43267b", "format": "docx", "archive_key": "documents/fdcad64e4130a5cab6d12eb2ae37e0c3ca0c811f827d999a8cd90e40ff43267b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764241885\"", "last_modified": "Thu, 27 Nov 2025 11:11:25 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1650, "changed_paragraphs": 314, "unassigned_changed_paragraphs": 10 }, "pipeline_version": "2.0.0" }, { "id": "source-f50536b23ca95ff95f71dd38", "medicine_id": "EMEA/H/C/005386", "medicine_name": "Phesgo", "medicine_slug": "phesgo", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/phesgo-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-10-28", "first_observed_at": "2026-10-12T19:04:32Z", "last_observed_at": "2026-10-12T19:04:32Z", "sha256": "731d9e2cd6114fa554c8d21517a3b069ac619f60e3b1e54370b6c0a8e711e058", "format": "docx", "archive_key": "documents/731d9e2cd6114fa554c8d21517a3b069ac619f60e3b1e54370b6c0a8e711e058.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1761661254\"", "last_modified": "Tue, 28 Oct 2025 14:20:54 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2438, "changed_paragraphs": 278, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-f5322b1394a7bd110d904829", "medicine_id": "EMEA/H/C/002389", "medicine_name": "Kadcyla", "medicine_slug": "kadcyla", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/kadcyla-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-03-26", "first_observed_at": "2026-10-12T19:47:18Z", "last_observed_at": "2026-10-12T19:47:18Z", "sha256": "990d83ef143daea413153a5d1e5b9b4e44f929105e709d49547e55fc2c69676e", "format": "docx", "archive_key": "documents/990d83ef143daea413153a5d1e5b9b4e44f929105e709d49547e55fc2c69676e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1742989877\"", "last_modified": "Wed, 26 Mar 2025 11:51:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1993, "changed_paragraphs": 413, "unassigned_changed_paragraphs": 11 }, "pipeline_version": "2.0.0" }, { "id": "source-f5df4e8e817e8d851e05c697", "medicine_id": "EMEA/H/C/004771", "medicine_name": "Imfinzi", "medicine_slug": "imfinzi", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/imfinzi-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-02-19", "first_observed_at": "2026-10-12T19:01:29Z", "last_observed_at": "2026-10-12T19:01:29Z", "sha256": "46a75ede1fd69a8882c6ca1703b3ce4ad577bd54d8e9ab16ecdd434e52200045", "format": "docx", "archive_key": "documents/46a75ede1fd69a8882c6ca1703b3ce4ad577bd54d8e9ab16ecdd434e52200045.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1771513877\"", "last_modified": "Thu, 19 Feb 2026 15:11:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 4685, "changed_paragraphs": 2, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-f614968be5cd56b9fe63ca36", "medicine_id": "EMEA/H/C/000338", "medicine_name": "Trizivir", "medicine_slug": "trizivir", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/trizivir-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-01-19", "first_observed_at": "2026-10-12T17:26:52Z", "last_observed_at": "2026-10-12T17:26:52Z", "sha256": "5918b624a0dd76d2fd01e258a05f77b7fa5395dbe1676ed085e1af8fe8011b0e", "format": "docx", "archive_key": "documents/5918b624a0dd76d2fd01e258a05f77b7fa5395dbe1676ed085e1af8fe8011b0e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1768816649\"", "last_modified": "Mon, 19 Jan 2026 09:57:29 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2122, "changed_paragraphs": 59, "unassigned_changed_paragraphs": 14 }, "pipeline_version": "2.0.0" }, { "id": "source-f6d71497d5a07722cd3a4024", "medicine_id": "EMEA/H/C/001058", "medicine_name": "Zyllt", "medicine_slug": "zyllt", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zyllt-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-05-14", "first_observed_at": "2026-10-12T19:39:25Z", "last_observed_at": "2026-10-12T19:39:25Z", "sha256": "a9c161a11d8945619860c96eeebfd5be900a3b67c54f818a3854e62860ccbc35", "format": "docx", "archive_key": "documents/a9c161a11d8945619860c96eeebfd5be900a3b67c54f818a3854e62860ccbc35.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1747206084\"", "last_modified": "Wed, 14 May 2025 07:01:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1290, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f6dcfff809498910a6b321e7", "medicine_id": "EMEA/H/C/000958", "medicine_name": "Stelara", "medicine_slug": "stelara", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/stelara-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-08-18", "first_observed_at": "2026-10-12T13:28:47Z", "last_observed_at": "2026-10-12T13:28:47Z", "sha256": "223b087541b035bf595b883823a1738a2f9006e4d21f8d9e30dd814609e4bce2", "format": "docx", "archive_key": "documents/223b087541b035bf595b883823a1738a2f9006e4d21f8d9e30dd814609e4bce2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1787061225\"", "last_modified": "Tue, 18 Aug 2026 13:53:45 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 8077, "changed_paragraphs": 270, "unassigned_changed_paragraphs": 14 }, "pipeline_version": "2.0.0" }, { "id": "source-f711dc069eae54d150373681", "medicine_id": "EMEA/H/C/003983", "medicine_name": "Nordimet", "medicine_slug": "nordimet", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nordimet-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-07-17", "first_observed_at": "2026-10-12T19:23:38Z", "last_observed_at": "2026-10-12T19:23:38Z", "sha256": "25d22351081aee73fdf7e08f96b6bba2f1ddc4530ae1ea59595c58160a048e43", "format": "docx", "archive_key": "documents/25d22351081aee73fdf7e08f96b6bba2f1ddc4530ae1ea59595c58160a048e43.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1752771204\"", "last_modified": "Thu, 17 Jul 2025 16:53:24 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 6643, "changed_paragraphs": 79, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f74dcef904cc632f29edd823", "medicine_id": "EMEA/H/C/006315", "medicine_name": "Nilotinib Accord", "medicine_slug": "nilotinib-accord", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/nilotinib-accord-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-27", "first_observed_at": "2026-10-12T19:15:27Z", "last_observed_at": "2026-10-12T19:15:27Z", "sha256": "bba909856e6ea7547e61362d98a9de24327a31121609bfbe8fe4a7965de6e3de", "format": "docx", "archive_key": "documents/bba909856e6ea7547e61362d98a9de24327a31121609bfbe8fe4a7965de6e3de.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1756309981\"", "last_modified": "Wed, 27 Aug 2025 15:53:01 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2966, "changed_paragraphs": 8, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f769d3a3b71962e9225efefc", "medicine_id": "EMEA/H/C/002173", "medicine_name": "Xgeva", "medicine_slug": "xgeva", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/xgeva-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-30", "first_observed_at": "2026-10-12T13:33:58Z", "last_observed_at": "2026-10-12T13:33:58Z", "sha256": "e8b324ef2257008b51e8b910d5a97a2bc87dbd7cab73aa445585c85b9bdacdd0", "format": "docx", "archive_key": "documents/e8b324ef2257008b51e8b910d5a97a2bc87dbd7cab73aa445585c85b9bdacdd0.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1782816881\"", "last_modified": "Tue, 30 Jun 2026 10:54:41 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2303, "changed_paragraphs": 20, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f7b68dcb050a536d8586dbbc", "medicine_id": "EMEA/H/C/002679", "medicine_name": "Ultibro Breezhaler", "medicine_slug": "ultibro-breezhaler", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/ultibro-breezhaler-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-07-25", "first_observed_at": "2026-10-12T19:22:58Z", "last_observed_at": "2026-10-12T19:22:58Z", "sha256": "7a8e17b6e96d132586ba251b55a8df6963d974237bd2c26e711f797281eae3e2", "format": "docx", "archive_key": "documents/7a8e17b6e96d132586ba251b55a8df6963d974237bd2c26e711f797281eae3e2.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1753433062\"", "last_modified": "Fri, 25 Jul 2025 08:44:22 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1947, "changed_paragraphs": 25, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f7c26df9492b886958386672", "medicine_id": "EMEA/H/C/000313", "medicine_name": "Aerius", "medicine_slug": "aerius", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/aerius-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-19", "first_observed_at": "2026-10-12T13:47:23Z", "last_observed_at": "2026-10-12T13:47:23Z", "sha256": "8089714a236ecbb1faa000fb644ac965ee1e9f984f6c5143625f5e9e54bac743", "format": "docx", "archive_key": "documents/8089714a236ecbb1faa000fb644ac965ee1e9f984f6c5143625f5e9e54bac743.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773917894\"", "last_modified": "Thu, 19 Mar 2026 10:58:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1880, "changed_paragraphs": 38, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f85d2111b5e1c18a6ab8027e", "medicine_id": "EMEA/H/C/000715", "medicine_name": "Lucentis", "medicine_slug": "lucentis", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lucentis-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-10-08", "first_observed_at": "2026-10-12T12:55:14Z", "last_observed_at": "2026-10-12T12:56:44Z", "sha256": "2258e54d672ce23513dcfdf067fa41c102c485fdf481a19758666450c867671e", "format": "docx", "archive_key": "documents/2258e54d672ce23513dcfdf067fa41c102c485fdf481a19758666450c867671e.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1791453645\"", "last_modified": "Thu, 08 Oct 2026 10:00:45 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3890, "changed_paragraphs": 38, "unassigned_changed_paragraphs": 2 }, "pipeline_version": "2.0.0" }, { "id": "source-f877ac6802936d81f763050f", "medicine_id": "EMEA/H/C/005304", "medicine_name": "Beyfortus", "medicine_slug": "beyfortus", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/beyfortus-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-06-17", "first_observed_at": "2026-10-12T19:35:14Z", "last_observed_at": "2026-10-12T19:35:14Z", "sha256": "b66eef75d4a6bf444085a7ac6e52784f998d961b9cf88de85b089c5975eba5c3", "format": "docx", "archive_key": "documents/b66eef75d4a6bf444085a7ac6e52784f998d961b9cf88de85b089c5975eba5c3.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750171336\"", "last_modified": "Tue, 17 Jun 2025 14:42:16 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1224, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f8af93bde444dc30d01f0a12", "medicine_id": "EMEA/H/C/000917", "medicine_name": "Zarzio", "medicine_slug": "zarzio", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zarzio-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-06-05", "first_observed_at": "2026-10-12T13:36:11Z", "last_observed_at": "2026-10-12T13:36:11Z", "sha256": "51d80b39d33523efaa2f2e8b5daf45ee3bba97f334c746631ab8a9aebbe7ce22", "format": "docx", "archive_key": "documents/51d80b39d33523efaa2f2e8b5daf45ee3bba97f334c746631ab8a9aebbe7ce22.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1780667435\"", "last_modified": "Fri, 05 Jun 2026 13:50:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1770, "changed_paragraphs": 1, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f92eb4804a196dfcc12278a6", "medicine_id": "EMEA/H/C/005898", "medicine_name": "Orserdu", "medicine_slug": "orserdu", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/orserdu-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-03-25", "first_observed_at": "2026-10-12T13:46:42Z", "last_observed_at": "2026-10-12T13:46:42Z", "sha256": "d5cdfca93c729744512a59e7e56b0160dd70975109dc5a576a9c5e79e2eccbfd", "format": "docx", "archive_key": "documents/d5cdfca93c729744512a59e7e56b0160dd70975109dc5a576a9c5e79e2eccbfd.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1774450440\"", "last_modified": "Wed, 25 Mar 2026 14:54:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1221, "changed_paragraphs": 4, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f9cee1a032291fa10f55a891", "medicine_id": "EMEA/H/C/003794", "medicine_name": "Strensiq", "medicine_slug": "strensiq", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/strensiq-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-03-18", "first_observed_at": "2026-10-12T13:49:10Z", "last_observed_at": "2026-10-12T13:49:10Z", "sha256": "1bb7c73286f57e11c88682980aa6f9ee26ad231f7581e9da57e308f067ba93fb", "format": "docx", "archive_key": "documents/1bb7c73286f57e11c88682980aa6f9ee26ad231f7581e9da57e308f067ba93fb.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1773842766\"", "last_modified": "Wed, 18 Mar 2026 14:06:06 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2255, "changed_paragraphs": 200, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-f9d1076b715f6519d207fadb", "medicine_id": "EMEA/H/C/000807", "medicine_name": "Eucreas", "medicine_slug": "eucreas", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/eucreas-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-12-08", "first_observed_at": "2026-10-12T17:28:48Z", "last_observed_at": "2026-10-12T17:28:48Z", "sha256": "d59a28863ac2d9c2278587c4b2c6d41894a855d0cf22a982e0110d39d445a95d", "format": "docx", "archive_key": "documents/d59a28863ac2d9c2278587c4b2c6d41894a855d0cf22a982e0110d39d445a95d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1764940569\"", "last_modified": "Fri, 05 Dec 2025 13:16:09 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1841, "changed_paragraphs": 39, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-fa766d966dea704c333b9969", "medicine_id": "EMEA/H/C/002702", "medicine_name": "Hexacima", "medicine_slug": "hexacima", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/hexacima-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-29", "first_observed_at": "2026-10-12T19:07:04Z", "last_observed_at": "2026-10-12T19:07:04Z", "sha256": "44c8996457a718019c75b8322ba07a5ae7af36377b1a6f1cf4ca5a30f9b72c23", "format": "docx", "archive_key": "documents/44c8996457a718019c75b8322ba07a5ae7af36377b1a6f1cf4ca5a30f9b72c23.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759145794\"", "last_modified": "Mon, 29 Sep 2025 11:36:34 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2146, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 1 }, "pipeline_version": "2.0.0" }, { "id": "source-fc5f396b773e2ce2361a4ea2", "medicine_id": "EMEA/H/C/002829", "medicine_name": "Cyramza", "medicine_slug": "cyramza", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cyramza-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-06-18", "first_observed_at": "2026-10-12T19:31:10Z", "last_observed_at": "2026-10-12T19:31:10Z", "sha256": "a7dbfe2516b330337c471624de6f529d539aca7620e7282bbc16b09bdbd63e2f", "format": "docx", "archive_key": "documents/a7dbfe2516b330337c471624de6f529d539aca7620e7282bbc16b09bdbd63e2f.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1750239674\"", "last_modified": "Wed, 18 Jun 2025 09:41:14 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2020, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 3 }, "pipeline_version": "2.0.0" }, { "id": "source-fc7809f4cbc58386db5fb631", "medicine_id": "EMEA/H/C/002695", "medicine_name": "Iclusig", "medicine_slug": "iclusig", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/iclusig-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-07-31", "first_observed_at": "2026-10-12T13:29:40Z", "last_observed_at": "2026-10-12T13:29:40Z", "sha256": "835939e8841a039c75ad2b71ddde4acef2e5acd9a5e0a25b63e6774a75837088", "format": "docx", "archive_key": "documents/835939e8841a039c75ad2b71ddde4acef2e5acd9a5e0a25b63e6774a75837088.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1785510182\"", "last_modified": "Fri, 31 Jul 2026 15:03:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5284, "changed_paragraphs": 2473, "unassigned_changed_paragraphs": 233 }, "pipeline_version": "2.0.0" }, { "id": "source-fcf8c5a834ee9c65d6a0ffd1", "medicine_id": "EMEA/H/C/001110", "medicine_name": "Revolade", "medicine_slug": "revolade", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/revolade-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-02-26", "first_observed_at": "2026-10-12T19:00:55Z", "last_observed_at": "2026-10-12T19:00:55Z", "sha256": "6b9f4ac47a3142f01fa9b1b3a0a492489bdb9a7be4121dbc6404de187bc02b9d", "format": "docx", "archive_key": "documents/6b9f4ac47a3142f01fa9b1b3a0a492489bdb9a7be4121dbc6404de187bc02b9d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1772096117\"", "last_modified": "Thu, 26 Feb 2026 08:55:17 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 5888, "changed_paragraphs": 6, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-fe09cd2dc16c35513064ef0d", "medicine_id": "EMEA/H/C/005188", "medicine_name": "Yuflyma", "medicine_slug": "yuflyma", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/yuflyma-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-09-29", "first_observed_at": "2026-10-12T19:06:41Z", "last_observed_at": "2026-10-12T19:06:41Z", "sha256": "5a101acc864f0889659ef981ca8eb6a99f3bf8834e486f11348c303ffbb5d75d", "format": "docx", "archive_key": "documents/5a101acc864f0889659ef981ca8eb6a99f3bf8834e486f11348c303ffbb5d75d.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1759132167\"", "last_modified": "Mon, 29 Sep 2025 07:49:27 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 12687, "changed_paragraphs": 81, "unassigned_changed_paragraphs": 68 }, "pipeline_version": "2.0.0" }, { "id": "source-fe0a18f5b9a3ab5d484ff430", "medicine_id": "EMEA/H/C/002322", "medicine_name": "Forxiga", "medicine_slug": "forxiga", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/forxiga-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2026-04-22", "first_observed_at": "2026-10-12T13:40:01Z", "last_observed_at": "2026-10-12T13:40:01Z", "sha256": "540ea105ea32cfc32c336c77246c9091551ce451c64a4a9654632340499b4667", "format": "docx", "archive_key": "documents/540ea105ea32cfc32c336c77246c9091551ce451c64a4a9654632340499b4667.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1776862175\"", "last_modified": "Wed, 22 Apr 2026 12:49:35 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2359, "changed_paragraphs": 17, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-fed2f7865d777cc52aa00a0f", "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2026-04-01", "first_observed_at": "2026-10-12T13:40:56Z", "last_observed_at": "2026-10-12T13:40:56Z", "sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "format": "docx", "archive_key": "documents/1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1775036893\"", "last_modified": "Wed, 01 Apr 2026 09:48:13 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1721, "changed_paragraphs": 49, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-fee9b9b02727587897fc30fc", "medicine_id": "EMEA/H/C/004644", "medicine_name": "Prasugrel Viatris (previously Prasugrel Mylan)", "medicine_slug": "prasugrel-viatris-previously-prasugrel-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/prasugrel-viatris-previously-prasugrel-mylan-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-26", "first_observed_at": "2026-10-12T19:07:47Z", "last_observed_at": "2026-10-12T19:07:47Z", "sha256": "acf933abde5473934b61c8ca6240a4468e73048b3490911740cacaf6076db16b", "format": "docx", "archive_key": "documents/acf933abde5473934b61c8ca6240a4468e73048b3490911740cacaf6076db16b.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1758895742\"", "last_modified": "Fri, 26 Sep 2025 14:09:02 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1787, "changed_paragraphs": 7, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ff374e236a5e5c8d097f6178", "medicine_id": "EMEA/H/C/004879", "medicine_name": "Amsparity", "medicine_slug": "amsparity", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/amsparity-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-05", "first_observed_at": "2026-10-12T19:15:12Z", "last_observed_at": "2026-10-12T19:15:12Z", "sha256": "24d0cc9d1a51b9be434880981aaadecfd5acfad769bf26ba5172cf74b57f6266", "format": "docx", "archive_key": "documents/24d0cc9d1a51b9be434880981aaadecfd5acfad769bf26ba5172cf74b57f6266.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757079270\"", "last_modified": "Fri, 05 Sep 2025 13:34:30 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 10850, "changed_paragraphs": 31, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ff48b23a80b98be4c15aa440", "medicine_id": "EMEA/H/C/004025", "medicine_name": "Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan)", "medicine_slug": "lopinavir-ritonavir-viatris-previously-ritonavir-mylan", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/lopinavir-ritonavir-viatris-epar-product-information-tracked-changes_fr.docx", "source_updated_at": "2025-09-08", "first_observed_at": "2026-10-12T19:14:59Z", "last_observed_at": "2026-10-12T19:14:59Z", "sha256": "d782e33ec97bc43bb54f942c83f07f89482c9a433e3846beaffe05b4a52b4b36", "format": "docx", "archive_key": "documents/d782e33ec97bc43bb54f942c83f07f89482c9a433e3846beaffe05b4a52b4b36.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1757337480\"", "last_modified": "Mon, 08 Sep 2025 13:18:00 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 3456, "changed_paragraphs": 11, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ff8e0599077f0d01044dc867", "medicine_id": "EMEA/H/C/002097", "medicine_name": "Fampyra", "medicine_slug": "fampyra", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fampyra-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-08-21", "first_observed_at": "2026-10-12T19:15:51Z", "last_observed_at": "2026-10-12T19:15:51Z", "sha256": "d9fe8aaaa611a84801d6308b13685258b5248df9022536697939afdf66fc1719", "format": "docx", "archive_key": "documents/d9fe8aaaa611a84801d6308b13685258b5248df9022536697939afdf66fc1719.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1755781911\"", "last_modified": "Thu, 21 Aug 2025 13:11:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 1635, "changed_paragraphs": 194, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" }, { "id": "source-ffe73c4dec44585125ce5eed", "medicine_id": "EMEA/H/C/000274", "medicine_name": "Orgalutran", "medicine_slug": "orgalutran", "language": "fr", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/orgalutran-epar-product-information-tracked-changes_fr.doc", "source_updated_at": "2025-12-18", "first_observed_at": "2026-10-12T17:27:43Z", "last_observed_at": "2026-10-12T17:27:43Z", "sha256": "2d9e439bea9a7077e081fe09c2c663cb7dbf7658041fd804d297ecf09dd78ffd", "format": "doc", "archive_key": "documents/2d9e439bea9a7077e081fe09c2c663cb7dbf7658041fd804d297ecf09dd78ffd.doc", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1766057443\"", "last_modified": "Thu, 18 Dec 2025 11:30:43 GMT", "comparison_basis": "word_tracked_revisions" }, { "id": "source-ffe8d8ad10c37b3e6d189f90", "medicine_id": "EMEA/H/C/005067", "medicine_name": "Atectura Breezhaler", "medicine_slug": "atectura-breezhaler", "language": "en", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/atectura-breezhaler-epar-product-information-tracked-changes_en.docx", "source_updated_at": "2025-11-20", "first_observed_at": "2026-10-12T17:31:00Z", "last_observed_at": "2026-10-12T17:31:00Z", "sha256": "133bd0404bdbff170159599404a23d36243637d8eae9c8dfe7cb9f3894ad2fdf", "format": "docx", "archive_key": "documents/133bd0404bdbff170159599404a23d36243637d8eae9c8dfe7cb9f3894ad2fdf.docx", "archive_public_url": null, "archive_available_locally": true, "etag": "\"1763636991\"", "last_modified": "Thu, 20 Nov 2025 11:09:51 GMT", "comparison_basis": "word_tracked_revisions", "extraction": { "paragraphs": 2808, "changed_paragraphs": 14, "unassigned_changed_paragraphs": 0 }, "pipeline_version": "2.0.0" } ]